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1. Zusammenfassung 
Der Bedarf an biopharmazeutischen Produkten für neuartige medizinische Anwendungen und 
klinische Studien wächst permanent. Biotherapeutika sind häufig rekombinante Proteine, wie 
zum Beispiel monoklonale Antikörper, welche meist in Säugerzellkultur produziert werden, um 
möglichst menschenähnliche posttranslationale Modifizierungen zu erhalten. Chinese hamster 
ovary (CHO) Zellen sind sehr gebräuchliche Wirtszelllinien, da sie aus behördlicher Sicht weder 
infektiös noch pathogen sind. Allerdings ist die Gewinnung von Produktionszelllinien sehr zeit- 
und arbeitsaufwendig und damit teuer. Deshalb sind viele pharmazeutische Unternehmen daran 
interessiert, diese zu beschleunigen und Kosten zu sparen. In diesem Zusammenhang war es 
das Ziel der vorliegenden Arbeit, eine produktunabhängige Plattformtechnologie für die 
Entwicklung und Selektion von hochproduktiven Klonen zu verbessern. 
Es wurde berichtet, dass einer der geschwindigkeitsbestimmenden Schritte bei der Produktion 
von sekretorischen Proteinen die Translokation in das Lumen des Endoplasmatischen 
Retikulums (ER) ist. Der erste Teil der Arbeit beschäftigt sich daher mit der Optimierung der 
Sekretionseffizienz. Dazu wurden verschiedene natürliche und künstliche Signalpeptide mit 
einem rekombinanten Antikörper fusioniert und in transienten Experimenten getestet. Die 
vielversprechendsten Kandidaten wurden, um ihre Leistungsfähigkeit weiter zu verbessern, 
gezielt mutiert. Interessanterweise konnte die Effizienz der Signalpeptide dadurch nicht erhöht 
werden. Die besten Ergebnisse wurden folglich mit den natürlichen Albumin- und Azurocidin-
Signalpeptiden erzeugt. Diese Ergebnisse wurden in fed-batch-Experimenten mit stabil 
transfizierten Zellpools bestätigt, wobei durch die Verwendung des Albumin-Signalpeptides 
zellspezifische Produktivität von bis zu 90 pg/Zelle/Tag und Produktkonzentrationen von bis zu 
4 g/L gemessen werden konnten. Der Fakt, dass diese Ergebnisse mit nicht optimierten fed-
batch-Prozessen unter der Verwendung von Zellpools anstatt von klonalen Zelllinien erzeugt 
wurden, zeigt eindrucksvoll, welches Potenzial die identifizierten Signalpeptide haben.  
Die Selektion von Klonen mit hoher Produktivität ist momentan einer der arbeits- und 
zeitaufwendigsten Schritte während der Entwicklung von Zelllinien zur Produktion von 
rekombinanten Proteinen. Daher war es im zweiten Teil der Arbeit das Ziel ein neuartiges 
Selektionssystem zu entwickeln, welches eine einfache und schnelle Identifikation und Isolation 
von hochproduktiven Klonen aus einem Zellpool erlaubt. Der Grundgedanke war dabei, dass 
die Überexpression von rekombinanten sekretorischen Proteinen ER Stress auslöst, welcher 
gemessen und zur Identifikation von hochproduktiven Klonen benutzt werden kann. Dazu 
wurden in einem Vorexperiment verschiedene Klone, welche unterschiedliche Mengen eines 
rekombinanten Antikörpers bilden, mittels Echtzeit RT-PCR untersucht. Dabei wurde eine 
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Korrelation zwischen der gebildeten Antikörpermenge und der Menge an mRNA für 
verschiedene ER Stress-Faktoren, wie zum Beispiel CALR, GRP78, GRP94 und XBP1 
(gespleißt), beobachtet. Basierend auf diesen Ergebnissen wurden verschiedene ER Stress-
Reporter-Konstrukte generiert. Diese bestanden aus GFP, welches entweder mit den 
natürlichen CALR, GRP78 und GRP94 Promotern oder einem SV40 Promoter, in Kombination 
mit verschiedenen ER Stress assoziierten Transkriptionsfaktor-Bindungsstellen (ERSE I, 
ERSE II, UPRE und AARE), zur Expression gebracht wurde. Zusätzlich wurde ein Reporter-
Konstrukt bestehend aus einem modifizierten GFP und einen XBP1 Fragment inklusive eines 
Introns generiert. Um die Leistungsfähigkeit aller Reporter-Konstrukte zu testen, wurden diese 
in Antikörper bildende und in Kontrollzellen ohne Antikörperexpression eingebracht und ihre 
GFP Fluoreszenz gemessen. Die Vergleichbarkeit wurde dabei durch die gezielte Integration 
(Rekombinase-vermittelten Kassettenaustausch) der Reporter-Konstrukte in denselben 
Integrationslokus gewährleistet. Auf diese Weise konnte gezeigt werden, dass weder die ER 
Stress-Response-Elemente (ERSE I, ERSE II, UPRE und AARE) noch der CALR, der GRP94 
Promoter oder das XBP1 Fragment signifikant durch die Antikörperbildung stimuliert wurden. Im 
Gegensatz dazu wurde eine starke Stimulation des GRP78 Promoters durch die 
Antikörperexpression beobachtet. Daraufhin wurde ein verkürzter GRP78 Promoter in einen 
GFP Reporter eingebracht und stabil in CHO DG44 Zellen integriert. Danach wurde in diese 
Zelllinien ein rekombinanter Antikörper eingebracht und eine standardisierte 
Zelllinienentwicklung durchgeführt. Die isolierten Klone zeigten erneut eine starke Korrelation 
zwischen der gebildeten Antikörpermenge und der gemessen GFP Fluoreszenz. Daher kann 
geschlussfolgert werden, dass der GRP78 Reporter in einem ER Stress basierten 
Selektionssystem für die Identifizierung und Isolierung von hochproduktiven Klonen eingesetzt 
werden kann. 
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2. Abstract  
The demand for biopharmaceutical drugs for novel medical applications and clinical trials 
increases permanently. Common biotherapeutics are recombinant proteins such as monoclonal 
antibodies which are mostly produced in mammalian cell cultures in order to obtain human-like 
post-translational modifications. Chinese hamster ovary (CHO) cells are widely used as host cell 
line because they are accepted by regulatory bodies as safe regarding infectious and 
pathogenic agents. However, the generation of production cell lines is very time-consuming, 
labour-intensive and expensive and pharmaceutical companies are interested in speeding up 
and reducing costs for this process. In this context, it was the aim of the present thesis to 
improve a product-independent platform technology for the development and selection of highly 
productive clones.  
In a first approach, the optimization of secretion efficiency was addressed, because it has been 
reported that the translocation into the lumen of the endoplasmatic reticulum (ER) is one of the 
rate limiting steps during the production of secretory proteins. Therefore, a variety of natural and 
artificial signal peptides were fused to a recombinant antibody and analysed by transient 
expression experiments. The most promising candidates were modified by introducing specific 
mutations to further improve their performance. Interestingly, it was not possible to achieve 
higher efficiencies in this way. Therefore, the best data were obtained with the natural signal 
peptides derived from human albumin and human azurocidin. These results were confirmed by 
fed-batch experiments with stably transfected cell pools, in which cell specific productivities up 
to 90 pg/cell/day and product concentrations of 4 g/L were measured using the albumin signal 
peptide. The fact that these data were generated in a non-optimized fed-batch process with cell 
pools instead of clonal cell lines demonstrates the potency of the identified signal peptides even 
more impressively. 
The selection of high-producing clones is currently one of the most laborious and time-
consuming steps during the development of cell lines expressing recombinant proteins. Thus, 
the second part of the present thesis was aimed at the establishment of a novel selection 
system for the rapid and easy identification and isolation of rare high producers out of cell pools. 
The basic idea of the selection system was that the overexpression of secretory recombinant 
proteins triggers ER stress, which could be measured and used to detect high-producing 
clones. In a preliminary experiment, several clones producing different amounts of a 
recombinant antibody were analysed by real time RT-PCR and a correlation between antibody 
expression and the mRNA level of the ER stress factors CALR, GRP78, GRP94 and spliced 
XBP1 was observed. Based on these results, several ER stress reporter constructs were 
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generated. They consisted of GFP driven either by the natural promoters of CALR, GRP78 and 
GRP94 or by a SV40 promoter in combination with ER stress-related transcription factor binding 
sites (ERSE I, ERSE II, UPRE and AARE). Additionally, a construct with a modified GFP 
version comprising an intron-containing XBP1 fragment was created. In order to evaluate their 
performance, all reporter constructs were once introduced in an antibody expressing producer 
cell line and once in a non-expressing control cell line and GFP fluorescences were determined. 
Comparability was ensured by using a targeted integration (recombinase mediated cassette 
exchange) approach, which allowed the integration of all constructs at the same genomic locus. 
In this way it was demonstrated that neither the ER stress response elements (ERSE I, 
ERSE II, UPRE, AARE) nor the CALR, the GRP94 promoter or the XBP1 fragment were 
significantly stimulated by antibody expression. In contrast, a strong stimulation was observed 
for the GRP78 promoter upon antibody expression. Based on these data, a truncated version of 
the GRP78 promoter was used to create a modified GFP reporter construct, which was stably 
integrated into CHO DG44 cells. Subsequently, the obtained cell line was applied to a standard 
cell line development procedure employing an antibody expression construct. The isolated 
clones showed a strong correlation between the amount of secreted antibody and the measured 
GFP fluorescence. Therefore, it was concluded, that the GRP78 reporter construct can be used 
as ER stress based selection system, which should be suitable for the identification and 
isolation of high producers. 
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3. Introduction 
3.1. High-level production of recombinant proteins in CHO cells 
The demand for biotherapeutics increases permanently, because many biopharmaceutical 
drugs are reaching later stage clinical trials. Most biotherapeutic drugs are recombinant 
monoclonal antibodies which are widely produced in mammalian cell lines (Birch 2006; Dübel 
2007; Winder 2005), because of the need for post-translational modifications (e.g. glycosylation) 
that should be identical or at least similar to those obtained in humans. The chinese hamster 
ovary cell line CHO DG44 is a very suitable expression system for this purpose (Walsh 2006; 
Schmidt 2004) that is accepted by regulatory bodies as safe regarding infectious and 
pathogenic agents (Wagner 2009; Hesse 2000). CHO DG44 cells have a number of intrinsic 
disadvantages causing their cultivation to be complicated, time–consuming and expensive. 
Especially the generation of monoclonal high-producer cell lines has been referred to be a main 
bottleneck in getting the first material required for clinical tests or in getting access to the 
manufacturing environment (Borth et al. 2000; Carroll 2004; Birch 2006). Hence, 
pharmaceutical companies are interested in speeding up and reducing costs for their upstream 
development. One approach is to establish a product-independent platform technology for the 
development of large-scale production processes for therapeutic proteins. Such a platform 
includes an adequate expression and selection system, which allows the generation of stable 
high expression cell lines, corresponding basal and feed media and a process scalable in larger 
bioreactors (Birch 2006). 
One of the most efficient expression and selection systems is based on the enzyme 
dihydrofolate reductase (dhfr), which catalyses the reduction of folic acid (FA) into 7,8-
dihydrofolate (7,8-DHF) and 5,6,7,8-tetrahydrofolate (5,6,7,8-THF) (Bailey 2009). 5,6,7,8-THF is 
required for the de novo biosynthesis of purines, thymidylate, and glycine. Therefore, when dhfr-
deficient CHO DG44 cells are transfected with a vector composed of a GOI and the dhfr-gene 
as a marker, cells expressing the GOI can be selected by cultivating in  medium without 
hypoxanthine, thymidine and glycine. Additionally, cells can be treated with MTX, a competitive 
inhibitor of dhfr, which causes an amplification process leading to increased gene copy numbers 
and thereby to increased productivity (Ludwig 2006; Kaufman 1982). However, it has been 
reported that the productivity of a cell line does not always correlate with its gene copy number 
(Bode 2003; Barnes 2003; Barnes 2004), because the level of transcription depends also on the 
genomic site of integration. Several strategies are used to overcome this so-called position 
effect (Kwaks 2006; Barnes 2006, Birch 2006). For example insulator elements (Recillas-
Targa 2002; Pikaart 1998) and Ubiquitous Chromatin Opening Elements (UCOEs) were 
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successfully applied in order to protect against unwanted transcriptional silencing mediated by 
the chromosomal environment (Harland 2002; Antoniou 2003; Williams 2005; Benton 2002). 
Moreover, Scaffold/Matrix Attachment Regions (S/MARs) (Bode 1992; Heng 2004; 
Boulikas 1993; Hancock 2000; Zahn-Zabal 2001; Kim 2004) and stabilizing and antirepressor 
elements (STAR elements) were implemented in order to block chromatin associated 
transcriptional silencing (Kwaks 2003; Kwaks 2005) or repeat induced silencing (Garrick 1998). 
Other ways to increase protein expression levels are the choice of alternative promoters 
(Addison 1997; Young 2008) or the optimization of the mRNA structure. Especially the removal 
of cryptic splice sites, cryptic poly-A signals and undesired structures such as stem-loops as 
well as the optimization of codon usage and GC content can result in increased productivity 
(Kalwy 2006; Young 2008; Stemmer 1993; Knappskog 2007). Furthermore, it has been reported 
that the rate-limiting step in the expression of proteins might not be the mRNA level, but rather 
inefficiencies in translocation, posttranslational modifications, folding or secretion of 
recombinant proteins (Shuster 1991; Barnes 2004; Birch 2006; Schweickhard 2002 (AU 
2002/338947 B2)). For this purpose, cell engineering tools were used to enhance the capacity 
of mammalian cell lines, e.g. by over-expressing chaperones like protein disulfide isomerase 
(PID) (Borth 2005) or factors related to the secretory pathway like ceramide transfer protein 
(CERT) (Florin 2009; Schlatter 2010 Sep; Schlatter 2010 Oct). 
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3.2. Protein secretion and signal peptides 
A huge variety of strategies are used to improve the production of recombinant proteins in 
mammalian cell lines. Many approaches are aimed at enhancing transcription of the GOI, but it 
has been reported that the expression of recombinant proteins does not always correlate with 
their mRNA levels (Barnes 2004). On the other hand, one limiting step within the classical 
secretory pathway is the translocation of secretory proteins into the lumen of the endoplasmic 
reticulum (ER) and it has been demonstrated that alternative signal peptides (signal sequences) 
can lead to an increased protein secretion (Knappskog 2007; Rance 2010; Young 2008 
(WO 2008/148519 A2), Zhang 2005). 
Most secretory proteins contain N-terminal signal peptides (von Heijne 1983) that emerge 
during their translation on the ribosomal exit tunnel. Hence, the signal recognition particle (SRP) 
recognizes and binds the signal peptide and the translation slows down (Keenan 1998). This 
process is called “translation arrest” and enables the complex consisting of SRP, nascent 
polypeptide chain and ribosome to bind to the SRP receptor, which is  located within the ER 
membrane (Walter 1981; Walter 1994). Subsequently, the complex interacts with the translocon 
(Sec61p complex) as well as with the TRAM protein and the SRP is released. Hence, 
translation is re-initiated and the nascent protein is pushed through the translocon whereas the 
signal peptide remains within the translocon or moves laterally into the membrane of the ER 
(Gorlich 1992; Kalies 1994; Jungnickel 1995; Mothes 1998; Martoglio 1995; Voigt 1996; 
Mothes 1997). Signal peptidase cleaves the signal peptide from the mature protein upon 
appearance of the cleavage site in the lumen of the ER (Blobel 1975).The cleaved signal 
peptide can be degraded by the signal peptide peptidase (Lemberg 2001; Lyko 1995; Martoglio 
1997). This process was postulated to be required in order to clear the ER membrane 
(Martoglio 2003) and it might be favourable for host cells, which secrete large amounts of 
recombinant proteins. Following translocation and cleavage of their signal peptides, proteins are 
transported through the ER and the Golgi apparatus and subjected to folding and assembly 
reactions as well as to post-translational modifications during this passage. Finally, processed 
proteins are packaged into secretory vesicles and externalized upon fusion of these vesicles 
with the plasma membrane. 
Signal peptides consist of a polar N-terminal region (n-region), a hydrophobic core (h-region) 
and a C-terminal region (c-region). Very often the n-region contains positively or negatively 
charged residues (von Heijne 1985; Zheng 1996), whereas the h-region consists of 6 to 15 
hydrophobic amino acids, which are able to form an alpha-helix (Bruch 1989). In the c-region, 
small uncharged residues like alanine, glycine, and serine are required at positions -3 and -1 for 
efficient cleavage by the signal peptidase (Folz 1988; Nielsen 1997), whereas aromatic or 
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hydrophobic residues are often found at position -2, and a proline at position -5. Hydrophobic 
residues like leucine or isoleucine are tolerated at position -4 (von Heijne 1983). However, 
signal peptides do not have a defined consensus sequence and are highly variable regarding 
their length and amino acid composition. The size of mammalian signal peptides mostly ranges 
between 15 and 30 amino acids residues in length (Johnson 1999; Martoglio 1998). The 
frequency of occurrence of important amino acids within the h- and c-region, which was 
determined based on a large number of different eukaryotic signal peptides, is shown in Tab. 1. 
Tab. 1: Frequency of occurrence of amino acids within eukaryotic signal peptides. About 118 eukaryotic signal peptides, 
all w ith known cleavage site were evaluated (von Heijne 1985) 
position
of residues -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 +1
Leu 58 52 34 43 29 6 19 5 17 1 6
Val 11 11 9 11 17 2 8 21 2 0 7
Phe 8 6 7 13 13 2 4 2 10 0 4
Ala 11 18 15 13 13 15 15 34 4 53 12
Gly 2 2 8 3 2 15 27 2 4 35 7
Pro 2 0 2 2 6 20 10 1 0 0 1
highest 
probability L L L L L P G A L A A  
Taking into account the observed variability, the optimization of signal peptides by changing 
their amino acid pattern is very difficult. Nevertheless, there are some clues how signal peptides 
should be constructed in order to enhance protein secretion. For example, it has been 
demonstrated that an increase of positive charges within the n-region leads to improved protein 
secretion (Tsuchiya 2003, Tsuchiya 2004). It is still unclear how many charged residues are 
required. Whereas Zhang et al. report that two arginines are optimal (Zhang 2005) and 
Tsuchiya et al. prefer three (Tsuchyia 2003, Tsuchya 2004). Surprisingly, signal peptides with 
negatively charged n-regions translocate as well (von Heijne 1986). 
The hydrophobic core of a signal peptide is of high importance, because the SRP binds this 
region and mediates a translation arrest, which is necessary to prevent that synthesized 
proteins are released into the cytosol (Belin 1996). Moreover, the hydrophobic core unlocks the 
translocon and is required to position the signal peptide within the ER membrane for the 
cleavage (von Heijne 1998; Nilsson 2002). Therefore, length and hydrophobicity of a signal 
peptide can be optimized. For example, it has been shown that the substitution of a single 
amino acid within the h-region can enhance translocation efficiency dramatically by increasing 
hydrophobicity (Rapoport 1986). The natural h-region can also be replaced by a single stretch 
of 10 leucines in order to improve translocation (Tsuchiya 2003, Tsuchiya 2004 and 
Zhang 2005). Additionally, the cleavage efficiency of a signal peptide depends on the length of 
its h-region (Nilsson 2002). The presence of small uncharged residues at position -3 and -1 and 
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the absence of proline at position -2 are essential for signal peptide cleavage (von Heijne 1983; 
Ping 1993; Nothwehr 1989). Additionally, the cleavage efficiency depends on the length of the 
h-region (Nilsson 2002). Interestingly, also mutations within the protein immediately 
downstream of the signal peptide can influence secretion efficiency by affecting signal peptide 
cleavage and protein translocation (Folz 1986; Andrews 1988; Wiren 1988). Finally, the c-region 
of a signal peptide is often separated from its hydrophobic core by a strong helix breaker like 
proline or glycine, the optimal distance between cleavage site and helix breaker being 4 to 6 
residues (Nothwehr 1989; Yamamoto 1989; Chou 1978). 
It has been demonstrated that signal peptides are extremely heterogeneous and that many 
prokaryotic and eukaryotic signal peptides are functionally interchangeable even between 
different species (von Heijne 1985; Gierasch 1989; Tan 2002). Based on these observations, 
signal peptides from other species can be used to express a gene of interest in a defined host 
cell system. Moreover, it has been demonstrated in CHO cells that a native signal peptide is not 
necessarily the most effective one (Hesketh 2005 (WO 2005/001099 A2)) and that signal 
peptides from other species can mediate an increased antibody secretion (Young 2008 (WO 
2008/148519 A2)). All the above mentioned observations might be exploited to select or design 
potent signal peptides that can be fused to recombinant proteins, in order to improve their 
secretion efficiency. 
3.3. Mammalian ER stress 
Most secretory and membrane proteins are synthesized on the ER surface and co-
translationally translocated into the ER lumen, where they undergo folding, oligomerization and 
posttranslational modifications before they leave the ER and are transported to the Golgi 
apparatus. Proper protein folding and modifications depend on the availability of molecular 
chaperones and enzymes located in the ER such as protein disulfide isomerase (PDI), calnexin 
(CANX), calreticulin (CALR), glucose-regulated protein 78 kDa (GRP78), glucose-regulated 
protein 94 kDa (GRP94). Conditions that exceed the protein folding capacity of the ER provoke 
ER stress and trigger the unfolded protein response (UPR), the ER overload response (EOR) or 
ER associated degradation (ERAD) (Rao 2004; Kaufman 1999; Kozutsumi 1988; El-Hadi 2005). 
The key UPR sensors are three transmembrane proteins called Inositol requiring enzyme 1 
(IRE1), pancreatic ER kinase (PKR)-like ER kinase (PERK) and activating transcription factor 6 
(ATF6), which are localized in the ER membrane. Under normal physiological conditions, the 
luminal domains of all three proteins are associated with GRP78. When unfolded proteins 
accumulate within the ER, GRP78 is released (Step 1 in Fig. 1) to support protein folding 
thereby activating UPR. Interestingly, the binding of GRP78 to UPR sensors can be also 
influenced by the expression of membrane proteins. For example, it has been reported that 
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GRP78 is involved in the folding and assembly of several viral membrane proteins (Cho 2003 
and Earl 1991). In the following, the underlying molecular mechanisms of the UPR are 
described in more detail: 
Upon dissociation of GRP78, IRE1 dimerizes and is autophosphorylated (Step 2 in Fig. 1) the 
IRE1 dimer causes a nonconventional splicing of X-box binding protein (XBP1) mRNA, which 
enables translation of the corresponding transcription factor XBP1 due to a frame shift 
(Sidrauski 1997; Yoshida 2001; Calfon 2002). In a similar way, dimerization and 
autophosphorylation (Step 3 in Fig. 1) of PERK occurs after GRP78 is released, resulting in the 
phosphorylation of eukaryotic translation initiation factor 2 (eIF2) by the PERK dimer. On the 
one hand, this modification downregulates global protein synthesis by reducing cap-dependent 
translation initiation, which antagonizes overloading of the protein folding capacity in the ER. On 
the other hand, provokes the phosphorylation of eIF2 selective translation and expression of the 
transcription factor ATF4 (Harding 1999; Harding 2000; Vattem 2004). In case of ATF6, the 
release of GRP78 from the full-length protein ATF6 (p90) mediates its translocation to the Golgi 
apparatus (Step 4 in Fig. 1), where it is cleaved by Site-1 and Site-2 protease. This liberates 
ATF6 (p50), the cytosolic domain of the protein, which acts as a transcription factor (Chen 2002; 
Haze 1999; Shen 2005; Ye 2000). 
The transcription factors XBP1, ATF4 and ATF6 translocate to the nucleus (Step 5 in Fig. 1) 
and bind to unfolded protein response elements (UPRE), ER stress elements (ERSE) and 
amino acid response elements (AARE). These are located in promoters such as GRP78, 
GRP94, CALR and CHOP, which are responsible for the transcription of genes involved in 
different posttranslational modifications, protein folding, protein synthesis and degradation as 
well as amino acid transport or other ER functions. Upon transcription factor binding, expression 
of the corresponding genes is upregulated and cells are able to expand and adjust the capacity 
of the ER on demand (Shaffer 2004; Pollard 2007). This is very important to prevent the 
accumulation of malfolded proteins and aggregates which are potentially toxic (Lai 2007).  
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Fig. 1: Schematic representation of ER stress pathways 
The ER overload response (EOR), another signal pathway triggered by ER stress, is activated 
by the accumulation of membrane proteins, e.g. due to protein over-expression (Meyer 1992; 
Pahl 1995 Mar; Pahl 1996; Pahl 1999; Liu 1995). Moreover, the EOR might be important for 
antiviral defence (Pahl 1995 Jun; Pahl 1997). Although parts of the EOR pathway remain to be 
elucidated, it is known that ER stress induces the phosphorylation and degradation of IϰB 
resulting in the release of NF-ϰB from a NF-ϰB/IϰB heterodimer located in the cytoplasm. 
Subsequently, the transcription factor NF-ϰB translocates to the nucleus and genes involved in 
immune response and inflammation such as interferones and cytokines are upregulated 
(Pahl 1995 Jun; Kaufman 1999). 
ER-associated degradation (ERAD) is another way to prevent the accumulation of toxic 
malfolded proteins in the ER. In this case, malfolded proteins are posttranslationally 
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retranslocated through the Sec61 pore complex and degraded by the ubiquitin-proteasome 
system (Meusser 2005; Tsai et al., 2002). Failed degradation can result in the inclusion of 
aggregated proteins within the ER, which are referred to as Russell bodies (Russell 1890; 
Martin-Noya 1999). Moreover, unresolved stress can activate the transcription factor C/EBP 
homologous protein (CHOP) or the c-Jun N-terminal kinase (JNK), which mediates a caspase 
activation thereby promoting apoptotic cell death (Szegezdi 2006). Both UPR and EOR can be 
also induced by drugs that perturb the normal ER function. An overview of these drugs, which 
are often used to stimulate ER stress in experimental systems, and their modes of action is 
given in Tab. 2. Brefeldin A (BFA), for example, disrupts the structure of the Golgi apparatus, by 
which the exit of proteins from the ER is blocked (Pollard 2007; Wang 2000). Tunicamycin and 
Castanospermine inhibit the formation of complex N-glycosylated proteins (Varki 1999; Saul 
1985; Ahmed 1995), whereas Thapsigargin blocks calcium pumps, which disrupts the calcium 
homeostasis in the ER (LI 2000). 
Tab. 2: Drugs that induce ER stress (Pahl 1999) 
Drugs that induce the UPR Drugs that activate NFkB
Drugs perturbing ER function Drugs perturbing ER function
Tunicamycin Tunicamycin
2-Deoxyglucose 2-Deoxyglucose
Brefeldin A Monensin
Castanospermine Brefeldin A
Glucosamine Thapsigargin
Thapsigargin Cyclopiazonic acid
AlF4-
Reducing agents
2-Mercaptoethanol
Dithiothreitol
Heavy metals
Cobalt
Nickel
Calcium ionophores
A-23187
Ionomycin  
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4. Aim of the thesis 
Platform technologies for the development of stable cell lines for the production of recombinant 
proteins are based on suitable expression and selection systems. Most approaches, which are 
performed to improve the expression of recombinant proteins focus on the optimization of the 
transcription and translation process. However, the translocation into the lumen of the ER has 
been reported as a limiting step during the production of secretory proteins. Considering these 
data, the aim of the first part of the present thesis is to enhance the productivity of expression 
cell lines by improving the ER translocation process. For this purpose, potent natural and 
artificial signal peptides are identified in a screening approach based on transient expression 
and promising candidates are optimized by introducing specific mutations. Finally, the 
performance of the best signal peptides in stably transfected cell lines is analyzed. The 
selection of high-producing clones is currently a very time-consuming and labour-intensive step 
during the development of cell lines expressing recombinant proteins. In this context, the aim of 
the second part of the present thesis is to establish a novel selection system based on ER 
stress, which allows the rapid identification and isolation of high-producers. The rationale of this 
approach is the assumption that the overexpression of secretory recombinant proteins triggers 
ER stress and that the extent of the stress response correlates with the expression level of the 
protein. In a first set of experiments, this hypothesis is verified by analyzing different production 
clones. Regulatory elements involved in ER stress pathways are identified, which could be 
suitable as sensors for ER stress. Several test cell lines are generated and the selected 
elements are used to create GFP-based reporter constructs for the detection of ER stress. 
Subsequently, the performance of the different constructs is analyzed by introducing them into 
the test cell lines using RMCE. Finally, the best construct is applied to the generation of a stable 
production cell line in order to evaluate its suitability as a selection system for high-expressing 
clones. 
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5. Materials and methods 
5.1. Materials 
5.1.1. Chemicals 
1 kb DNA Ladder      New England Biolabs, Frankfurt 
100 bp DNA Ladder      New England Biolabs, Frankfurt 
Accudrop Beads     Becton, Dickinson, Franklin Lakes, USA 
Agarose NEEO Ultra      Carl Roth, Karlsruhe 
Ampicillin Ready Made Solution, 100 mg/mL Sigma Aldrich Chemie, Steinheim 
AquaGenomic Solution    MoBiTec, Göttingen  
Brefeldin A (BFA)     Sigma Aldrich Chemie, Steinheim 
BSA (Purified)     New England Biolabs, Frankfurt 
Castanospermine (CSN)    Sigma Aldrich Chemie, Steinheim 
Casy ton isotonic saline solution   Roche Diagnostic, Mannheim 
dNTP Mix      Fermentas, Sankt Leon-Rot 
Dulbecco's Phosphate Buffered Saline (PBS) Sigma Aldrich Chemie, Steinheim 
Ethanol, 99.8%, p.a     Carl Roth, Karlsruhe 
Ethanol, 70.0%, p.a.     Carl Roth, Karlsruhe 
Ethidium bromide solution, 1%   Carl Roth, Karlsruhe  
FACS Clean      Becton Dickinson, Franklin Lakes, USA 
Folinic acid calcium salt hydrate   Sigma Aldrich Chemie, Steinheim 
Gel Loading Dye Blue, 6x     New England Biolabs, Frankfurt 
Glycerol, 87%      AppliChem, Darmstadt 
Glycine      Sigma Aldrich Chemie, Steinheim 
D-Glucose      Sigma Aldrich Chemie, Steinheim 
H2SO4 (2M)       Carl Roth, Karlsruhe 
HCl (2M)      Merk, Darmstadt 
Human Reference Serum    Bethyl Laboratories, USA 
Kanamycin Solution, 50 mg/mL   Sigma Aldrich Chemie, Steinheim 
NaCl       Merk, Darmstadt 
NaH2PO4      Merk, Darmstadt 
NaOH (2M)      Merk, Darmstadt 
TMB Supersensitive One Component    
HRP Mircowell substrate    BioTX Laboratories, OwingsMills, USA  
Tris Buffer, pH 8.0 (1M)    AppliChem, Darmstadt 
Tris Buffered Saline, with BSA, pH 8.0  Sigma Aldrich Chemie, Steinheim 
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Tris Buffered Saline, with Tween 20, pH 8.0 Sigma Aldrich Chemie, Steinheim 
Turbofect in vitro Transfection Reagent  Fermentas, Sankt Leon-Rot 
Tween 20, 10%     Bethyl Laboratories, USA 
L-Glutamine      Sigma Aldrich Chemie, Steinheim 
LB-Agar      Carl Roth, Karlsruhe 
LB-Broth      Carl Roth, Karlsruhe 
Methotrexate hydrate (MTX)    Sigma Aldrich Chemie, Steinheim 
PEG 4000, 50% (w/v)    Fermentas, Sankt Leon-Rot 
Rotiphorese 10X TBE Buffer    Carl Roth, Karlsruhe 
2-Propanol, 99.8%, p.a    Carl Roth, Karlsruhe 
S.O.C. Medium      New England Biolabs, Frankfurt 
Terrific-Broth modified    Carl Roth, Karlsruhe 
Wasser für die Molekularbiologie   Carl Roth, Karlsruhe 
Water for injection (WFI)    Rentschler Biotechnologie, Laupheim 
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5.1.2. Buffers, media and supplements for cell culture 
CD CHO Medium     Invitrogen, Karlsruhe 
CD DG44 Medium     Invitrogen, Karlsruhe 
CD Hybridoma Medium    Invitrogen, Karlsruhe 
Cholesterol Lipide Concentrate, 250x  Invitrogen, Karlsruhe 
FB Serum      Hyclone, Logan, USA  
G-418 Sulphate Solution, 50 mg/mL   PAA Laboratories, Pasching, Austria 
HT Supplement, 50x      Invitrogen, Karlsruhe 
Hygromycin B Solution, 50 mg/mL   PAA Laboratories, Pasching, Austria 
Modified CD CHO Medium    Invitrogen, Karlsruhe 
Medium C1      Described in capter 5.3.5 
Medium C2      Described in capter 5.3.5 
Medium D1      Described in capter 5.3.1 
Medium D2      Described in capter 5.3.2 
Medium D3      Described in capter 5.3.2 
Medium D4      Described in capter 5.3.2 
Medium D5      Described in capter 5.3.2 
Medium D6      Described in capter 5.3.2 
Medium K1      Described in capter 5.3.1 
Medium K2      Described in capter 5.3.2 
Medium S1      Described in capter 5.3.1 
Medium S2      Described in capter 5.3.1 
PID1-MD-SMD10     Cellca, Laupheim 
PID1-MD-SMD13     Cellca, Laupheim 
PID1-MD-PM55     Cellca, Laupheim 
PID1-MD-FMA70     Cellca, Laupheim 
PID1-MD-FMB16     Cellca, Laupheim 
Pluronic F-68 Solution, 10%    Invitrogen, Karlsruhe 
Production Medium     Described in capter 5.3.6 
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5.1.3. Enzymes and reaction buffers 
Antarctic Phosphatase    New England Biolabs, Frankfurt 
Baseline-Zero DNase     Epicentre, Madison, USA 
Baseline-Zero DNase Reaction Buffer, 10x  Epicentre, Madison, USA 
Baseline-Zero DNase Stop Solution, 10x  Epicentre, Madison, USA 
Buffer for T4 DNA Ligase, 10X   New England Biolabs, Frankfurt 
M-MulV Reverse Transcriptase   Fermentas, Sankt Leon-Rot 
Mung Bean Nuclease     New England Biolabs, Frankfurt 
NEBuffer 1      New England Biolabs, Frankfurt 
NEBuffer 2      New England Biolabs, Frankfurt 
NEBuffer 3      New England Biolabs, Frankfurt 
NEBuffer 4      New England Biolabs, Frankfurt 
NEBuffer for Antartic Phosphatase   New England Biolabs, Frankfurt 
NEBuffer for EcoRI     New England Biolabs, Frankfurt 
NEBuffer for Mung Bean Nuclease    New England Biolabs, Frankfurt 
Oligo (dT)18 Primer     Fermentas, Sankt Leon-Rot 
Phusion DNA Polymerase    Finnzymes, Espoo, Finland 
Phusion GC Reaction Buffer, 5x   Finnzymes, Espoo, Finland 
Phusion HF Reaction Buffer, 5x   Finnzymes, Espoo, Finland 
Reaction Buffer for M-MuLV RT, 5x    Fermentas, Sankt Leon-Rot 
Restriction enzymes (diverse)   New England Biolabs, Frankfurt 
ScriptGuard RNase     Epicentre, Madison, USA 
T4 DNA Ligase      New England Biolabs, Frankfurt 
T4 DNA Ligase Reaction Buffer, 10X  New England Biolabs, Frankfurt 
T4 DNA Polymerase      New England Biolabs, Frankfurt 
5.1.4. Molecular biological and biochemical k its 
Clone JET PCR Cloning Kit    Fermentas, Sankt Leon-Rot  
Dual-Glo Luciferase Reporter Assay System Promega, Madison, USA 
DyNamo Flash SYBR Green qPCR Kit   Finnzymes, Espoo, Finland 
E.Z.N.A. Gel Extration Kit    Omega Bio-Tek, Norcross, USA 
E.Z.N.A. Plasmid Mini Kit I    Omega Bio-Tek, Norcross, USA 
Human IgG ELISA Quantitation Kit   Bethyl Laboratories, USA 
Nucleofector Kit V for CHO    Lonza Cologne, Köln 
Phusion High Fidelity PCR-Kit   New England Biolabs, Frankfurt 
PureLink HiPure plasmid Filter Maxiprep Kit Invitrogen, Karlsruhe 
  Materials and methods 
Page 18 
QIAshredder (50)     Qiagen, Hilden 
QuikChange II Site-Directed Mutagenesis Kit Stratagene, La Jolla, USA 
RNeasy Plus Mini Kit (50)    Qiagen, Hilden 
5.1.5. Bacterial strains 
JM110 Stratagene Competent cells   Stratagene, La Jolla, USA 
NEB 5-alpha Competent E. coli   New England Biolabs, Frankfurt 
NEB 10-beta Competent E. coli   New England Biolabs, Frankfurt 
5.1.6. Mammalian cells  
CHO K1 cells (ATCC no.: CCL-61)   DSMZ, Braunschweig 
CHO DG44 cells     L. Chasin, Columbia University, New York 
5.1.7. Consumables 
Casy cups      Roche Diagnostic, Mannheim 
CryoPure Tube, 1.8 mL white   Sarstedt, Nümbrecht 
Shake Flask 125 mL (Erlenmeyer)   Corning, NY, USA  
Shake Flask 250 mL (Erlenmeyer)   Corning, NY, USA  
Shake Flask 500 mL (Erlenmeyer)   Corning, NY, USA  
LightCycler 480 Multiwell Plate 96, white  Roche Diagnostic, Mannheim 
MultiDish 6 Wells     Nunc, Roskilde, Denmark 
SafeSeal Tubes 1.5 mL    Sarstedt, Nümbrecht 
SafeSeal Tubes 2.0 mL    Sarstedt, Nümbrecht 
Surgical blades     Swann Morton, Sheffield, UK 
TC Microwell 96U     Nunc, Roskilde, Denmark 
TC Microwell 96F     Nunc, Roskilde, Denmark 
TC Plate 24-Well Flat Susp Cell   Sarstedt, Nümbrecht 
TC-Plate 12 Well     greiner bio-one, Frickenhausen 
Tube 13 mL      Sarstedt, Nümbrecht 
Tube 15 mL      Sarstedt, Nümbrecht 
Tube 50 mL      Sarstedt, Nümbrecht 
Polystyrene Round-Bottom Tube  
with Cell Strainer Cap 5 mL    Becton Dickinson, Franklin Lakes, USA 
Polystyrene Round-Bottom Tube 5 mL  Becton Dickinson, Franklin Lakes, USA 
Ziploc bags      Melitta Haushaltsprodukte, Minden 
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5.1.8. Technical devices 
ABL800 FLEX     Radiometer, Willich 
Appliskan microplate reader    Thermo Scientific, Karlsruhe 
Biofuge fresco     Heraeus, Hanau 
Biofuge pico      Heraeus, Hanau 
Biofuge stratos     Heraeus, Hanau 
Bio Photometer     Eppendorf, Hamburg 
Bühler Shaker, KS-15    Edmund Bühler, Hechingen 
Certomat IS incubation shaker    Sartorius, Göttingen 
Cell Counter Analyser  
System (CASY), Model TTC    Roche Diagnostic, Mannheim 
E.A.S.Y. 440K Win32 Gel Documentation System Herolab Laborgeräte, Wiesloch 
Electrophoresis chamber Sub-Cell GT WIDE MINI Bio-Rad Laboratories, München 
FACSAria      Becton Dickinson Bioscience, Heidelberg 
Galaxy Mini Star centrifuge    VWR International, Darmstadt 
HERA cell 240 incubator    Thermo Scientific, Karlsruhe 
HERA safe laminar flow    Heraeus, Hanau 
HPLC, Finnigan Surveyor Plus   ThermoFinnigan, San Jose, USA 
Incu-line incubation shaker    VWR International, Darmstadt 
LA 230P-OCE balance    Sartorius, Göttingen 
Leica DM IL microscope    Leica Microsystems, Wetzlar 
Light Cycler 480     Roche Diagnostic, Mannheim 
Multifuge 3s-r      Heraeus, Hanau 
MyCycler termal cycler    Bio-Rad Laboratories, München 
Nucleofector II     Lonza Cologne, Köln 
Pipetboy acu       Integra Biosciences, Fernwald 
Pipet Research 2.5 µL     Eppendorf, Hamburg 
Pipet Research 10 µL    Eppendorf, Hamburg 
Pipet Research 100 µL     Eppendorf, Hamburg 
Pipet Research 200 µL    Eppendorf, Hamburg 
Pipet Research 1000 µL     Eppendorf, Hamburg 
Power Pac 200 gel electrophoresis system  Bio-Rad Laboratories, München  
Protein A column, Poros, 20 µm   Applied Biosystems, Foster City, USA 
Thermomixer compact    Eppendorf, Hamburg 
UV Detector, Surveyor PDA Plus Detector  Thermo Electron, San Jose, USA 
Vortex-Genie2     Scientific Industries, Bohemia, USA 
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Water bath W22     Preiss-Daimler, Medingen, Dresden 
Wellwash 4 Mk 2 microplate washer   Thermo Scientific, Karlsruhe 
5.1.9. Software 
Chrom Quest Software     ThermoFinnigan, Waltham, USA 
Light Cycler 480 Software, LCS480 1.5.0.39 Roche Diagnostic, Mannheim 
Universal ProbeLibrary    Roche Diagnostic, Mannheim 
AUG_hairpin      Kochetov, A.V. et al. 2007 
BD FACSDiva software    Becton Dickinson Bioscience, Heidelberg 
QuikChange Primer Design    Stratagene, La Jolla, USA 
Vector NTI software     Invitrogen, Karlsruhe 
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5.1.10. Plasmids 
Tab. 3: Overview of first generation expression vectors (Signal peptide constructs) 
Vector 
number
Containing 
signal peptide Provider
446 A2 created during this study
447 B created during this study
448 C created during this study
449 D created during this study
450 E created during this study
451 F created during this study
452 G created during this study
453 H created during this study
455 J created during this study
456 K created during this study
457 L created during this study
458 M created during this study
459 N created during this study
460 O created during this study
461 P created during this study
462 Q created during this study
463 R created during this study
464 S created during this study
465 T created during this study  
Tab. 4: Overview of second generation expression vectors (Signal peptide constructs) 
Vector 
number
Containing 
signal peptide Provider
601 A2 created during this study
602 B created during this study
603 E created during this study
604 M created during this study
661 B1 created during this study
662 E1 created during this study
663 E2 created during this study
664 E3 created during this study
665 E4 created during this study
666 E5 created during this study
841 E6 created during this study
842 E7 created during this study
843 E8 created during this study  
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Tab. 5: Overview of third generation expression vectors (Signal peptide constructs) 
Vector 
number
Containing 
signal peptide Provider
1171 A2 created during this study
1157 B created during this study
1158 E created during this study
1159 E3 created during this study  
Tab. 6: Overview of ER stress RMCE donor constructs 
Vector 
number
Containing
ER stress reporter Provider
1188 SV40-eGFP control created during this study
1192 3 x ERSE I created during this study
1193 3 x ERSE II created during this study
1194 3 x UPRE created during this study
1995 3 x AARE created during this study
917 SV40-d2eGFP control created during this study
1023 Intron created during this study
1101 CALR created during this study
1103 GRP78 created during this study
1104 GRP94 created during this study  
Tab. 7: Overview of additional vectors 
Vector 
number
Containing 
construct Provider
314 LC HC dhfr Cellca, Laupheim
527 trunc GRP78 Reporter created during this study
673 FLPO created during this study
726 HC LC dhfr Cellca, Laupheim
957 DsRed RMCE Acceptor Cellca, Laupheim
1071 GTN RMCE Donor Cellca, Laupheim
1096 dhfr created during this study  
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Tab. 8: Overview of vectors from external providers 
Vector 
number
Containing 
construct
Vector name 
of provider
Provider
(Reference)
719 GTN pF3ESGTNWF kindly provided by Prof. Bode
(Baer 2002)
721 FLPO pFlpo-Puro 
(flpo-IRES-pac)
kindly provided by Prof. Bode
(Raymond 2007)
722 DsRed HygTK pF3HygTKF kindly provided by Prof. Bode
(Schlake 1994)
944 DsRed pDsRed-Express-N1 Clontech
N/A Cloning site pJET1.2/blunt vector Fermentas  
Tab. 9: Overview of cloning vectors 
Vector 
number
Type of 
cloning vector Provider
377 basic Cellca, Laupheim
386 basic Cellca, Laupheim
526B basic Cellca, Laupheim
556 basic Cellca, Laupheim
560 basic Cellca, Laupheim
881 basic Cellca, Laupheim
949 basic Cellca, Laupheim
951 basic Cellca, Laupheim
1152 basic Cellca, Laupheim
377B intermediate created during this study
412 intermediate created during this study
556B intermediate created during this study
560B intermediate created during this study
701 intermediate created during this study
952 intermediate created during this study
954 intermediate created during this study
955 intermediate created during this study  
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5.2. Molecular biological methods 
5.2.1. Cloning of DNA constructs 
Molecular cloning means the creation of a DNA construct by the assembly of a DNA fragment 
and a plasmid, which enables the propagation of the construct in E. coli. For this purpose, the 
plasmid of choice (also referred to as vector or plasmid) was cleaved with appropriate restriction 
enzymes and enzymatically dephosphorylated. The desired DNA fragment (also referred to as 
insert) was excised with corresponding restriction enzymes. Both digestion reactions were 
subjected to gel electrophoresis and the fragments of interest were extracted and purified. 
Subsequently, vector and insert were ligated, introduced into E. coli by transformation and the 
cells were spread and cultivated on LB agar plates. Grown single colonies were cultivated in LB 
medium, plasmid DNA was isolated by mini preparation and correct clones were identified by 
restriction analysis. 
5.2.2. Cloning of signal peptide constructs 
During the first part of the present study, three types of vectors, each coding for the same 
recombinant model antibody were used. They differ only with regard to the composition 
(promoters, poly-A signals) and the arrangement of the individual expression cassettes on the 
plasmid. Moreover, different marker genes were placed on these constructs. The plasmids are 
designated as first, second and third generation expression vectors, respectively. The features 
of these vectors are summarized in Tab. 10 
Tab. 10: Features of used signal peptide constructs 
Expression 
vector
HC and LC 
expression was 
under control of 
marker 
genes
Position of 
HC on 
vector 
Position of 
LC on 
vector 
Position of 
marker gene 
on vector 
first generation SV40 Promoter hRluc second first third
second generation CMV Promoter hRluc first third second
third generation SV40E Promoter dhfr first second third  
Various signal peptides were inserted in front of the heavy and the light antibody chain of these 
vectors as described in Fig. 4, Fig. 5 and Fig. 6. In order to simplify the schematic 
representations, parts of vectors are shown as dashed line. Nevertheless, they are generally 
based on the pGL3 plasmid backbone comprising an origin of replication and the beta-
lactamase gene who mediates an ampicillin resistance in E. coli. 
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In case of first and second generation expression vectors, an EcoRV restriction site was 
introduced within the first two codons of the immunoglobulin heavy and light chain in order to 
allow the insertion of different signal peptides. All necessary mutations were done by site-
directed mutagenesis (see chapter 5.2.6), and the resulting changes in the nucleotide and the 
amino acid sequence are shown in Fig. 2. 
      E   V 
5’   gag gtg wild-type 
 
      D   I 
5’   gat atc mutation 
 
Fig. 2: Nucleotide sequence of the first two codons of the immunoglobulin heavy chain 
The first two amino acids of the mature immunoglobulin heavy chain are indicated with capital letters and the created EcoRV 
restriction site is underlined. 
      D   I 
5’   gac atc wild-type 
 
      D   I 
5’   gat atc mutation 
 
Fig. 3: Nucleotide sequence of the first two codons of the immunoglobulin light chain 
The first two amino acids of the mature immunoglobulin light chain are indicated w ith capital letters and the created EcoRV 
restriction site is underlined. 
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The cloning procedure for the insertion of signal peptides into first generation expression 
vectors is described in Fig. 4. 
 
Fig. 4: Schematic representation of the cloning procedure for first generation expression vectors 
For each signal peptide (listed in Tab. 34), oligonucleotides containing a Kozak consensus sequence and the respective sequence 
coding for the signal peptide were synthesized (Eurogentec) and annealed in order to create a dsDNA with a 5’ aatt extension 
compatible w ith EcoRI as w ell as a blunt end. Step 1 and step 2: Vector 377 and vector 386 were digested with the restriction 
endonucleases EcoRI and EcoRV and the annealed oligonucleotides were cloned into these vectors. Step 3: A BamHI/XhoI DNA 
fragment w as transferred from vector 377B into vector 412, resulting in the f inal expression vector. 
  
Vector 377 
Vector 377B 
Vector 446-465 
Vector 412 
Vector 386 
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The cloning procedure for the insertion of signal peptides into second generation expression 
vectors is described in Fig. 5. 
 
Fig. 5: Schematic representation of the cloning procedure for second generation expression vectors 
For each signal peptide (listed in Tab. 35), oligonucleotides containing a Kozak consensus sequence and the respective sequence 
coding for the signal peptide were synthesized (Eurogentec) and annealed in order to create a dsDNA with a 5’ aatt extension 
compatible w ith EcoRI as w ell as a blunt end. Step 1 and step 3: Vector 560 and vector 556 were digested with the restriction 
endonucleases EcoRI and EcoRV and the annealed oligonucleotides w ere cloned into these vectors. Step 2: A NdeI/ApaI DNA 
fragment w as transferred from vector 560B to vector 701. Step 4: Follow ing the insertion of the NdeI/ApaI fragment (Step 2), a 
BamHI/SbFI fragment w as transferred from vector 556B to vector 701 resulting in the f inal expression vector. 
The cloning procedure for the insertion of signal peptides into third generation expression 
vectors is described in Fig. 6. In this case, signal peptides were introduced via BbsI and BsmBI 
sites (see Fig. 7 and Fig. 8), thereby avoiding changes in the antibody amino acid sequence of 
the heavy and light chain. 
Vector 601-604 
Vector 661-666 
Vector 841-843 
Vector 560 
Vector 560B 
Vector 701 
Vector 556B 
Vector 556 
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Fig. 6: Schematic representation of the cloning procedure for third generation expression vectors 
For each signal peptide  (listed in Tab. 35), oligonucleotides containing a Kozak consensus sequence and the respective sequence 
coding for the signal peptide w ere synthesized (Eurogentec) and annealed in order to create a dsDNA w ith a 5’ aatt (sense strand) 
and a 5’ tcgg (antisense strand) extension compatible w ith extensions created w ith restriction endonuclease BsbI and BsmBI (see 
Fig. 7 and Fig. 8). Step 1: Vector 1152 was digested with the restriction endonuclease BbsI and the annealed oligonucleotides were 
cloned into this vector. Step 2: Follow ing the insertion of the annealed oligonucleotides via BbsI (Step 1), the vector was digested 
with the restriction endonuclease BsmBI and the annealed oligonucleotides were cloned in, resulting in the f inal expression vectors. 
                                                     E  V  
5’   gaattcggtc ttcatgaccg atatcttggg acagaagacc tccgaggtg 
3’   cttaagccag aagtactggc tatagaaccc tgtcttctgg aggctccac 
 
Fig. 7: Nucleotide sequence of the BbsI/BbsI cloning s ite in front of the immunoglobulin heavy chain 
The BsbI restriction sites are underlined and the DNA extensions generated upon cleavage are boxed. The f irst two amino acids of 
the mature immunoglobulin heavy chain are indicated w ith capital letters 
                                                   D  I  
5’   gaattcgaga cgatgaccga tatcttggga cacgtctctc cgacatc 
3’   cttaagctct gctactggct atagaaccct gtgcagagag gctgtag 
 
Fig. 8: Nucleotide sequence of the BsmBI/BsmBI cloning site in front of the immunoglobulin light chain 
The BsmBI restriction sites are underlined and DNA extensions generated upon cleavage are boxed. The f irst two amino acids of 
the mature immunoglobulin light chain are indicated w ith capital letters 
  
Vector 1157-1159 
Vector 1171 
Vector 1152 
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5.2.3. Cloning of ER stress constructs 
During the second part of the present thesis, a variety of vectors (also termed as RMCE donor 
constructs) were used. The cloning procedure of these constructs is described in the following.  
In order to create reporter constructs containing different ER stress response elements, 
vector 1188 comprising heterospecific FRT-sites (FRTwt and FRT3), a promoterless neomycin 
resistance gene, a AsiSI/BglII cloning site and an SV40 promoter followed by eGFP was used 
(see Fig. 9). 
 
Fig. 9: Schematic representation of vector 1188 (SV40-eGFP control) 
DNA fragments containing the transcription factor binding sites ERSE I, ERSE II, UPRE and 
AARE were synthesized (Gene art) and the elements were inserted into vector 1188 via 
AsiSI/BglII resulting in vector 1192, 1193, 1194 and 1195, respectively. The corresponding 
sequences of the promoter region upstream of eGFP are depicted for all generated constructs 
as well as for the SV40-eGFP control vector 1188 (Fig. 10). 
 
-333                                tta attaatatcg gaccggctat cgtacgttct 
 
-300   agacgttggc gatcgcttgc ttcgaagcat ggcgcgccag atctgcgatc tgcatctcaa 
 
-240   ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa ctccgcccag 
 
-180   ttccgcccat tctccgcccc atcgctgact aatttttttt atttatgcag aggccgaggc 
 
-120   cgcctcggcc tctgagctat tccagaagta gtgaggaggc ttttttggag gcccaggctt 
 
-60    ttgcaaaatc gattctatcc tagggtcagg gccggccgct agggatccga attcgccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
Fig. 10: Nucleotide sequence upstream of the eGFP reporter gene of vector 1188 (SV40-eGFP control) 
The AsiSI and the BglII restriction sites are underlined. The SV40 promoter region is located at -54 and -256, and the translation 
start site at +1. 
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-432                                                       tt aattaatatc 
                                                                                 ERSE I 
-420   ggaccggcta tcgtacgttc tagacgttgg cgatcgcttg cttcgaactg ccaatcggcg 
                                                           ERSE I 
-360   gcctccacgc catcaagata tccaagggcc caatcggcgg cctccacgag ctgatttcga 
                             ERSE I 
-300   acggcgtccc aatcggcggc ctccacgcca ggcgcgccag atctgcgatc tgcatctcaa 
 
-240   ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa ctccgcccag 
 
-180   ttccgcccat tctccgcccc atcgctgact aatttttttt atttatgcag aggccgaggc 
 
-120   cgcctcggcc tctgagctat tccagaagta gtgaggaggc ttttttggag gcccaggctt 
 
-60    ttgcaaaatc gattctatcc tagggtcagg gccggccgct agggatccga attcgccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 11: Nucleotide sequence upstream of the eGFP reporter gene of vector 1192 (3 x ERSE I reporter) 
The ERSE I consensus sequences are boxed and the AsiSI and the BglII restriction sites are underlined. The SV40 promoter region 
is located from -54 to -256, and the translation start site is located at +1. 
 
-408                ttaattaa tatcggaccg gctatcgtac gttctagacg ttggcgatcg 
                                ERSE II                                   ERSE II 
-360   cttgcttcga actgattggg ccacgccatc aagatatcca agggcattgg gccacgagct 
                                  ERSE II 
-300   gatttcgaac ggcgtcattg ggccacgcca ggcgcgccag atctgcgatc tgcatctcaa 
 
-240   ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa ctccgcccag 
 
-180   ttccgcccat tctccgcccc atcgctgact aatttttttt atttatgcag aggccgaggc 
 
-120   cgcctcggcc tctgagctat tccagaagta gtgaggaggc ttttttggag gcccaggctt 
 
-60    ttgcaaaatc gattctatcc tagggtcagg gccggccgct agggatccga attcgccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 12: Nucleotide sequence upstream of the eGFP reporter gene of vector 1193 (3 x ERSE II reporter) 
The ERSE II consensus sequences are boxed and the AsiSI and the BglII restriction sites are underlined. The SV40 promoter 
region is located from -54 to -256, and the translational start is located at +1. 
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-399                          ttaattaat atcggaccgg ctatcgtacg ttctagacgt 
                                           UPRE                                   UPRE 
-360   tggcgatcgc ttgcttcgaa ctgtgacgtg gccatcaaga tatccaaggg ctgacgtgga 
                                     UPRE 
-300   gctgatttcg aacggcgtct gacgtggcca ggcgcgccag atctgcgatc tgcatctcaa 
 
-240   ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa ctccgcccag 
 
-180   ttccgcccat tctccgcccc atcgctgact aatttttttt atttatgcag aggccgaggc 
 
-120   cgcctcggcc tctgagctat tccagaagta gtgaggaggc ttttttggag gcccaggctt 
 
-60    ttgcaaaatc gattctatcc tagggtcagg gccggccgct agggatccga attcgccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 13: Nucleotide sequence upstream of the eGFP reporter gene of vector 1194 (3 x UPRE reporter) 
The UPRE consensus sequences are boxed and the AsiSI and the BglII restriction sites are underlined. The SV40 promoter region 
is located from -54 to -256, and the translation start site is located at +1. 
 
-402                      tt aattaatatc ggaccggcta tcgtacgttc tagacgttgg 
                               AARE                            AARE 
-360   cgatcgcttg cttcgaactg gttgcatcac catcaagata tccaagggcg ttgcatcaag 
                             AARE 
-300   ctgatttcga acggcgtcgt tgcatcacca ggcgcgccag atctgcgatc tgcatctcaa 
 
-240   ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa ctccgcccag 
 
-180   ttccgcccat tctccgcccc atcgctgact aatttttttt atttatgcag aggccgaggc 
 
-120   cgcctcggcc tctgagctat tccagaagta gtgaggaggc ttttttggag gcccaggctt 
 
-60    ttgcaaaatc gattctatcc tagggtcagg gccggccgct agggatccga attcgccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 14: Nucleotide sequence upstream of the eGFP reporter gene of vector 1195 (3 x AARE reporter) 
The AARE consensus sequences are boxed and the AsiSI and the BglII restriction sites are underlined. The SV40 promoter region 
is located from -54 to -256, and the translation start site is located at +1. 
Additional reporter constructs (also termed RMCE donor constructs) were generated by the 
insertion of natural ER stress promoters into vector 917 comprising heterospecific FRT-sites 
(FRTwt and FRT3), a promoterless neomycin resistance gene, a BglII/EcoRI cloning site and an 
SV40 promoter followed by d2eGFP (see Fig. 15). 
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Fig. 15: Schematic representation of vector 917 (SV40-d2eGFP control) 
By preparative PCR, the promoter regions of GRP78 and GRP94 were isolated using genomic 
DNA derived from CHO DG44 cells and the promoter region of CALR was isolated using 
genomic DNA derived from human blood. The obtained PCR products were cloned into the 
pJET1.2/blunt vector (Fermentas) and for each promoter, a 1500 bp fragment including the 
5’ UTR (except the Kozak sequence) was amplified by PCR. Thereby, BbsI restriction sites that 
upon cleavage result in DNA extensions compatible with BglII and EcoRI were introduced at the 
5’ and the 3’ end, respectively. Subsequently, the SV40 promoter present in vector 917 was 
replaced by the individual ER stress promoters via BglII/EcoRI, resulting in vector 1101, 1103 
and 1104. The corresponding DNA sequences upstream of d2eGFP are depicted for generated 
constructs as well as for the SV40-d2eGFP control vector 917. 
 
-331                                  t taattaatat cggaccggct atcgtacgtt 
 
-300   ctagacgttg gcgatcgctt gcttcgaagc atggcgcgcc agatctgcga tctgcatctc 
 
-240   aattagtcag caaccatagt cccgccccta actccgccca tcccgcccct aactccgccc 
 
-180   agttccgccc attctccgcc ccatcgctga ctaatttttt ttatttatgc agaggccgag 
 
-120   gccgcctcgg cctctgagct attccagaag tagtgaggag gcttttttgg aggcccaggc 
 
-60    ttttgcaaaa tcgattctat cctagggtca gggccggccg ctagggatcc gaattccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 16: Nucleotide sequence upstream of the d2eGFP reporter gene of vector 917 (SV40-d2eGFP control) 
The BglII and the EcoRI restriction sites are underlined. The SV40 promoter region is located from -51 to -260, and the translation 
start site is located at +1. 
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-1587                                      ttaatta atatcggacc ggctatcgta   
       
-1560  cgttctagac gttggcgatc gcttgcttcg aagcatggcg cgccagatct aactgaccta  
 
-1500  aaatgatctg cccgcctcgg cctccccaag tgctgggttt acaggcgtga gccactgcgc 
                                                                    UPRE reverse 
-1440  ccggccacca tttctttttt ttttttttaa ccagagaccc ttgccaagtc attcccccca  
 
-1380  ctccacttta ttttcctttt cattttttcc ttcctctctt ttctgagtca caaccattag 
 
-1320  ccaggaagca ccccctcccc accctctttc ctggatcccc ctcattccct ccttccatag 
 
-1260  tccactcccg cgctcccagg tccagggctt atttgcccag agtttggaaa acccccagct 
                                          ERSE I reverse 
-1200  ctccttcctc ctttctacag cgtgggggca gggtactggt gccagtcacg tgcctctggc 
 
-1140  ttctgaagaa gactctagac tggggtcggg gggtgggtcc tgcccatctc cctagcatct 
 
-1080  tatcgtccct accatctgtg tcttttttcc ctccccaaac ggaaccccct gccctctcgc 
 
-1020  ctgcctatag ccgtttaatt gcaaaagcca ggccgtttgt gggagaccac agacagcgac 
 
-960   ccccttcatt taccggttga gaggagggta aaggggcggc tgcaatctgg gtaataaccc 
 
-900   tatccccact ccaggagtca cagtcacatc gttaagcctt cctcccctct tgtcccagga 
 
-840   cagctttaaa aacgttaaaa gcatttctgc tgggtagcat ctggccaggg tcgccccctc 
                                    UPRE reverse 
-780   tgtctgctca ggaacgtctg tcacttcaga gagcttaagt gacttgcccc ggtcacacag 
 
-720   cagcagtccg ataggctgcc agggctctag gggcagaagg aggagagggc tggcattctt 
 
-660   cccaccggcc cgcgtgactg tagcaccggg gtgcagcgaa gccccaaggg ccccaatccg 
 
-600   tgagctctct cccatcccag gcaggggtgg gggagcagca gtggggtgct ggttctcaaa 
 
-540   tgcaagataa gagctggcta agaaagcctt gcccagcccc tccacctaga gggaatggga 
 
-480   gggagagaag ctgagggcag ggtcccggtc ccgcgtggag acagctgcgc tcccgcggtt 
 
-420   tctttaaacg cccagatggg caacgacgcg cgcggacgag ggcggggttg ggttcaggtc 
                       UPRE  
-360   tggtcacatg acctggcctg aggtgctcgc ggcccccacc ccaccagtgg gcgtcccccc 
                   ERSE I reverse 
-300   cacgcgtggt cgaccatcat tggtcggtgg tgaggccaat agaaatcggc catctgggaa 
 
-240   cccagcgttc cgaggcgcag cctaacatag tgaaccgacg aaggtccaat ggaaaaagac 
 
-180   ggccatgggc atagaccaat gacaaagtgg caggggcggg cccaagggct gggtcaggtt 
 
-120   ggtttgagag gcgggtgggt ataaaagtgc aaggcgggcg gcggcgtccg tccgtactgc 
 
-60    agagccgctg ccggagggtc gttttaaagg gcccgcgcgt tgccgccccc gaattccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 17: Nucleotide sequence upstream of the d2eGFP reporter gene of vector 1101 (CALR reporter) 
Different cis-acting elements are boxed and the BglII and the EcoRI restriction sites are underlined. Deviations from the consensus 
sequence of the cis-acting elements are indicated in red. The CALR promoter region including the 5’ UTR is located from -11 to       
-1510, and the translation start site is located at +1. 
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-1588                                     ttaattaa tatcggaccg gctatcgtac 
 
-1560  gttctagacg ttggcgatcg cttgcttcga agcatggcgc gccagatctt atcaattcta 
 
-1500  cctgtaccac tcaccagtga ctattctatt tagccacccc ccccccaatg atctcttctg 
 
-1440  gaaaatggga aacatctacc aagaattaat caaaggacta aatgacacat gcaaaaaaaa 
 
-1380  aaaaacctta gaacagtgtt ttaagcagga taagtagttc aagaccagtt tggaccatgt 
 
-1320  ctcaaaacta aaggaacaac gaagtacatt tagtattttt tgcaacatgt tattattaca  
            AARE 
-1260  tagcatcagg aagacaattt tttctttgtc tgctaaatgc ctttgtcata tcagacctat 
 
-1200  ttcaagagtc aggatagaat ggtgtcaaga agggatgagg aaggacttgt aaattataac 
 
-1140  caagccacaa atgaaaatga tagacaagga tcgggaacat tatggggcga caagctagag 
 
-1080  aaaaaaaatg atatattcca gggtggaaag tgctcgcttg actattcata gaacagaata 
 
-1020  gccacagcat agcggggggc tcagtactag gttgcaaatg gccaggccaa ttctgggact 
 
-960   taaccccaag aaaagaaaaa ttggcaaggc caggatagac aaatgcagct ggcctagggg 
 
-900   tgaagggaaa acagttggct gagaagagcc acgattcgca gagaggcaga acacagacta 
 
-840   ggacccagct cgagacgtgc aggccgggtg ggtaacatag agcccgggcg ctcggctacc 
 
-780   cgagaacgtg agggaggctt ggaagggcag agatgcgttc ccaggcgacc acagcatcta 
 
-720   tgctgaggct gagcagctcg ggacccgagg ggacttagga ggagaaaagg ccgcatactg 
 
-660   cttcggggta agggacagac cggggaagga cccaagtccc accgcccaga gggaactgac 
                                                         UPRE 
-600   acgcagaccc cgcagcagtc cccgggggcc gggtgacggg aggacctgga cggttaccgg 
 
-540   cggaaacggt ctcgggttga gaggtcacct gagggacagg cagctgctga accaatagga 
 
-480   ccggcgcaca gggcggatgc tgcctctcat tggcggccgt tgagagtaac cagtagccaa 
                                             UPRE 
-420   tgagtcagcc cggggggcgt agcggtgacg taagttgcgg aggaggccgc ttcgaatcgg 
                                     ERSE II reverse and ERSE I 
-360   cagcggccag cttggtggca tggaccaatc agcgtcctcc aacgagaagc gccttcacca 
                ERSE I 
-300   atcggaggcc tccacgacgg ggctgggggg agggtatata agccaagtcg gcggcggcgc 
 
-240   gctccacact ggccaagaca acagtgaccg gaggacctgc ctttgcggct ccgagaggta 
 
-180   agcgccgcgg cctgctcttg ccagacctcc tttgagcctg tctcgtggct cctcctgacc 
 
-120   cggggtgctt ctgtcgccct cagatcggaa cgccgccgcg ctccgggact acagcctgtt 
 
-60    gctggacttc gagactgcag acggaccgac cgctgagcac tggcccacag gaattccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 18: Nucleotide sequence upstream of the d2eGFP reporter gene of vector 1103 (GRP78 reporter) 
Different cis-acting elements are boxed and the BglII and the EcoRI restriction sites are underlined. Deviations from the consensus 
sequence of the cis-acting elements are indicated in red. The GRP78 promoter region including the 5’ UTR is located from -11 to     
-1511, and the translation start site is located at +1. 
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-1587                                      ttaatta atatcggacc ggctatcgta 
 
-1560  cgttctagac gttggcgatc gcttgcttcg aagcatggcg cgccagatct ttcaggaatt 
 
-1500  tggacgatcc gaaaacaact ccaattttct tggaggaagc ggtgatggag cgggtgtgtt 
 
-1440  agagacaggt gctcgtgata gtggaaaatt tgttaaaata cgactaaaga gcttagaaaa 
 
-1380  catttaggag tgcacaagct ggcgttaggg acttccctca ccagaaagag ccctccgctg 
 
-1320  tctttcggaa ggcggaaagg tgtttctatg aaattacaaa gccacagtcc aggctatttg 
 
-1260  caagctctgc ggcttttgct ctcaagtatc tacaaatgcc ctttcctgct gtgggttagc 
 
-1200  ctggacttca cgccgcgcgg tcctgctgac tcacagaggg gatgcgggat ttccaaggcg 
 
-1140  ctccttggaa ttcactggga tgtcaaagga acgagtcctt ggagtttccc tcggggttgg 
                                           UPRE reverse 
-1080  ggacctaggc actctctact gcaaaccaag tcaaagaggt caggaggctc gggcagcgaa 
 
-1020  acgccaggtg tagctgaagg ctccacgcgc ccgcccggag tgacgcacaa gaaggctgac 
         UPRE 
-960   ctggaaacca gcgtgccacc accggccagg gctggctctc ggcaccggac gaataggaag 
 
-900   gctctccagg tccgcctctg aaaactatgt gaattacagt accgcaacaa gcacagatct 
 
-840   aatctgcaat cagaataatg tggaaatcct aaatcactca gggtacatgg cccgcaggta 
 
-780   caagacgaga atgcgcaaag gccaaactac gcctactggc tctaaggcca aagactacga 
 
-720   ttcccagcat tcataagtct agtgcgttgc atgccgggaa ttgtagtttc tcactaccat 
 
-660   ccatacgcac ccaggaagag tgttctaccc tttacatatt tccctttttc gaaaagcgat 
 
-600   aacgaacaga aaggtgacgg cgagcgtagc ggaaacggct cccaacatta ccctcacccc 
 
-540   gtcgtagacg ggaaaagggt aaaaaacgcg ttgtcttagc taccgtttcc cctagtcacg 
 
-480   gactaaacgt tctgtaggaa ccggaagtgg ttccccggga cctctaggaa aagacagacg 
 
-420   tgctatgcgc tgacgttcat tggacggttt tcctcagagg ccacggcttc ccaggccagg 
                                               ERSE I reverse 
-360   gggtggccct gcgtgtgaga ggcccgcgga gccatgtgat tggaggacag ctgctggccg 
                      ERSE I                                            ERSE I reverse 
-300   agcccaatcg gaaggagcca cgcttcgggc atcgggcacc gcacctggac agttccgatt 
                                                                           ERSE I reverse 
-240   ggtgggctgc ggtccccccc gggcgtcccc attgggtgcg gggagtgcgt ggtgaggtgc 
 
-180   gattggtgtg ttcgtgtttc ccgtcccccg cccgcaagcc gtgcggtgaa aagcagcccg 
 
-120   acctgcgcgc gggttagtgg gcggaccgcg cggctggagg tgtgaggacc tgaggctcgg 
 
-60    ggtgggggcg gaggcggctc ctgcgaccga agaggacttg cgactcgccg gaattccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 19: Nucleotide sequence upstream of the d2eGFP reporter gene of vector 1104 (GRP94 reporter) 
Different cis-acting elements are boxed and the BglII and the EcoRI restriction sites are underlined. Deviations from the consensus 
sequence of the cis-acting elements are indicated in red. The GRP94 promoter region including the 5’ UTR is located from -11 to     
-1510, and the translation start site is located at +1. 
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In order to create a reporter construct responsive to XBP1-mediated ER stress, an intron 
sequence derived from XBP1 was inserted in the d2eGFP coding region of vector 917. 
Therefore, a NotI/SacII cloning site followed by an artificial translation stop codon (tag) were 
introduced between the coding sequence of eGFP and the adjacent PEST signal by site-
directed mutagenesis. Subsequently, a XBP1 fragment was isolated from genomic DNA derived 
from CHO DG44 cells by preparative PCR, thereby introducing a NotI and a SacII site at the 5’ 
and the 3’ end, respectively. This fragment was inserted into the mutated vector 917 via 
NotI/SacII, resulting in vector 1023. The corresponding DNA sequence of the modified eGFP is 
depicted in Fig. 20. 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
+61    ggcgacgtaa acggccacaa gttcagcgtg tccggcgagg gcgagggcga tgccacctac 
 
+121   ggcaagctga ccctgaagtt catctgcacc accggcaagc tgcccgtgcc ctggcccacc 
 
+181   ctcgtgacca ccctgaccta cggcgtgcag tgcttcagcc gctaccccga ccacatgaag 
 
+241   cagcacgact tcttcaagtc cgccatgccc gaaggctacg tccaggagcg caccatcttc 
 
+301   ttcaaggacg acggcaacta caagacccgc gccgaggtga agttcgaggg cgacaccctg 
 
+361   gtgaaccgca tcgagctgaa gggcatcgac ttcaaggagg acggcaacat cctggggcac 
 
+421   aagctggagt acaactacaa cagccacaac gtctatatca tggccgacaa gcagaagaac 
 
+481   ggcatcaagg tgaacttcaa gatccgccac aacatcgagg acggcagcgt gcagctcgcc 
 
+541   gaccactacc agcagaacac ccccatcggc gacggccccg tgctgctgcc cgacaaccac 
 
+601   tacctgagca cccagtccgc cctgagcaaa gaccccaacg agaagcgcga tcacatggtc 
 
+661   ctgctggagt tcgtgaccgc cgccgggatc actctcggca tggacgagct gtacaaggcg 
 
+721   gccgctgatc ctgacgaggt tccagagacg gagtccaagg gaaatggagt aaggccggtg 
                                                       intron 
+781   gccgggtctg ctgagtccgc agcactcaga ctacgtgcac ctctgcagca ggtgcaggcc 
 
+841   cagttgtcac ctccccagaa catcttcccg cggagtagcc atggcttccc gccggaggtg 
 
+901   gaggagcagg atgatggcac gctgcccatg tcttgtgccc aggagagcgg gatggaccgt 
 
+961   caccctgcag cctgtgcttc tgctaggatc aatgtgtag                       
 
Fig. 20: Nucleotide sequence of the XBP1 intron reporter gene of vector 1023 (Intron Reporter) 
The NotI and SacII restriction sites are underlined, the introduced stop codon (TAG) and a 26 bp intron is boxed. The coding region 
of eGFP is located from +1 to +717, and the XBP1 fragment from +726 to +867. The coding region of the PEST sequence from 
murine ornithine decarboxylase (MODC) is located from +877 to +999. 
A truncated GRP78 promoter was cloned into vector 526B using the SpeI restriction site. The 
obtained construct comprised a TK promoter followed by a neomycin resistance gene and the 
eGFP reporter gene driven by the truncated GRP78 promoter. The cloning procedure for the 
insertion of the truncated GRP78 promoter into vector 526B is described in Fig. 21. 
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Fig. 21: Schematic representation of the cloning procedure of vector 527 
By preparative PCR, a truncated GRP78 promoter region w as isolated using genomic DNA derived from CHO DG44 cells. Thereby, 
a SpeI restriction site was introduced at the 5’ and the 3’ end. The obtained PCR product was digested with the restriction 
endonuclease SpeI and the GRP78 promoter (606 bp) was inserted in vector 526B via SpeI, resulting in vector 527. The 
corresponding DNA sequence upstream of the eGFP of the ER stress reporter constructs is shown in Fig. 22. 
 
-691                                  t aaaatcgata agatccgtcg acaaaccaca 
                                                                              UPRE 
-660   actagaatgc agtactagag gcgcccttgc tcaccatggt ggcgactagt gacgggagga 
 
-600   cctggacggt taccggcgga aacggtctcg ggttgagagg tcacctgagg gacaggcagc 
 
-540   tgctgaacca ataggaccgg cgcacagggc ggatgctgcc tctcattggc ggccgttgag 
                                                                    UPRE 
-480   agtaaccagt agccaatgag tcagcccggg gggcgtagcg gtgacgtaag ttgcggagga 
                                                           ERSE II reverse and ERSE I 
-420   ggccgcttcg aatcggcagc ggccagcttg gtggcatgga ccaatcagcg tcctccaacg 
                                    ERSE I 
-360   agaagcgcct tcaccaatcg gaggcctcca cgacggggct ggggggaggg tatataagcc 
 
-300   aagtcggcgg cggcgcgctc cacactggcc aagacaacag tgaccggagg acctgccttt 
 
-240   gcggctccga gaggtaagcg ccgcggcctg ctcttgccag acctcctttg agcctgtctc 
 
-180   gtggctcctc ctgacccggg gtgcttctgt cgccctcaga tcggaacgcc gccgcgctcc 
 
-120   gggactacag cctgttgctg gacttcgaga ctgcagacgg accgaccgct gagcaactag 
 
-60    tgaggggagg acctgaacgg tcagcccgcc tgcctgactg ctgagcgcct agtcgccacc 
 
+1     atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 
 
Fig. 22: Nucleotide sequence upstream of the eGFP reporter gene of vector 527 
Different cis-acting elements are boxed, and the SpeI restriction sites are underlined. Deviations from the consensus sequence of 
the cis-acting elements are indicated in red. The truncated GRP78 promoter region is located from -66 to -671, and the translation 
start site is located at +1. 
Vector 526B 
Vector 527 
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In order to achieve enhanced FLPO expression, vector 673 was created as described in Fig. 23. 
 
Fig. 23: Schematic representation of vector 673 
Vector pFlpo-Puro (Raymond 2007) w as kindly provided by Prof. Bode (HZI Braunschweig). The FLPO w as isolated by a PCR and 
the obtained fragment was then cloned in a vector which enables to express the FLPO under the control of a CMV promoter.  
Vector 957 was created in order to tag CHO DG44 cells with an exchangeable DsRed RMCE 
acceptor construct. The cloning procedure of vector 957, comprising a SV40E promoter, a 
DsRed fluorescence gene, an IRES element, a HygTK fusion protein and heterospecific FRT-
sites (FRTwt and FRT3) is described in Fig. 24.  
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Fig. 24: Schematic representation of vector 957 
Step 1: By preparative PCR, the coding region for DsRed was amplif ied using the pDsRed-Express-N1 vector (Clontech) as PCR 
template. Thereby, BglII and SalI restriction sites were introduced at the 5’ and the 3’ end, respectively. The obtained PCR product 
was cloned into the pJET1.2/blunt vector (Fermentas) and digested with the restriction endonucleases BglII and SalI. After that, 
vector 951 was digested with the restriction endonucleases BamHI and XhoI and the DsRed fragment was transferred into this 
vector, resulting in vector 952. (Comment: The cleavage w ith the restriction endonucleases BglII and BamHI as w ell as SalI and 
XhoI creates compatible DNA extensions). Step 2: The EcoRV/NheI DNA fragment was transferred from vector 952 to vector 954. 
Step 3: Vector pF3HygTKF (Schlake 1994) was used to isolate the HygTK sequence by preparative PCR. Thereby, the restriction 
sites XbaI/AsiSI and AgeI w ere introduced at the 5’ and the 3’ end, respectively . The obtained PCR product w as cloned into the 
pJET1.2/blunt vector (Fermentas) and digested w ith the restriction endonucleases XbaI and AgeI. The obtained DNA fragment w as 
cloned into vector 881, resulting in vector 955. Step 4: The AsiSI/NheI DNA fragment was transferred from vector 955 to vector 954 
resulting in the f inal expression vector 957. 
Vector 881 
Vector 955 
Vector 951 
Vector 952 
Vector 954 
Vector 957 
  Materials and methods 
Page 40 
Vector 1071 is a RMCE donor construct coding for GTN, flanked by heterospecific FRT-sites. 
This vector was generated as described in Fig. 25. 
 
Fig. 25: Schematic representation of vector 1071 
Vector pF3ESGTNWF (Baer 2002) was used by Cellca GmbH to isolate the GTN sequence by preparative PCR. Thereby, EcoRV 
and PmlI restriction sites were introduced at the 5’ and the 3’ end, respectively. The obtained PCR product was cloned into the 
pJET1.2/blunt vector (Fermentas). After that, the MluI, KpnI, BspEI and SpeI restriction sites within the coding sequence of GTN 
were destroyed by the silent mutations 742G>C, 1243C>T, 1136T>C and 1846T>C. All mutations were done with the aid of the 
QuikChange II Site-Directed Mutagenesis Kit (Stratagene). The obtained construct was digested w ith the restriction endonucleases 
EcoRV and PmlI and the optimized GTN fragment w as cloned into vector 949, resulting in vector 1071. 
  
Vector 1071 
Vector 949 
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Vector 726 has been used to develop antibody producing cell lines. As control construct a 
corresponding mock vector expressing only dhfr was developed. The cloning procedure is 
described in Fig. 26. 
 
Fig. 26: Schematic representation of vector 1096  
The coding region for the immunoglobulin heavy and light chains, as w ell as, their promoters were removed with the aid of the 
restriction endonucleases NdeI and NheI. After blunting w ith T4 polymerase and religation, the Mock vector was generated. This 
vector comprised the remaining TK promoter and the dhfr gene. 
5.2.4. Preparative polymerase chain reaction on genomic DNA 
In order to isolate specific DNA sequences from mammalian cells, genomic DNA was prepared 
(see chapter 5.2.21) and a PCR mixture was set up as shown in Tab. 11. The PCR was 
performed according to the cycling conditions listed in Tab. 12 
Tab. 11: Reaction mixture for preparative PCR on genomic DNA 
Component
9.85 µL Water
3.0 µL HF buffer 1 x
0.2 µL genomic DNA 2.0 ng/µL
0.75 µL forward Primer 0.5 µM
0.75 µL reverse Primer 0.5 µM
0.3 µL dNTPs 200 µM
0.15 µL Phusion DNA Polymerase 0.02 U/µL
15 µL
Volume
----------
Final concentration
 
  
Vector 726 
Vector 1096 
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Tab. 12: PCR cycling conditions 
Denaturation 98°C for 30 s
Amplification 98°C for 15 s Denaturation
X °C for 15 s Hybridization 35x
72°C for 90 s Elongation
Final Extension 72°C for 10 min
Cooling 4°C hold endless  
All primers were self designed and synthesized by a commercial provider (Eurogentec). The 
sequences of the used primer pairs and the corresponding targets are shown in Tab. 13. 
Tab. 13: Used PCR primers and their targets on genomic DNA  
Target Sequence of primer (5'-3')
Name of 
primer Amplicon TM
CALR agtggagatgggttttcacc ON49-1D 1643 bp 60.0 °C
acctccgtccaagaactgctc ON49-2C
GRP78 tcaatgttatgacagtattacaagc ON49-5B 2463 bp 64.0 °C
atcctccttcttgtcctcctc ON49-6
GRP94 catcatctgcagaaacttctacc ON49-7 2012 bp 55.0 °C
ggtcactcaccgaaggtcagc ON49-8
XBP1 gggaatgcggccgctgatcctgacgaggttccagag ON48-1 168 bp 50.0 °C
cagagtccgcgggaagatgttctgggg ON48-2  
5.2.5. Analytical polymerase chain reaction on genomic DNA 
To verify recombinase mediated cassette exchange (RMCE) of tagged clones, genomic DNA 
was prepared (see chapter 5.2.21) and PCR mixtures were set up as shown in Tab. 14. As 
described in Tab. 16, various primer combinations were used to differentiate between authentic 
exchange events (ON62-1C and ON62-3C), unexchanged acceptor cassettes (ON62-1C and 
ON62-4) and random integrations of the donor construct (ON62-2 and ON62-3C). All primers 
were self designed and synthesized by a commercial provider (Eurogentec). PCRs were 
performed according to the cycling conditions listed in Tab. 15. 
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Tab. 14: Standard analytical PCR reaction on genomic DNA 
Component
9.3 µL Water
3.0 µL Buffer 1 x
0.75 µL genomic DNA 5.0 ng/µL
0.75 µL forward Primer 0.5 µM
0.75 µL reverse Primer 0.5 µM
0.3 µL dNTPs 200 µM
0.15 µL Phusion DNA Polymerase 0.02 U/µL
15 µL
Volume
----------
Final concentration
 
Tab. 15: PCR cycling conditions 
Denaturation 98°C for 2 min
Amplification 98°C for 10 s Denaturation
64°C for 15 s Hybridization 35x
72°C for 25 s Elongation
Final Extension 72°C for 2 min
Cooling 4°C hold endless  
Tab. 16: Used PCR primers  and their targets on genomic DNA 
Target Sequence of primer (5'-3') Name of primer Amplicon
SV40E on RMCE acceptor tgaggcggaaagaaccag ON62-1C 549 bp
neo on RMCE donor atcagagcagccgattgtc ON62-3C
SV40E on RMCE acceptor tgaggcggaaagaaccag ON62-1C 749 bp
DsRed on RMCE acceptor cgtcctcgaagttcatcac ON62-4
SR on RMCE donor aaataggggttccgcgcac ON62-2 293 bp
neo on RMCE donor atcagagcagccgattgtc ON62-3C  
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5.2.6. Site-directed mutagenesis 
Point mutations on plasmids were introduced with the QuikChange II Site-Directed Mutagenesis 
Kit (Stratagene) as described in the manufacturer’s manual. The used primers had a length of 
25 bp to 45 bp and annealed to the same sequence on opposite strands of the plasmid. They 
were designed with the web-based program QuikChange Primer Design (Stratagene) and 
synthesized by a commercial provider (Eurogentec). 
5.2.7. Oligonucleotide annealing 
In order to generate short dsDNA linkers (20-60 bp), two complementary oligonucleotides were 
annealed. Therefore, a solution containing 1x Buffer for T4 DNA Ligase (NEB), 25 µM of the 
forward and 25 µM of the reverse oligonucleotide was prepared, mixed and transferred to a 
thermocycler. Following an incubation period of 10 min at 95°C, the temperature was stepwise 
decreased every 27 s by 0.7°C. After 100 steps a temperature of 25°C was reached and the 
mixture was directly used or stored at -20°C. 
5.2.8. Restriction digests, blunting, and dephosphorylation  
Plasmid DNA or linear DNA, which was generated by PCR, was digested by restriction 
endonucleases (NEB), using the recommended buffer and 1x BSA solution as described by the 
manufacturer. 2 U enzym per 1 μg DNA were added and the reaction mixture was incubated for 
at least 1 h at the appropriate temperature (mostly at 37°C). Single-stranded 5’ DNA extensions 
were filled up by using the 5’ to 3’ DNA synthesis activity of T4 DNA Polymerase (NEB). For this 
purpose, standard digestion reaction mixtures containing Buffer 1, 2, 3, or 4 (NEB) were 
supplemented with 100 µM dNTPs and 1 U T4 DNA Polymerase per 1 µg DNA followed by an 
incubation period of 15 min at 12°C. Alternatively, single-stranded 5’ or 3’ DNA extensions were 
removed by the endonuclease activity of Mung Bean Nuclease (NEB). For this purpose, 
standard digestion reaction mixtures containing Buffer 1, 2, or 4 (NEB) were supplemented with 
1 U Mung Bean Nuclease per 1 µg DNA and incubated for 30 min at 30°C. To avoid religations 
of linearized vectors during ligation reactions, 5’ phosphate groups were removed with Antarctic 
Phosphatase (NEB). Therefore, digestion reaction mixtures were supplemented with Antarctic 
Phosphatase Buffer (NEB) and 0.2 to 1 U Antarctic Phosphatase per 1 µg DNA. The reaction 
mixture was incubated at 37°C for 15 min in case of 5’ extensions or blunt ends and for 60 min 
in case of 3’ extensions. 
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5.2.9. Agarose gel electrophoresis 
Agarose gel electrophoresis was used, in order to separate DNA fragments according to 
fragment size. For the preparation of agarose gels, between 0.8-3% agarose were dissolved in 
100 mL 1x TBE buffer by heating in a microwave. Then, ethidium bromide was added in a final 
concentration of 0.5 µg/mL and the mixture was filled in a gel tray placed in a casting chamber. 
A plastic comb was inserted to form slots for the DNA samples. After the gel was cooled down, 
the comb was removed and the gel was transferred to an electrophoresis chamber (Bio-Rad) 
filled with 1x TBE buffer or stored at 4°C. 
DNA samples supplemented with 5x Loading Dye (NEB) and DNA size standards (Tab. 17) 
were filled into the slots and a constant voltage of 140 V was applied for 30 to 60 min by a 
Power Pac 200 gel electrophoresis system (Bio-Rad). Subsequently, the separated DNA 
fragments were visualized and documented with a gel documentation system (E.A.S.Y. 400K  
Win32 Gel Documentation System; Herolab). If necessary, desired DNA fragments were 
excised with surgical blades (Swann Morton) and the DNA was extracted and purified as 
described in chapter 5.2.10. 
Tab. 17: DNA size standards 
Component Specification
100 bp DNA 
Ladder (NEB)
100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1200, 1517 bp 
1 kb DNA 
Ladder (NEB)
0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 10.0 kb 
 
5.2.10. Gel extraction and purification of DNA 
To remove disturbing buffers and enzymes from DNA samples or to isolate DNA fragments from 
agarose gels, the E.Z.N.A. Gel Extraction Kit (Omega) was used according to the 
manufacturer’s manual. The purified DNA was eluted with 30 µL WFI. 
5.2.11. Ligation of DNA fragments 
To ligate two DNA fragments, vector and insert DNA were used in a molar ratio of 1 to 4. A 
standard ligation mixture of 10 µL contained 100 ng total DNA, 1x Buffer for T4 DNA Ligase 
(NEB), 2.5% PEG 4000 (Fermentas) and 0.5 µL T4 DNA Ligase (NEB) was prepared and 
incubated for 1 to 2 h at room temperature. 
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5.2.12. Preparation of agar plates  
Agar plates were prepared to cultivate transformed bacteria. Therefore, 40 g/L LB-agar (Roth) 
was dissolved in WFI and autoclaved for 20 min at 121°C. After the medium cooled down to 
about 50°C the appropriate antibiotics (100 µg/mL Ampicillin (Sigma) or 50 µg/mL Kanamycin 
(Sigma)) were supplemented. Hence approximately around 25 mL media has been filled into 
10 cm petri dishes and after 1 h all plates were stored at +4°C. 
5.2.13. Transformation of bacteria 
An aliquot of 25 µL transformation competent E. coli (see Tab. 18) was thawed at 4°C and 
transferred to a pre-chilled 1.5 mL tube (Sarstedt). 2.5 µL DNA solution (e.g. a ligation mixture) 
was added, the cells were mixed by tapping and incubated for 30 min at 4°C. Subsequently, the 
cells were heat pulsed for 30 s at 42°C and placed again at 4°C for 5 min. 250 µL S.O.C. 
medium (NEB) was added followed by an incubation period of 1 h at 37°C and 300 rpm in a 
thermomixer (Eppendorf). Finally, the transformed cells were spread on agar plates containing 
appropriate antibiotics and cultivated over night at 37°C. 
Tab. 18: Overview of E. coli  stains and their application 
Recommended application
NEB 5-alpha used for plasmids smaller than 10 kbp
NEB 10-beta used for plasmids larger than 10 kbp
JM100 used in order to produce plasmids free of Dam and Dcm methylation 
E. coli  stains
 
5.2.14. Linearization of plasmids for transfection  
In order to generate linear DNA constructs for the transfection of mammalian cells, a reaction 
mixture was prepared as shown in Tab. 19 and incubated at 37°C for at least 3 h. 
Tab. 19: Standard reaction mixture for plasmid linearization 
Component
108.5 µL Water
15.0 µL 10x Buffer 4 1 x
19.0 µL plasmid DNA 0.25 µg/µL
7.5 µL BspHI 2.0 U/µg DNA
150 µL
Volume
----------
Final concentration
 
The linearized DNA was purified and concentrated by isopropanol precipitation (see 
chapter 5.2.16), dissolved in 50 µL Tris Buffer (10 mM, pH 8.0, Applichem) and stored at -80°C. 
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5.2.15. Excision of plasmids for transfection 
In order to generate linear DNA constructs for the transfection of mammalian cells, which are 
free of the bacterial vector backbone, a reaction mixture was prepared as shown in Tab. 20 and 
incubated at 37°C for at least 3 h. Subsequently, the DNA was separated by agarose gel 
electrophoresis and the desired DNA fragment was excised and subjected to gel extraction. The 
eluted DNA was purified and concentrated by isopropanol precipitation (see chapter 5.2.16), 
dissolved in 50 µL of Tris Buffer (10 mM, pH 8.0, Applichem) and stored at -80°C. 
Tab. 20: Standard reaction mixture for plasmid excision 
Component
101.0 µL Water
15.0 µL 10x Buffer 3 1 x
19.0 µL plasmid DNA 0.25 µg/µL
7.5 µL MluI 2.0 U/µg DNA
7.5 µL SalI-HF 2.0 U/µg DNA
150 µL
Volume
----------
Final concentration
 
5.2.16. Isopropanol precipitation 
Isopropanol precipitation was performed in order to concentrate linearized plasmid DNA prior to 
transfection. A standard mixture was prepared in a sterile 1.5 mL tube as exemplified shown in 
Tab. 21 and gently mixed. 
Tab. 21: Standard mixture for isopropanol precipitation 
1.0 mL DNA Solution
0.7 mL 2-propanol (99.8 %)
0.1 mL sodium acetate (3 M, pH 5.2)
Composion of standard mixture
 
The mixture, containing the formed precipitate was centrifuged with a Biofuge fresco (Heraeus) 
for 30 min at 13000 rpm and 4°C and the supernatant was discarded. Subsequently, the DNA 
pellet was washed twice as follows: 1 mL ethanol (70%) was added, the tube was centrifuged at 
4°C for 5 min at 13000 rpm and the supernatant was decanted. The tube was placed in a 
laminar flow box and dried until the pellet appeared transparent. The pellet was resuspended in 
sterile Tris Buffer (10 mM, pH 8.0, Applichem), mixed and incubated for about 1 h at room 
temperature. The DNA concentration was adjusted to 2000 ng/µL by using sterile Tris Buffer 
(10 mM, pH 8.0, Applichem). Before storage, concentration and quality of the prepared DNA 
was checked by measuring OD230, OD260 and OD280 with a Photometer (Bio Photometer, 
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Eppendorf). Pure DNA should have an OD260/OD280 ratio between 1.80 and 2.00 and an 
OD260/OD230 ratio between 1.90 and 2.40. 
5.2.17. Preparation of glycerol stock cultures 
Glycerol stock cultures were prepared to store transformed bacteria for a longer time. 
Therefore, 1 mL of a bacterial culture, grown for around 16 h, was transferred to a 1.8 mL 
CryoPure tube (Sarstedt) and supplemented with glycerol (Applichem) to a final concentration of 
17.5%. The suspension was thoroughly mixed and stored at -80°C. 
5.2.18. Preparation of LB and TB medium 
LB and TB medium were used during mini or maxi preparation of plasmid DNA from bacteria. In 
order to prepare the LB medium 25 g/L LB-Broth (Roth) was dissolved in WFI, autoclaved for 
20 min at 121°C and stored at +4°C. TB medium was autoclaved and stored in the same way, 
but this time 47.6 g/L TB medium powder (Roth) and 4 mL/L glycerol (Applichem) were 
dissolved in WFI. The appropriate antibiotics were supplemented immediately before use. 
5.2.19. Maxi preparation of plasmid DNA from bacteria 
In order to prepare large amounts of plasmid DNA, 200 mL TB medium (Roth) supplemented 
with 100 µg/mL Ampicillin (Sigma) or 50 µg/mL Kanamycin (Sigma) were filled in a 500 mL 
shake flask (Corning) and inoculated with a single bacterial colony or from a glycerol stock 
culture. The medium was placed in an incubator (Certomat IS, Sartorius) and shaken at 
240 rpm and 37°C for 16 h. Subsequently, the plasmid DNA was prepared with the PureLink 
HiPure plasmid Filter Maxiprep Kit (Invitrogen) as described in the manufacturer’s manual. The 
obtained DNA was dissolved in 200 µL Tris Buffer (10 mM, pH 8.0, Applichem) and stored at 
+4°C. Before storage, concentration and quality of the prepared DNA was checked by 
measuring OD230, OD260 and OD280 with a Photometer (Bio Photometer, Eppendorf). Pure 
DNA should have an OD260/OD280 ratio between 1.80 and 2.00 and an OD260/OD230 ratio 
between 1.90 and 2.40. 
5.2.20. Mini preparation of plasmid DNA from bacteria 
A single bacterial colony was used to inoculate a 13 mL tube (Sarstedt) filled with 5 mL LB-
medium (Roth) containing 100 µg/mL Ampicillin (Sigma) or 50 µg/mL Kanamycin (Sigma). The 
tube was placed in an incubator (Certomat IS, Sartorius) and shaken at 240 rpm and 37°C for 
16 h. Subsequently, the plasmid DNA was prepared with the E.Z.N.A. Plasmid Mini Kit I 
(Omega) according to the manufacturer’s manual and stored at +4°C. 
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5.2.21. Preparation of genomic DNA from mammalian cells and from blood  
In order to isolate genomic DNA from mammalian cells or from human blood, 6 x 105 cells or 
1 mL blood, respectively, were treated with the AquaGenomic Kit (MoBiTec) as described in the 
manufacturer’s manual. The prepared genomic DNA was dissolved in 100 µL water (Roth) and 
stored at -20°C. 
5.2.22. Preparation of total RNA from mammalian cells and cDNA synthesis 
In order to prepare total RNA from mammalian cells, 6 x 105 cells were transferred to a 1.5 mL 
tube (Sarstedt) and centrifuged with a Biofuge pico (Heraeus) for 2 min at 2000 rpm. The 
supernatant was discarded and the RNA was prepared using QIAshredder columns (Qiagen) 
and the RNeasy Plus Mini Kit (Qiagen) according to the manufacturer’s instructions. To remove 
remaining genomic DNA, 3 µL of the obtained RNA solution were treated with 1x Baseline-Zero 
DNase Reaction Buffer (Epicentre) and supplemented with 1 µg/µL Baseline-Zero DNase I 
(Epicentre). After 30 min at 37°C, the reaction was stopped by the addition of 1x Baseline-Zero 
DNase Stop-Solution (Epicentre) followed by an incubation period of 10 min at 65°C. 
The DNase-treated RNA was directly used for cDNA synthesis. For this purpose, the reaction 
mixture shown in Tab. 22 was prepared and incubated for 80 min at 37°C followed by 10 min at 
70°C. The obtained cDNA was stored at -70°C. 
Tab. 22: Reaction mixture for cDNA synthesis 
Component
33.25 µL Water (RNAse-free)
7.0 µL poly(A) Template RNA 1-50 ng
3.5 µL oligo(dT)18 Primer 25.0 ng/µL
14.0 µL Reaction buffer 1 x
1.75 µL ScriptGuard Rnase Inhibitor 1.0 U/µL
7.0 µL dNTP mix 1.0 mM
3.5 µL M-MuLV Reverse Transcriptase 1.0 U/µL
70 µL
----------
Volume Final concentration
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5.3. Cell biological methods 
5.3.1. Mammalian cells and media 
CHO K1 cells (ATCC no.: CCL-61) and CHO DG44 cells were obtained from the German 
Collection of Microorganisms and Cell Cultures (DSMZ) and from Lawrence Chasin (Columbia 
University, New York), respectively. CHO DG44 is a dhfr-deficient cell line, which was created 
by gamma ray mutagenesis of CHO K1 cells (Urlaub 1983). Originally, both cell lines were 
adherent and were cultivated in two different serum containing media Medium S1 and 
Medium S2, see Tab. 23. 
At Cellca, the cells were adapted to serum free suspension growth conditions by using 
Medium D1 (for CHO DG44 cells) or Medium K1 (for CHO K1 cells)), respectively (see   
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Tab. 24). The serum concentration within both culture media was reduced gradually. Cells 
adapted to serum free media were finally cultivated under standard conditions as described in 
chapter 5.3.2. 
Tab. 23: Culture media for adherent cell cultures 
Composition of the first cultivation medium  
(Medium S1) 
1 L CD Hybriboma Medium 
100 mL FB Serum 
30 mL L-Glutamine (200 mM) 
20 mL HT Supplement 
 
Composition of the second cultivation medium  
(Medium S2) 
1 L Modified CD CHO Medium 
100 mL FB Serum 
30 mL L-Glutamine (200 mM) 
20 mL HT Supplement 
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Tab. 24: Culture media for cell line adaption 
Composition of adaption medium for CHO DG44 cells 
(Medium D1) 
1 L CD DG44 Medium 
100 mL FB Serum 
30 mL L-Glutamine (200 mM) 
10 mL Pluronic F-68 Solution 
Composition of adaption medium for CHO K1 cells  
(Medium K1) 
1 L CD Hybridoma Medium 
100 mL FB Serum 
30 mL L-Glutamine (200 mM) 
20 mL HT Supplement 
4 mL Cholesterol Lipid Concentrate 
5.3.2. Maintenance of cell lines cultivated under standard conditions 
CHO DG44 and CHO K1 cells as well as all stable transfected cell lines created during this 
thesis were cultivated in 6 well plates filled with 3-5 mL or in 125 mL shake flasks (Corning) 
filled with 25 mL of the appropriate culture medium (see Tab. 25). After a cultivation period of 3 
to 4 days, viable cell densities and viabilities were determined with a CASY cell counter (Roche) 
and cells were split into fresh medium at a concentration of 1 to 3 x 105 cells/mL. Throughout 
this study, all cells were cultivated under linear shaking (110 rpm, Bühler shaker, E. Bühler) in a 
humid atmosphere at 36.8°C and 7.5% pCO2 (HERAcell 240, Thermo), unless otherwise noted 
(standard conditions). 
Tab. 25: Culture media for cultivation under standard conditions 
Composition of medium for CHO K1 wt cells 
(Medium K2) 
1 L CD Hybridoma Medium 
30 mL L-Glutamine (200 mM) 
20 mL HT Supplement 
4 mL Cholesterol Lipid Concentrate 
 
Composition of medium for CHO DG44 wt cells 
(Medium D2) 
1 L CD DG44 Medium 
30 mL L-Glutamine (200 mM) 
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Composition of medium for CHO DG44 cells  
transfected with dhfr 
(Medium D3) 
1 L CD CHO Medium 
30 mL L-Glutamine (200 mM) 
10 mL Pluronic F-68 Solution 
 
Composition of medium for CHO DG44 wt cells 
(Medium D4) 
1 L PID1-MD-SMD13 
20 mL HT Supplement 
1 mL Folinic acid (97.2 g/L) 
1 mL Glycine (4 g/L) 
 
Composition of medium for CHO DG44 cells  
transfected with dhfr 
(Medium D5) 
/ PID1-MD-SMD13 
 
Composition of medium for CHO DG44 cells  
transfected with dhfr 
(Medium D6) 
/ PID1-MD-SMD10 
5.3.3. Transfection and sub-cultivation of CHO DG44 and CHO K1 cells 
One day before transfection, cells were split 1:3 into fresh culture medium (Medium D2 for CHO 
DG44 cells and Medium K2 for CHO K1 cells). On the day of transfection, 3 to 10 µg circular, 
linearized or excised plasmid DNA were transferred to a 1.5 mL tube (Sarstedt) and 1 x 106 
cells were centrifuged at 190 g for 3 min (Biofuge stratus, Heraeus). The supernatant was 
discarded, and the cell pellet was resuspended in 100 µL Nucleofector solution V (Nucleofector 
Kit for CHO, Lonza), which had been mixed before with Supplement 1 as described by the 
manufacturer. The cell suspension was transferred to the 1.5 mL tube containing the plasmid 
DNA and all components were mixed with a pipette and placed in an electroporation cuvette 
(Lonza). Subsequently, cells were transfected with a Nucleofector II device (Lonza) using 
program U24, 600 µL pre-warmed Medium D2 (for CHO DG44 cells) or Medium K2 (for CHO 
K1 cells) were added and the cell suspension was transferred to a 6-well plate filled with 3.3 mL 
  Materials and methods 
Page 54 
of the same medium. Following an incubation period of 1 h at 36.8°C and 7.5% pCO 2 without 
shaking, transfected cells were cultivated under standard conditions (see chapter 5.3.2). 
5.3.4. Generation and sub-cultivation of mini-pools 
Mini-pools were generated to separate different clones as early as possible, thereby avoiding 
overgrowth of high-expressing cells by low-producers. For this reason, 2 to 4 transfections each 
with 10 µg linearized DNA were performed as described in chapter 5.3.3. One day after 
transfection, all transfected cells were pooled and the viable cell concentration was determined. 
Subsequently, cells were subdivided into two pools and centrifuged at 190 g for 3 min (Biofuge 
stratus, Heraeus). One cell pellet was resuspended in pre-warmed Medium D3 and the other in 
pre-warmed Medium D3 supplemented with different MTX concentrations and with or without 
Hygromycin B. The viable cell concentrations were adjusted to 6667 cells/mL by using 
appropriate media volumes. For each pool, two 96 well flat bottom plates were filled with 150 µL 
cell suspension per well (resulting in 1000 cells/well) and incubated for 1 h under standard 
conditions without shaking. Subsequently, the plates were put into a ¾ closed Ziploc bag 
(Melitta) and cultivated under the same conditions for at least two weeks. 
All grown mini-pools that covered 25-50% of the 96 well bottom were transferred into 24 well 
plates containing 1.0 mL/well of the appropriate selective medium (Medium D3 supplemented 
with different MTX concentrations and with or without Hygromycin B) and cultivated under 
standard conditions without shaking. Around three-fourths of the supernatant was exchanged 
for fresh medium every 3 to 4 days until clear cell accumulations became visible. All grown mini-
pools were transferred into 12 well plates filled with 2.0 mL/well of the appropriate selective 
medium (Medium D3 supplemented with different MTX concentrations and with or without 
Hygromycin B) and treated as described for 24 well plates. Finally, all grown mini-pools were 
transferred to 6 well plates containing 4 mL/well of the same medium and cultivated under 
standard conditions for 3 to 4 days. From now on, mini-pools were subcultivated in 6 well plates 
or shake flask as described in chapter 5.3.2. 
5.3.5. Single cell cloning and clone expansion 
To generate monoclonal cell lines, single cell cloning employing a FACSAria cell sorter (Becton) 
was performed. For this purpose, at least 1 x 106 cells were filtered into a cell strainer tube 
(Becton) and used for FACS analysis and cell sorting. Death cells or cell aggregates were 
excluded by FSC/SSC gating and viable cells were analyzed with regard to DsRed or GFP 
fluorescence or other parameters, respectively. Desired clones were sorted (1 cell/well) into 96 
well round bottom plates (TC Microwell 96U, Nunc) filled with 150 µL pre-warmed Medium C1 or 
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Medium C2. Following an incubation period of 1 h under standard conditions without shaking, 
the plates were put into a ¾ closed Ziploc bag (Melitta) and cultivated under the same 
conditions for at least two weeks. 
All grown colonies with a diameter of around 2-3 mm were transferred into 24 well plates 
containing 1.0 mL/well of the selective medium (supplemented with MTX, G418 or 
Hygromycin B) which had been used before single cell cloning. Subsequently, cells were 
cultivated under standard conditions without shaking until a clear cell pellet was visible (usually 
after 3 to 5 days). After this time three-fourths of their supernatant was discarded, all grown 
clones were transferred into 12 well plates filled with 2.0 mL/well of the appropriate selective 
medium and cultivated for 3 to 4 days under standard conditions without shaking. Finally, all 
grown clones were transferred into 6 well plates filled with 4.0 mL/well of the same medium as 
described for 12 well plates and cultivated for 2 to 3 days under standard conditions. From now 
on, clones were subcultivated in shake flasks as described in chapter 5.3.2. 
Tab. 26: Culture media for single cell cloning 
Composition of medium for single cell cloning 
(Medium C1) 
1 L CD CHO Medium 
40 mL Cellca´s proprietary cloning supplement 
10 mL L-Glutamine (200 mM) 
0.5 mL Cellca´s proprietary cloning supplement 
 
Composition of medium for single cell cloning 
(Medium C2) 
1 L CD DG44 Medium 
40 mL Cellca´s proprietary cloning supplement 
10 mL L-Glutamine (200 mM) 
10 mL Pluronic F-68 Solution 
0.5 mL Cellca´s proprietary cloning supplement 
5.3.6. Fed-batch experiments 
In order to perform fed-batch experiments, shake flasks containing 25 mL Production°Medium 
(Tab. 27) were inoculated with a viable cell concentration of 3 x 105 cells/mL and cultivated 
under standard conditions. The cultures were fed with Feed Medium A (PID1-MD-FMA70) and 
Feed Medium B (PID1-MD-FMB16) as depicted in Tab. 28. Every day, 1 mL sample was taken 
and viable cell density as well as viability were determined with a CASY cell counter (Roche). 
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Additionally, product concentrations were measured by Protein A-HPLC and pH, lactate and 
glucose concentration were determined with a blood gas analyzer (ABL800 FLEX, Radiometer). 
Whereas it was not necessary to adjust the pH or the L-glutamine concentration during the 
whole process, the glucose concentration was adjusted to 2 - 6 g/L by adding appropriate 
volumes of a 250 mM D-glucose solution. 
Tab. 27: Culture media for fed-batch experiments 
Composition of production medium 
(Production°Medium) 
1 L PID1-MD-PM55 
30 mL L-Glutamine (200 mM) 
 
Tab. 28: Feed media for fed-batch experiments 
Day 3 4 5 6 7 8
9 until end 
of process
Feed Medium A [mL] 0.7 0.7 1.0 1.0 1.3 1.3 1.0
Feed Medium B [mL] 0.1 0.1 0.1 0.1 0.1 0.1 0.1  
5.3.7. Recombinase mediated cassette exchange (RMCE) 
For RMCE experiments, a genomically anchored DsRed RMCE acceptor construct comprising 
heterospecific FRT-sites (FRTwt and FRT3) has been used (Schlake 1994). An absolute lack of 
cross-interaction between both FRT-sites has been shown (Bode 2000 Sep-Oct). This enables 
a site specific exchange of the genomically anchored DsRed RMCE acceptor construct against 
a RMCE donor construct without a cross-interaction between both FRT-sites and the loss of the 
vector cassette (Bode 2000; Baer 2001). 
RMCE of cell lines tagged with the DsRed RMCE acceptor construct was performed as follows: 
Cells were split into Medium D2 supplemented with 200 mg/L Hygromycin B at a viable cell 
concentration of 1 x 105 cells/mL and cultivated under standard conditions for 3 days. 1 x 106 
cells were centrifuged (190 g, 3 min, room temperature), resuspended in 4 mL pre-warmed 
Medium D2 and transferred into a 6 well plate. Additionally, 0.4 mL Medium D2 was placed in a 
1.5 mL tube and 6 µg of the desired RMCE donor construct, 1 µg of the FLPO construct, and 
10 µL Turbofect reagent (Fermentas) were added. All components were mixed and incubated at 
room temperature for 15 min. The mixture was added to the cells previously prepared in 6 well 
plate followed by an incubation period of two days under standard conditions. Subsequently, the 
transfected cells were centrifuged (190 g, 3 min, room temperature), resuspended in 
Medium D2 supplemented with 500 mg/L G418 and subcultivated as described in chapter 5.2.2. 
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5.3.8. Calculation of cell specific productivity 
Cell specific productivities were calculated based on viable cell densities measured with a 
CASY cell counter (Roche) and product concentrations determined with ELISA or Protein A-
HPLC by using the following equation: 
    
     
       
          
          
  
 
QP = cell specific productivity [pg/cell/day] 
P1 = initial product concentration 
P2 = final product concentration 
x1 = initial cell concentration 
x2 = final cell concentration 
t1 = start date of cultivation 
t2 = final date of cultivation 
5.3.9. Calculation of renilla specific product concentration 
Product concentrations and renilla luminescence were determined on day 3 or 4 after 
transfection. The renilla specific product concentration was calculated by using the following 
equation: 
    
     
   
 
 
PRL = Renilla specific product concentration [g/mL/RLU] 
P1 = initial product concentration 
P2 = final product concentration 
RL2 = final renilla luminescence 
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5.4. Analytical and biochemical methods 
5.4.1. Measurement of viable cell concentration and v iability 
The viable and total cell concentration as well as the viability of a cell suspension was 
measured as follows: The cell suspension was thoroughly mixed by pipetting or swirling and an 
aliquot of 50 µL was taken and diluted in 10 mL CASY-ton isotonic solution (Roche) and 
analyzed with a CASY cell counter (Roche) as described in the manufacturer ’s manual. 
Because the CASY cell counter does not accept suspensions with very high cell concentrations, 
such samples were pre-diluted in an adequate volume of CASY-ton isotonic solution. For all 
measurements, the evaluation cursor (discriminates between live and dead cells) was set to 
11.72 µm and the normalization cursor (discriminates between cell aggregates and dead cells) 
was set to 6.1 µm. 
5.4.2. Human IgG enzyme-linked immunosorbent assay (qELISA, nqELISA) 
Monoclonal antibody concentrations were determined by quantitative ELISA (qELISA) using the 
Human IgG ELISA Quantitation Kit (Bethyl) according to the manufacturer’s instructions. Briefly, 
96 well plates (MultiDish 6 Well, Nunc) were coated by adding 100 µL Coating Buffer containing 
1 µL Capture Antibody Solution to each well. After 60 min, all wells were washed 3 times with 
200 µL Wash Solution and 200 µL Blocking Solution were added. Following an incubation 
period of 30 min, the plates were washed again with 200 µL Wash Solution per well and stored 
at 4°C or used directly. 
To create a standard curve, a series of 1:2 dilutions ranging from 0.5 µg/mL to 
0.0078125 µg/mL was prepared with Human Reference Serum and Sample Diluent. Based on 
their expected concentration, the samples were diluted with Sample Diluent in an adequate 
manner to be within the range of the standard curve. 100 µL of samples and standards were 
then transferred to coated 96 well plates and incubated for 60 min. Subsequently, all wells were 
washed 5 times with 200 µL Wash Solution and incubated with 100 µL of a 1:150000 dilution of 
HRP Conjugate in Sample Diluent for 60 min. Again, all wells were washed 5 times with 200 µL 
Wash Solution and 100 µL “TMB Supersensitive One Component HRP Mircowell substrate” 
solution (BioTX Laboratories) were transferred to each well. After 10 min, the reaction was 
stopped by adding 100 µL 2 M H2SO4 (Roth) per well and absorbance at a wavelength of 
450 nm was measured with an Appliskan microplate reader (Thermo). The antibody 
concentration was calculated according to the generated standard curve. 
Non-qualitative ELISA (nqELISA) was performed in the same way as qELISA, but by 
comparison, all samples were diluted 1:20 and no standard curve was implemented. 
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Tab. 29: Used ELISA components 
Component Specification
Coating Buffer 0.05 M Carbonate-Bicarbonate, pH 9.6
Wash Solution 50 mM Tris, 0.138 M NaCl, 0.0027 M KCl, 
0.05% Tween 20, pH 8.0
Blocking Solution 50 mM Tris, 0.138 M NaCl, 0.0027 M KCl,  
1% BSA, pH 8.0
Sample Diluent 50 mM Tris, 0.138 M NaCl, 0.0027 M KCl, 
1% BSA, 0.05% Tween 20
Capture Antibody Solution Goat anti-Human IgG-Fc affinity purified
HRP Conjugate Goat x-Human IgG-Fc HRP conjugated
Human Reference Serum Human Reference Serum  
5.4.3. High pressure liquid chromatography (HPLC) 
Antibody concentrations of fed-batch experiments were determined with a HPLC device 
(Finnigan Surveyor Plus, Thermo Electron) equipped with a protein A column (Poros, 20 micron, 
Applied Bio systems). Depending on the expected antibody concentration between 1 and 50 µL 
sample (1 to 20 µg antibody) as well as 1, 5, 10, 15 and 20 µg of an antibody standard were 
injected, eluted as depicted in Tab. 30 and detected with an UV Detector (Surveyor PDA Plus 
Detector, Thermo Electron) at 280 nm. All chromatograms were integrated and the antibody 
concentration was calculated based on the generated standard curve by using Chrom Quest 
software (Thermo Electron). 
Tab. 30: Elution conditions and components of mobile phase A and B 
Time [min] Fluids Flow [mL/min]
01:00 100 % Mobile Phase A 2
03:05 Gradient: 
from 80/20 % Mobile Phase A/B
to 100 % Mobile Phase B
2
00:15 100 % Mobile Phase B 2
02:55 100 % Mobile Phase A 2  
Component Specification
Mobile Phase A 10 mM NaH2PO4, 150 mM NaCl, pH 7.5
Modile Phase B 10 mM HCl, 150 mM NaCl, pH 2.0  
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5.4.4. FACS analysis 
DsRed and GFP fluorescence of the cells were determined, employing a FACSAria flow 
cytometer (Becton). Therefore, around 1 x 106 cells were filtered into a cell strainer tube and 
used for FACS analysis. By a selective FSC/SSC gating procedure, dead cells and cell 
aggregates were excluded and viable cells were measured with regard to DsRed and GFP 
fluorescence. 
5.4.5. Dual luciferase assay 
All buffers and substrates required to determine renilla luminescence are included in the Dual-
Glo Luciferase Reporter Assay System (Promega) and were prepared according to the 
manufacturer’s instructions. Cell lines transiently transfected with plasmids coding for an 
antibody and the renilla luciferase reporter gene (hRluc) were used for analysis. For lysis, 75 µL 
cell suspension was transferred into a white flat bottom 96 well plate, 75 µL Dual-Glo Luciferase 
Reagent was added and the plate was mixed for 10 s. After an incubation time of 10 min at 
room temperature, 75 µL Dual-Glo Stop & Glo Reagent was added and the 96 well plate was 
mixed for 10 s and incubated for 10 min at room temperature. Finally, renilla luminescence was 
measured for 5 s using an Appliskan microplate reader (Thermo). 
5.4.6. Real time RT-PCR 
In order to perform real time RT-PCR reactions, the DyNamo Flash SYBR Green qPCR Kit 
(Finnzymes) was used according to the manufacturer’s manual to set up a reaction mixture 
containing 0.5 µM of each primer (see Tab. 33) and around 7 µg cDNA (prepared as described 
in chapter 5.2.22). 20 µL of this mixture was transferred to a white “LightCycler 480 Multiwell 
Plate 96” (Roche) and the PCR program depicted in Tab. 31 was run using a Light Cycler 480 
(Roche). All samples were analyzed in triplicate. 
Tab. 31: PCR cycling conditions 
Hot Start Activation 95°C for 5 min
Amplification 95°C for 10 s Denaturation
63°C for 10 s Hybridization 45x
72°C for 10 s Elongation
 
The crossing points were determined by the Light Cycler software and relative mRNA levels 
(fold induction) were calculated based on the following equation using beta-actin or neomycin 
as reference genes. 
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Cp = crossing point 
Tc = target gene, calibrator 
Ts = target gene, sample 
Rc = reference gene, calibrator 
Rs = reference gene, sample 
 
In order to determine PCR efficiencies, a 1 : 5 dilution series (5 dilutions) of one sample was 
prepared, the obtained crossing points were plotted against the logarithmic cDNA dilutions and 
a standard curve was generated. The PCR efficiency was calculated based on the slope of the 
standard curve with the following equation. 
     
 
  
     
 
  
 
Slope = slope of the standard curved derived from a cDNA dilution plot  
E = PCR efficiency 
 
PCR efficiencies were determined for all primer pairs they were very similar and almost 2.0. 
Primers for intron spanning assays were designed employing the “Universal ProbeLibrary” 
(Roche) for Cricetulus griseus. If a sequence was not available for Cricetulus griseus, one 
primer pair was calculated for Mus musculus and one for Rattus norvegicus (see Tab. 32), and 
the Cricetulus griseus primers were self-designed based on an alignment of the sequences 
obtained for mouse and rat. All primers were synthesized by a commercial provider 
(Eurogentec). The sequences of all primer pairs used during this study and the corresponding 
target genes are shown in Tab. 33. 
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Tab. 32: Rat and mouse target genes for RT-PCR primer design 
Target
gene
Accession 
number Organism
CALR NM_007591 Mus musculus
NM_022399 Rattus norvegicus
GRP78 NM_022310 Mus musculus
BC062017 Rattus norvegicus
GRP94 NM_011631 Mus musculus
NM_001012197 Rattus norvegicus
XBP1 NM_013842 Mus musculus
unspliced NM_001004210 Rattus norvegicus
XBP1 NM_013842 Mus musculus
spliced NM_001004210 Rattus norvegicus  
Tab. 33: RT-PCR primers and their corresponding target genes 
Target
gene
Accession 
number Organism Sequence of primer (5'-3')
Name of 
primer
beta actin U20114 Cricetulus griseus ccaaggccaaccgtgaaaag ON40-13
accagaggcatacagggaca ON40-14
CALR N/A Cricetulus griseus aagaatgtgctgatcaacaagg ON45-3
tgttgtctggccgcacaatc ON45-4
GRP78 N/A Cricetulus griseus gtaacaatcaaggtctatgaagg ON40-5
aaggtgacttcaatctggggta ON40-6
GRP94 N/A Cricetulus griseus tacttcatggctgggtcaagc ON47-1
attcatccacaggctctgtgag ON47-2
neo V00618 Escherichia coli gatgcctgcttgccgaatatc ON46-1
gccacagtcgatgaatccaga ON46-2
XBP1 N/A Cricetulus griseus ggttgagaaccaggagttaag ON43-1
unspliced tgcagaggtgcacatagtctg ON40-2
XBP1 N/A Cricetulus griseus ggttgagaaccaggagttaag ON43-3
spliced ttctggggaggtgacaactg ON40-4  
5.4.7. DNA sequencing 
All plasmids created during this study were analyzed by the sequencing provider GATC 
(Konstanz) to verify the DNA sequence of the constructs. Sequencing results were evaluated by 
using Vector NTI software (Invitrogen). 
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6. Results 
6.1. Increase of antibody secretion by signal peptide optimization 
The signal peptide has a major impact on the synthesis and secretion of recombinant proteins 
expressed in mammalian cells (Stern 2007). On the other hand, it has been demonstrated, that 
signal peptides are extremely heterogeneous regarding to their sequence, translocation and 
secretion efficiency. It has also been demonstrated, that many prokaryotic as well as eukaryotic 
signal peptides are functionally interchangeable between species (von Heijne 1985; 
Young 2008 (WO 2008/148519 A2); Stern 2007; Hesketh 2005 (WO 2005/001099 A2); 
Gierasch 1989; Tan 2002). Based on these observations, 19 promising signal peptides were 
identified by an extensive literature search and their potential to increase the extracellular 
amount of a monoclonal antibody expressed in CHO cells was tested. The selection included 
natural signal peptides covering a broad spectrum of species (mammals, fish, scorpions, snails, 
fungi, plants, viruses and bacteria) as well as artificial signal peptides, which are listed in Tab. 
34. Especially, the signal peptides of human albumin, human azurocidin, human cystatin and 
yeast Alfa-Galactosidase (mutant m3) have been described as very potent (Sleep 2004 (WO 
2004/009819 A2); Olczak 2006; Barash 2002; Hofmann 1991). 
The three artificial signal peptides were designed according to rules reported in different 
publications, which are discussed in the following: Folz 1988 and Perlman 1983 report, that the 
c-region of a signal peptide requires small uncharged residues at position -3 and -1 for efficient 
cleavage by the signal peptidase (cf. Tab. 1). An aromatic and more often a hydrophobic 
residue are found at position -2, proline is very often found at position -5 and a hydrophobic 
residue like leucine or isoleucine is tolerated at position  -4. (von Heijne 1983). Therefore, 
PLALA or PIALA was chosen as c-region of the designed signal peptides. 
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The key component of a signal peptide is its h-region, a simple stretch of about ten hydrophobic 
residues that primes the SRP, unlocks the translocon and positions the peptide for cleavage 
(von Heijne 1998). Rapoport 1986 showed, that the introduction of non-hydrophobic residues in 
the h-region dramatically reduces the translocation efficiency. Interestingly, an increase of 
hydrophobicity very often enhances the amount of secreted protein and a single poly-L10 
stretch can be better than a natural h-region (Tsuchiya 2003; Tsuchiya 2004; Zhang 2005). 
Taking into account, that the maximum length of the hydrophobic poly-L stretch, which allows 
efficient cleavage, is 16 residues (Nilsson 2002), one h-region containing a poly-L12 and one 
containing a poly-I12 stretch was designed. 
Moreover, it has been reported, that an increase of positive charge within the n-region resulted 
in an improved secretion (Tsuchiya 2003; Tsuchiya 2004), however, it is still unclear how many 
charged residues are required. Zhang 2005 postulated, that two arginine residues are optimal, 
whereas Tsuchiya 2003, Tsuchiya 2004 preferred 3 residues. Some signal peptides even 
contain negatively charged residues in their n-region (von Heijne 1986). Additionally, the most 
crucial element for efficient translation initiation is a guanine directly after the AUG start codon 
(Kozak 1986 Jan). In order to fulfil all these requirements, MARR or MAKK were used as n-
region of the artificial signal peptides. 
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Tab. 34: Overview of all tested signal peptides 
Name of
construct
Signal peptide
sequence
Accession 
number Protein Organism
A2 MDMRAPAGIFGFLLVLFPGYRS / Ig kappa light chain 
precursor 
(mutant A2)
Mus musculus
B MKWVTFISLLFLFSSAYS NP_000468 serum albumin
preproprotein 
Homo
sapiens
C MDWTWRVFCLLAVTPGAHP AAA52897 immunoglobulin
heavy chain 
Homo 
sapiens
D MAWSPLFLTLITHCAGSWA AAA59018 immunoglobulin
light chain 
Homo 
sapiens
E MTRLTVLALLAGLLASSRA        NP_001691 azurocidin
preproprotein 
Homo
sapiens
F MARPLCTLLLLMATLAGALA NP_001890 cystatin-S
precursor
Homo
sapiens
G MRSLVFVLLIGAAFA AAC32752 trypsinogen 2
precursor
Pseudo-
pleuronectes 
americanus
H MSRLFVFILIALFLSAIIDVMS ABR14604 potassium 
channel blocker 
Mesobuthus 
martensii
J MGMRMMFIMFMLVVLATTVVS AAS93426 alpha conotoxin 
lp1.3 
Conus 
leopardus
K MRAFLFLTACISLPGVFG    / Alfa-Galactosidase 
(mutant m3)
Saccharo-
myces
cerevisiae
L MKFQSTLLLAAAAGSALA CAA03658 Cellulase Aspergillus 
niger
M MASSLYSFLLALSIVYIFVAPTHS Q766C3 Aspartic proteinase 
nepenthesin-1
Nepenthes 
gracilis
N MKTHYSSAILPILTLFVFLSINPS
HG
ABF74624 acid 
chitinase
Nepenthes 
rafflesiana
O MESVSSLFNIFSTIMVNYKSLVLA
LLSVSNLKYARG
2205370A K28 
prepro-toxin 
M28 
Virus
P MKAAQILTASIVSLLPIYTSA AAM54023 killer toxin 
zygocin precursor 
Zygosaccharo-
myces bailii
Q MIKLKFGVFFTVLLSSAYA BAA06291 cholera
toxin 
Vibrio 
cholerae O139
R MARRLLLLLLLLLLLLPLALA / artificial 
construct
/
S MARRIIIIIIIIIIIIPIALA / artificial 
construct
/
T MAKKIIIIIIIIIIIIPIALA / artificial 
construct
/
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6.1.1. Evaluation of natural and artificial signal peptides by transient transfection 
In order to test their impact on the secretion of recombinant antibodies, all chosen signal 
peptides shown in Tab. 34 were fused to the N-terminus of the heavy and the light chain of a 
model antibody and inserted into a first generation standard expression vector (see chapter 
5.2.2). These constructs were screened for antibody expression in transient transfection 
experiments, in order to identify the most promising signal peptides. For this purpose, 1 x 106 
CHO K1 cells were transfected with 10 µg of each vector and cultivated in Medium K2. After an 
incubation time of 4 days, viable cell concentrations and antibody concentrations were 
measured and cell specific productivities were calculated. 
 
Fig. 27: Screening of different natural and artificial signal peptides in transiently transfected CHO K1 cells 
CHO K1 cells were transiently transfected with different f irst generation expression vectors (see Fig. 4), comprising the heavy and 
the light chain of a model antibody fused to the indicated signal peptides (listed in Tab. 34). Four days after transfection, viable cell 
densities and product concentrations were determined and cell specif ic produc tivities were calculated. All values represent the 
average of three independent experiments and are normalized to signal peptide A2, which is set to 100%. 
As depicted in Fig. 27, the determined cell specific productivity was strongly dependent on the 
used signal peptide. Interestingly, natural signal peptides from a human IgG heavy or light chain 
(Fig. 27 construct C and D) showed a 25% lower productivity than the control signal peptide 
(Fig. 27 construct A2). Most signal peptides derived from fungi or virus, showed a very low 
specific productivity (Fig. 27 construct L, O, and P) as well as signal peptide H and the artificial 
signal peptide R. Only signal peptides B, E and M resulted in increased productivity compared 
to the control.   
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To confirm these results, signal peptide B, E and M as well as the control signal peptide A2 
were tested again by transient transfection as described above. In addition to cell specific 
productivities renilla specific product concentrations were calculated. The renilla luciferase 
reporter gene is localized on the expression vector and co-expressed as an internal control. In 
this way, different transfection efficiencies can be compensated by normalizing antibody 
concentrations to the activity of renilla luciferase. 
   A    B 
  
Fig. 28: Evaluation of selected signal peptides in transiently transfected CHO K1 cells 
CHO K1 cells w ere transfected w ith selected f irst generation expression vectors (see Fig. 4) as described in Fig. 27. Four days after 
transfection, viable cell densities, product concentrations and the luminescence of co-expressed renilla luciferase were determined 
and cell specif ic productivities (A) as well as renilla specif ic productivities (B) were calculated. All values represent the average of 
three independent experiments and are normalized to signal peptide A2, which is set to 100%. 
As shown in Fig. 28, signal peptides B, E and M mediated again higher cell specific 
productivities and the results were not distorted by varying transfection efficiencies. 
6.1.2. Evaluation of mutated signal peptides by transient transfection 
In chapter 6.1.1, the natural signal peptides B, E and M were identified as being more potent 
than the control signal peptide A2. In order to further improve productivities, specific mutations 
were inserted (see Tab. 35), that might optimize the performance of these signal peptides. The 
mutations were chosen based on observations from the literature as described in the following: 
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Tab. 35: Overview of all tested natural and mutated signal peptides 
Signal peptides B and E are shown with their protein and nucleotide sequences. All mutations introduced into the wild-type signal 
peptides B and A are highlighted in red and noted according to the recommended system (den Dunnen 2001). 
Name of
construct
Signal peptide
sequence
Nucleotide
sequence Mutation
A2 MDMRAPAGIFGFLLVLFPGYRS ATGGATATGCGCGCGCCGGCCGGC
ATTTTTGGCTTTCTGCTGGTACTG
TTTCCGGGCTATCGCAGC
/
B MKWVTFISLLFLFSSAYS ATGAAGTGGGTGACCTTCATCTCC
CTGCTGTTCCTGTTCTCCTCCGCC
TACTCC
/
B1 MKWVTFISLLFLFSSARS ATGAAGTGGGTGACCTTCATCTCC
CTGCTGTTCCTGTTCTCCTCCGCC
AGGTCC
Y17R
E MTRLTVLALLAGLLASSRA        ATGACCCGGCTGACCGTGCTGGCC
CTGCTGGCCGGCCTGCTGGCCTCC
TCCAGGGCC
/
E1 MTRLTVLALLAGLLASSLA        ATGACCCGGCTGACCGTGCTGGCC
CTGCTGGCCGGCCTGCTGGCCTCC
TCCCTGGCC
R18L
E2 MARLTVLALLAGLLASSRA        ATGGCCCGGCTGACCGTGCTGGCC
CTGCTGGCCGGCCTGCTGGCCTCC
TCCAGGGCC
T2A
E3 MATRLTVLALLAGLLASSRA        ATGGCCACCCGGCTGACCGTGCTG
GCCCTGCTGGCCGGCCTGCTGGCC
TCCTCCAGGGCC
M1_T2
insA
E4 MTRLTVLALLALLLASSRA        ATGACCCGGCTGACCGTGCTGGCC
CTGCTGGCCCTGCTGCTGGCCTCC
TCCAGGGCC
G12L
E5 MTRLLVLALLAGLLASSRA        ATGACCCGGCTGCTGGTGCTGGCC
CTGCTGGCCGGCCTGCTGGCCTCC
TCCAGGGCC
T5L
E6 MTRLTVLAL-AGLLASSRA        ATGACCCGGCTGACCGTGCTGGCC
CTGGCCGGCCTGCTGGCCTCCTCC
AGGGCC
L10del
E7 MTRLTVLALLLAGLLASSRA        ATGACCCGGCTGACCGTGCTGGCC
CTGCTGCTGGCCGGCCTGCTGGCC
TCCTCCAGGGCC
L10_A11
insL
E8 MTRLTVLALLAGLLASSRA        ATGACCCGGCTGACCGTGCTGGCC
CTGCTGGCCGGCCTGCTGGCCTCC
TCCCGCGCC
52A>C; 
54G>C
M MASSLYSFLLALSIVYIFVAPTHS ATGGCCTCCTCCCTGTACTCCTTC
CTGCTGGCCCTGTCCATCGTGTAC
ATCTTCGTGGCCCCCACCCACTCC
/
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Signal peptide E contains an unusual arginine at position -2. In mutant E1, this arginine was 
substituted by a leucine, which is more common at this position (von Heijne 1983). On the other 
hand, one can speculate, that the high efficiency of signal peptide E could depend exactly on 
this arginine at position -2. Therefore, in signal peptide B1, the tyrosine residue at position -2 
was replaced by an arginine in order to prove this assumption. Kozak (1986 Jan; 1987) reports, 
that a guanine directly after the AUG start codon is very important for translation initiation. 
Signal peptide E does not fulfil this requirement and might therefore suffer from a lowered 
translation rate. Codons with a guanine at the first position only exist for alanine, aspartatic acid, 
glutamic acid, glycine, and valine. Since aspartatic and glutamic residues are charged, valine is 
very hydrophobic, and glycine increases the protein flexibility, the alanine codon was used to 
introduce a guanine directly downstream of the AUG start codon of signal peptide E, resulting in 
mutant E3. In comparison in mutant E2 was the threonine at position -18 replaced by an 
alanine. The alanine and the glycine localized within the hydrophobic core of signal peptide E 
were substituted by a hydrophobic leucine, resulting in mutant E4 and E5, respectively. This 
was done, because it has been reported, that a hydrophobic core is required for a strong 
translation arrest, mediated by the signal recognition particle and that the translocation 
efficiency of a protein could be increased by this process (Belin 1996). Efficient cleavage was 
postulated to depend on the length of a signal peptide (Nilsson 2002). In order to test this issue, 
a shortened version of signal peptide E was generated by deleting (mutant E6) and an 
elongated version (mutant E7) by inserting a leucine within the hydrophobic core. It was shown 
that secondary mRNA structures close to the AUG start codon can influence translation 
initiation (Baim 1985; Kozak 1986 May; Kozak 1990). By mutating one codon (mutant E8), the 
secondary mRNA structure formed by signal peptide E was predicted to become less stable, 
resulting in a reduction of the calculated energy from -34.1 kcal/mol to -26.0 kcal/mol (see Fig. 
29). 
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Fig. 29: Secondary mRNA structure of signal peptide E and E8 
The secondary mRNA structure of signal peptide E (A) and E8 (B) was predicted w ith the “AUG_hairpin” software. The analyzed 
sequence includes 10 base pairs of the 5’ UTR follow ed by the signal peptide and the f irst three codons of the mature antibody. 
Whereas the f irst three codons, of both chains (light and heavy chain) are similar. The methionine start codon is indicated in red and 
the main hairpin is indicated in blue. The arrow  highlights the mutated codon. 
Taken together, 8 mutants of signal peptide E, and one mutant of signal peptide B were 
generated. Those mutants as well as the wild-type signal peptides B, E, M and A2 (control) 
were fused to the model antibody and inserted into an optimized second generation expression 
vector containing a renilla luciferase gene as described in chapter 5.2.2. The performance of all 
signal peptides was analyzed by transient transfection using the respective constructs. 
To this end, 1 x 106 CHO K1 cells were transfected with 10 µg of each vector and cultivated in 
Medium K2. After 3 days, viable cell concentration, antibody concentration and renilla 
fluorescence were measured and cell specific productivities as well as renilla specific product 
concentrations were calculated (Fig. 30). As expected, transfected cells showed much higher 
productivities when compared to Fig. 27 due to the improved expression vector. 
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Fig. 30: Analysis of natural and mutated signal peptides in transiently transfected CHO K1 cells 
CHO K1 cells w ere transiently transfected with different second generation expression vectors  (see Fig. 5), comprising the heavy 
and the light chain of a model antibody fused to the indicated signal peptides (listed in Tab. 34). Three days after transfection, viable 
cell densities, product concentrations and the luminescence of co-expressed renilla luciferase were determined and cell specif ic 
productivities (A) as well as renilla specif ic productivities (B) were calculated. All values represent the average of three independent 
experiments and are normalized to signal peptide A2, which is set to 100%. 
In accordance with the previous experiments, signal peptide B and E resulted in clearly 
increased cell specific productivities, whereas no improvement was observed for signal 
peptide M compared to the control (see Fig. 30). However, with the exception of E3, none of the 
mutated versions of signal peptide B or E showed substantially better productivities than the 
corresponding natural signal peptides, i.e. almost all mutations resulted in clearly decreased 
expression levels. Similar results were obtained when the antibody concentration was 
normalized to renilla luciferase to exclude influences of variable transfection efficiencies. In 
order to verify these observations, a selection of signal peptide constructs was transfected and 
analyzed again as described above. 
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   A    B 
  
Fig 31: Evaluation of selected natural and mutated signal peptides in transiently transfected CHO K1 cells 
CHO K1 cells w ere transfected with selected antibody expression constructs as described in Fig. 30. Three days after transfection, 
viable cell densities, product concentrations and the luminescence of co-expressed renilla luciferase were determined and cell 
specif ic productivities (A) as well as renilla specif ic productivities (B) were calculated. All values represent the average of three 
independent experiments and are normalized to signal peptide A2, which is set to 100%. 
The overall results depicted in Fig 31 resembled thus derived from the previous experiment with 
the exception of signal peptide E3, which showed a slightly decreased performance. Taken 
together, based on all transient transfection experiments it can be concluded, that signal peptide 
B, E and E3 were the most potent ones in CHO K1 cells, because increased cell specific 
productivities were observed in case these signal peptides were fused to the heavy and the light 
chain of the used model antibody instead of the control signal peptide A2.  
6.1.3. Evaluation of signal peptides in stably transfected cell lines (Mini-pools) 
Although signal peptide B, E and E3 mediated improved cell specific productivities in transiently 
transfected cells, their performance in stable cell lines might differ (Rance 2010; Kalwy 2006). 
Hence, it had to be verified, whether these signal peptides were able to produce increased 
amounts of recombinant antibodies in stably transfected cells. Many clones had to be generated 
for this approach. For this purpose, heavy and light chain of the model antibody were fused to 
the selected signal peptides and to the control A2 followed by their insertion into third 
generation expression vectors as described in chapter 5.2.2. This vector contains a dhfr 
cassette and can be used for the development of stable cell lines in combination with dhfr-
deficient CHO DG44 cells. Moreover, in order to achieve enhanced productivities, gene 
amplification processes can be induced by adding the competitive dhfr inhibitor methotrexate 
(MTX) to the culture medium (Ludwig 2006; Kaufman 1982). 
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Tab. 36: Third generation expression vectors used to create stable cell lines 
Vector 
number
Containing 
signal peptide
1171 A2
1157 B
1158 E
1159 E3  
The created expression vectors (see Tab. 36) were employed to develop stable cell lines 
according to the mini-pool method. Therefore, 1 x 106 CHO DG44 cells were transfected with 
10 µg of each construct (linearized with BspHI), 384 mini-pools per signal peptide were 
generated and cultivated in Medium D3 supplemented with 10 nM MTX (see 5.3.4). Grown mini-
pools were analyzed by nqELISA and for each signal peptide those 36 mini-pools showing the 
highest amount of expressed antibody were selected and transferred to 24 well plates. Every 3 
to 4 days, about 75% of the supernatant was exchanged for Medium D3 containing 25 nM MTX 
until the cultures started to grow. Following this amplification procedure, all mini-pools were 
expanded up to 6 well level, where most of them had viabilities >90% and showed a good 
growth behaviour (see Tab. 37). At this time, antibody concentrations were determined by 
qELISA and 20 mini-pools with the best the cell specific productivities were selected for each 
signal peptide and used for further experiments. 
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Tab. 37: Overview of selected mini-pools 
CHO DG44 cells w ere transfected with third generation antibody expression constructs comprising the indicated signal peptides  and 
mini-pools were generated according to the standard procedure. For each signal peptide, 36 mini-pools were selected by nqELISA 
and inoculated with 2 x 105 cells/mL in 6-w ell plates. After 3 days, viable cell concentrations (VCD), viabilities and expressed 
antibody concentrations (Product c.) w ere measured and cell specif ic product concentrations (QP) were calculated. For each signal 
peptide 20 mini-pools show ing the highest specif ic product concentrations (indicated in red) were tested for a performance test 
during fed-batch (fed-batch numbers are indicated). 
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20.4 95 12 5 12.6 95 22 13 14.0 94 43 23 41 20.4 93 54 23 61
25.4 94 30 11 1 11.8 94 37 22 21 22.0 93 64 25 42 19.0 94 13 6
23.0 95 23 9 2 8.0 85 120 92 22 23.8 91 34 13 8.8 93 6 4
16.8 93 13 6 18.0 92 45 20 23 25.0 92 62 23 43 22.2 93 61 24 62
1.6 86 0 0 21.2 92 51 21 24 20.4 93 48 20 44 20.0 93 27 12
16.6 96 11 5 22.8 94 45 18 19.6 94 14 6 26.2 94 22 8
21.2 95 16 7 17.0 92 40 19 25 20.8 93 45 19 45 31.0 91 79 25 63
18.4 94 12 5 19.8 92 70 30 26 23.4 94 60 23 46 26.6 92 18 6
23.8 93 8 3 12.6 92 67 39 27 14.6 95 42 22 47 19.6 92 49 21 64
22.4 92 29 11 3 23.8 94 45 17 14.4 93 23 12 25.0 93 20 7
17.8 92 8 4 14.4 93 51 27 28 20.4 94 30 13 23.2 90 71 27 65
20.0 92 39 17 4 26.6 92 33 11 17.2 91 38 18 48 22.8 92 47 18 66
4.4 90 3 3 20.0 95 197 84 29 25.8 93 66 24 49 17.2 91 35 16 67
17.6 93 29 13 5 17.0 94 67 32 30 24.8 92 85 31 50 38.8 90 88 24 68
11.6 93 14 9 6 18.4 91 170 77 31 17.2 94 27 13 28.8 92 13 4
12.6 94 20 11 7 18.2 92 46 21 32 6.0 92 14 13 19.0 94 46 20 69
15.8 92 19 10 8 26.8 94 176 61 33 18.8 94 19 8 21.6 93 36 15 70
25.6 91 19 7 25.6 94 67 24 34 15.6 93 31 16 20.8 94 26 11
27.6 91 71 24 9 25.4 94 35 13 17.0 91 33 16 20.0 92 26 11
20.0 94 14 6 2.4 84 2 3 16.2 93 18 9 22.6 91 10 4
20.0 94 24 10 10 20.4 94 23 10 29.2 89 8 3 21.2 93 20 8
17.4 93 25 12 11 20.2 96 28 12 28.8 91 51 17 18.4 95 26 12
17.8 94 18 8 14.0 91 29 16 18.0 92 36 16 18.8 95 27 12
12.6 92 26 15 12 15.8 92 26 13 31.2 93 42 13 20.4 95 43 18 71
24.0 92 25 10 13 24.8 93 78 29 35 27.0 92 92 32 51 26.4 94 126 44 72
33.2 90 59 18 14 25.8 94 88 31 36 16.6 90 118 57 52 18.4 94 28 13 73
18.6 90 23 10 15 27.0 94 116 40 37 33.2 90 7 2 19.4 93 26 11
17.0 94 24 12 16 21.8 91 46 19 14.8 93 60 31 53 18.6 94 31 14 74
16.8 94 33 16 17 17.2 93 28 13 15.4 95 83 42 54 14.6 93 39 20 75
21.4 94 13 5 27.2 91 72 25 38 16.0 92 42 21 55 28.4 93 42 14 76
19.2 93 24 10 18 21.2 93 53 22 39 23.8 91 59 22 56 39.2 91 45 12 77
19.2 92 23 10 19 25.0 92 110 40 40 15.8 92 87 43 57 8.2 92 7 5
15.2 94 23 12 20 27.0 86 39 13 18.6 94 59 27 58 27.0 92 69 24 78
15.4 96 16 8 26.0 91 43 15 20.4 93 64 27 59 21.2 92 60 24 79
28.2 94 7 2 18.8 94 8 4 15.6 94 37 19 60 8.6 91 13 10
26.4 93 18 6 25.0 94 32 12 12.6 93 24 14 29.6 91 97 32 80
Signal peptide A2 Signal peptide B Signal peptide E Signal peptide E3
 
In order to adapt the chosen mini-pools to fed-batch process conditions, they were cultivated for 
one passage on 6 well plates in Medium D5 containing 25 nM MTX, followed by two passages 
with 25 mL of the same medium in shake flasks. At this stage, all mini-pools grew very well and 
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had an average viability of 94%. Subsequently, fed-batch cultures were inoculated with all mini-
pools and cell specific productivities were calculated at day 3.  
   A    B 
 
                                           Signal Peptide 
 
                                           Signal Peptide 
Fig. 32: Cell specific productivities of mini-pools used for fed-batch experiments 
For each indicated signal peptide, 20 mini-pools selected for fed-batch experiments were cultivated in 6 well plates w ith Medium D3 
(A) or in shake f lasks w ith Production°Medium (B). After three days, viable cell densities and antibody concentrations were 
measured and cell specif ic productivities were calculated. Mean values are represented by red bars. 
As shown in Fig. 32, the highest cell specific productivities were obtained for mini-pools 
generated based on signal peptide B followed by signal peptide E and A2, regardless of the 
cultivation level (6 well or shake flask). Surprising mini-pools generated based on signal peptide 
B showed a cell specific productivity up to 80 or 90 pg/cell/day.  However, in 6 well plates and 
Medium D3 all mini-pools showed generally higher cell specific productivities than upon 
cultivation in shake flask and Production°Medium (see Tab. 27).  
It is well known, that the cell specific productivity of a cell line does not always correlate with the 
product concentration observed during a fed-batch process (Birch 2006). Therefore, the 
performance of signal peptide B, E, E3 and A2 in a production process was analyzed by 
subjecting all selected mini-pools to fed-batch experiments. 
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   C 
 
Fig. 33: Fed-batch experiments with selected mini-pools 
For each indicated signal peptide, 20 mini-pools were subjected to fed-batch experiments. During the process all cultures were daily 
analyzed regarding their viable cell concentration (A), viability (B) and product concentration (C), and the respective mean values 
were calculated for every signal peptide. 
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During the fed-batch processes (Fig. 33 A and B), mini-pools grew very well independently of 
the used signal peptide and they showed similar viabilities. However, clear differences were 
observed regarding the measured product concentrations. Whereas an average final product 
concentration of 0.7 g/L was obtained for signal peptide A2, 1.2 g/L could be reached with 
signal peptide E and E3 and even 1.6 g/L with signal peptide B (see Fig. 33). 
 
Fig. 34: Fed-batch experiments with selected mini-pools  
For each indicated signal peptide, the f inal product concentration (day 13) of every individual mini-pool, which was obtained during 
the fed-batch process described in Fig. 33, is depicted. Mean values are represented by red bars. 
Fig. 34 shows the individual product concentrations at day 13 for all tested mini-pools during the 
fed-batch as well as the mean values (red bars; correspond to the maximum values seen in Fig. 
33 (C). Although the mean values are almost identical for signal peptide E and E3 and the 
individual mini-pools derived from E3 show an increased heterogeneity. The mini-pools with the 
most impressive product concentrations (3.3 g/L and 4.0 g/L antibody in 13 days) resulted from 
signal peptide B. In summary, it can be concluded, that regarding the development of stable 
antibody production cell lines, the control signal peptide A2 is clearly outperformed by all other 
tested signal peptides with signal peptide B being by far the most efficient one. 
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6.2. General outline: Development of an alternative selection system for high 
producing clones 
The selection of rare high-expressing clones out of a pool predominantly consisting of low and 
medium producers is one of the most challenging problems during the development of 
mammalian cell lines for the production of recombinant antibodies or non-antibody proteins. 
Therefore, it was the aim of the second part of this thesis, to develop a novel selection system, 
which allows the fast and easy identification and isolation of clones producing high amounts of 
antibody. The chosen approach is based on the hypothesis that the overexpression of 
recombinant antibodies in CHO cells causes ER stress during the secretion process and that 
the extent of the triggered stress response is correlated to the level of antibody expression. The 
system is exemplified by Fig. 35. 
 
Fig. 35: Schematic representation of the novel selection system based on ER stress (exemplified shown with GRP78 
promoter) 
Step 1: Overexpression of secretory recombinant proteins causes dissociation of GRP78 from various ER stress sensors like IRE1, 
PERK or ATF6 (Step 2). Step 3: Transcription factors (TF) like XBP1, ATF4 or ATF6 are formed (Pathw ay is simplif ied shown). 
Step 4: Genes involved in many ER functions are upregulated upon transcription factor binding to UPRE, ERSE or AARE elements 
which are located in various promoters (e.g. GRP78). Step 5: If so, than reporter genes like d2eGFP are also stimulated by ER 
stress pathways and increased GFP fluorescence can be detected by FACS. 
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In a first set of experiments, this hypothesis was verified by analyzing the correspondence 
between antibody production and ER stress pathways. For this purpose, mRNA levels of 
several prominent factors involved in stress responses were determined in a variety of cell lines 
showing different antibody expression rates. At this way, promising ER stress promoters and 
regulatory elements that were stimulated by antibody production were identified. Later these 
promoters and regulatory elements were used to create several ER stress reporter constructs, 
which were intended to allow the detection of high producers based on their GFP fluorescence 
intensity. In a second set of experiments, the performance of different reporter constructs 
(identified as described in chapter 6.3) was assessed and compared by analyzing their 
response to antibody expression. For this purpose, several cell lines were generated as 
depicted in Fig. 36.  
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Fig. 36: General outline of the generation of Master 1 Master 2A and Mock cell lines and their conversion to ER stress 
reporter cell lines  
Step 1: At f irst, the Master 1 cell line was created by tagging CHO DG44 cells w ith an exchangeable DsRed RMCE acceptor 
construct. Step 2: The Master 2 cell line w as derived from Master 1 by introducing an antibody expression construct. Step 3: The 
Mock cell line w as derived from Master 1 by introducing a dhfr expression construct. Step 4 and Step 5: The genomically anchored 
DsRed RMCE acceptor construct of three different Master cell lines (exemplif ied shown for Master 2A) and a Mock cell line was 
exchanged with an ER stress reporter construct (exemplif ied shown for the GRP78 Reporter construct) by targeted integration 
(RMCE). The ER stress reporter elements (GRP78 Promoter) are highlighted by red arrows.  
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Fig. 37: General outline of the conversion of Master 2A and Mock cell lines in control cell lines 
GRP78 Reporter constructs were introduced in Master 2A and Mock cell line by subjecting them to an RMCE procedure as shown 
in Fig. 36. All other ER stress reporter and control constructs were introduced in the same way as previously described. Exemplif ied 
shown is the integration of a control construct (SV40-d2eGFP control, highlighted by red arrow) by RMCE (Fig. 37 step 6 and 7). 
As exemplified in Fig. 36 and Fig. 37, ER stress reporter cell lines and appropriate control cells 
were generated by using the Master 2 and the Mock cell line. This was achieved by 
recombinase mediated cassette exchange of the DsRed acceptor construct against the ER 
stress reporter constructs. At this way, it was possible to identify the construct, which mediated 
the most pronounced induction of GFP fluorescence upon antibody expression. Finally, a new 
reporter cell line was created with the best-performing construct and applied to the development 
of an antibody producing cell. Thus, it was evaluated whether the novel ER stress reporter 
system is suitable to identify and isolate high-expressing clones. 
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6.3. Analyzing the influence of antibody expression on ER stress 
In order to investigate a potential correlation between antibody expression and ER stress, the 
expression of some prominent factors involved in ER stress responses was analyzed in a 
number of production clones. These cell lines were available at Cellca and cover a broad range 
of productivities from 1.1 to 3.8 g/L in fed-batch processes as shown in Tab. 38. 
Tab. 38: Overview of fed-batch results for the selected clones used for real time RT-PCR analysis 
Clone 1 2 3 4 5 6 7 8
Product concentration 
on day 11 [g/L] 1.9 3.8 1.7 2.2 1.1 3.4 1.3 1.5  
All clones in stock culture were split into fresh Medium D5 containing 38 nM MTX with a 
concentration of 1 to 3 x 105 cells/mL and cultivated under standard conditions (see 
chapter 5.3.2). The corresponding wild-type cell CHO DG44 was cultivated in a comparable 
MTX free medium (Medium D4) and treated in the same way as previously described. On day 3, 
the total RNA was isolated from all clones as well as from the corresponding wild-type cell CHO 
DG44, and mRNA levels of CALR, GRP78, GRP94 and spliced XBP1 were determined by real 
time RT-PCR. 
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   A           CALR, R2 = 0.25 
 
 
   B           GRP78, R2 = 0.78 
 
 
   C           GRP94, R2 = 0.75 
 
  
DG44 wt 
Clone 5 Clone 7 
Clone 8 
Clone 3 
Clone 1 
Clone 4 
Clone 6 
Clone 2 
100 
150 
200 
250 
300 
350 
400 
450 
0,0 1,0 2,0 3,0 4,0 
 R
e
la
ti
v
e
 C
a
lr
 m
R
N
A
 L
e
v
e
l [
%
] 
Product Concentration [g/L] 
DG44 wt 
Clone 5 
Clone 7 
Clone 8 
Clone 3 
Clone 1 
Clone 4 
Clone 6 
Clone 2 
100 
150 
200 
250 
300 
350 
400 
450 
0,0 1,0 2,0 3,0 4,0 
R
e
la
ti
v
e
 G
R
P
7
8
 m
R
N
A
 L
e
v
e
l [
%
] 
Product Concentration [g/L] 
DG44 wt 
Clone 5 
Clone 7 
Clone 8 
Clone 3 Clone 1 
Clone 4 
Clone 6 
Clone 2 
100 
150 
200 
250 
300 
350 
400 
450 
0,0 1,0 2,0 3,0 4,0 
R
e
la
ti
v
e
 G
R
P
9
4
 m
R
N
A
 L
e
v
e
l [
%
] 
Product Concentration [g/L] 
  Results 
Page 84 
   D           spliced XBP1, R2 = 0.81 
 
Fig. 38: Correlation between antibody productivity and mRNA levels of ER stress factors in selected production clones  
8 production clones expressing a monoclonal model antibody were cultivated in fed-batch experiments and product concentrations 
were measured. The same clones as w ell as the CHO DG44 cell line w ere subjected to real time RT-PCR analysis in order to 
determine the mRNA levels of CALR, GRP78, GRP94 and spliced XBP1. All mRNA levels were normalized to beta-actin and to the 
results obtained for CHO DG44 cells, which were set to 100%. For each clone, the fed-batch product concentrations from day 11 
were plotted against the relative mRNA levels of CALR (A), GRP78 (B), GRP94 (C) and spliced XPB1(D), respectively (The mRNA 
values represent the average of three independent experiments). 
Fig. 38 shows for each individual clone the relative mRNA levels of CALR, GRP78, GRP94, and 
spliced XBP1 as well as the corresponding antibody concentration reached in a fed-batch 
process on day 11. For CALR, the relative mRNA level showed a weak correlation with antibody 
production (Fig. 38 A), whereas ((Fig. 38 B, C, and D) for GRP78, GRP94 and spliced XPB1 a 
stronger correlation was observed. From these results it can be concluded, that at least some 
ER stress response elements might be adequate detectors for antibody expression. 
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6.4. Generation and analysis of Master 1 cell lines containing an RMCE acceptor 
construct (RMCE target) 
In order to evaluate the ability of the constructs generated in chapter 5.2.3 to function as 
reporter system for the expression of antibodies, several test cell lines were developed. In a first 
step, a so called Master 1 cell line was created by tagging wild-type cells with an exchangeable 
RMCE acceptor construct (Fig. 39). 
 
Fig. 39: Schematic representation of vector 957 
For this purpose, 1 x 106 CHO DG44 cells were transfected with 3 µg of vector 957 excised with 
MluI and SalI. After two days, Medium D2 was replaced by Medium D2 containing 100 mg/L 
Hygromycin B. On day 8, the Hygromycin B concentration was increased to 200 mg/L. On day 
18, clones showing a very high DsRed fluorescence (top 0.7%) were isolated as described in 
Fig. 40 and cultivated in Medium D2 for two weeks. 
 
Fig. 40: Single cell sorting after transfection with vector 957 
On day 18, follow ing transfection of the CHO DG44 cells w ith a DsRed RMCE acceptor construct (vector 957) all cells were 
analyzed regarding DsRed and GFP fluorescence by f low cytometry.  DsRed positive (top 0.7%) and GFP negative (low auto-
f luorescence) single clones were isolated by sorting as indicated (gate “sorted”).  
All 19 grown clones were expanded up to the 24 well transferred into Medium D2 containing 
200 mg/L Hygromycin B, and analyzed by FACS. Those 5 clones showing the highest DsRed 
fluorescence were selected (Fig. 41), and the exchangeability of the acceptor construct was 
analyzed by subjecting them to an RMCE procedure as shown in Fig. 42.  
   A    B    C 
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   D    E  
  
 
Fig. 41: FACS analysis of Master 1 cell clones containing a DsRed RMCE acceptor construct 
Follow ing transfection of CHO DG44 cells w ith a DsRed RMCE acceptor construct (vector 957), DsRed positive clones were 
isolated by FACS sorting. All grown clones were expanded and analyzed w ith regard to DsRed fluorescence by f low cytometry. Five 
clones showing the highest f luorescence are depicted: (A) clone 32, (B) clone 41, (C) clone 42, (D) clone 43 and (E) clone 46. 
 
 Fig. 42: Schematic representation of RMCE procedure 
During the RMCE procedure clones were transfected with 6 µg of vector 1071, and 1 µg of the 
Flpo vector 721. Three days after transfection, the used Medium D2 was replaced by 
Medium D2 containing 500 mg/L G418. Only three clones grew up under these conditions and 
were analyzed by FACS on day 27. 
  
Vector 1071 
Vector 957 
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    A1        before RMCE    A2        after RMCE 
FACS analysis  
of Clone 41 
  
DsRed fluorescence [au] 833 662 
GFP fluorescence [au] 95 321 
 
    B1        before RMCE    B2        after RMCE 
FACS analysis 
of Clone 43 
  
DsRed fluorescence [au] 370 71 
GFP fluorescence [au] 85 536 
 
    C1        before RMCE    C2        after RMCE 
FACS analysis  
of Clone 46 
  
DsRed fluorescence [au] 562 313 
GFP fluorescence [au] 82 66 
Fig. 43: FACS analysis of Master 1 cell clones before and after RMCE 
5 Master 1 cell clones stably transfected with a DsRed RMCE acceptor construct (vector 957) were co-transfected with a GTN 
RMCE donor and a FLPO construct and cultivated for 24 days in Medium D2 containing 500 mg/L G418. All grow ing clones were 
analyzed with regard to GFP and DsRed fluorescence by f low cytometry and their mean fluorescence intensities (after RMCE) w ere 
determined: clone 41 (A2), clone 43 (B2), clone 46 (C2). For comparison reasons, corresponding FACS data generated before 
transfection are shown for each clone (A1, B1 and C1). 
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As seen in Fig. 43 (A2), clone 41 showed two populations, the one being positive for DsRed and 
GFP fluorescence and the other for DsRed only. This implies that several DsRed RMCE 
acceptor cassettes are present in the genome of clone 41 and that this clone was only partially 
exchanged. For clone 46, a reduction in DsRed but no relevant increase in GFP fluorescence 
was observed after the RMCE procedure (Fig. 43 C1, C2), indicating that the DsRed RMCE 
acceptor construct was not authentically exchanged for the GTN donor construct. Possibly, 
clone 46 contains multiple copies of the DsRed RMCE acceptor construct at the same 
integration site, some of which have been excised by the flippase. In conclusion it can be stated 
that both clones (Clone 41 and 46) are not suitable for further experiments. 
Finally, after transfection with the GTN RMCE donor construct, clone 43 showed a reduction of 
DsRed and an increase of GFP fluorescence Fig. 43 (B1, B2). Based on these results it was 
concluded, that the DsRed RMCE acceptor construct of clone 43 can be authentically 
exchanged. Consequently, clone 43 was renamed as Master 1 cell line and used for further 
experiments. 
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6.5. Generation and analysis of Mock and Master 2 cell lines 
To provide an adequate test system for the evaluation of the ER stress reporter constructs, 
additional cell lines had to be created based on the Master 1 cell line. So called Master 2 cell 
lines stably expressing a recombinant model antibody were generated by means of a dhfr 
selection procedure. As control a corresponding mock cell line expressing only dhfr was 
developed (see schematic presentation in Fig. 36). For the Mock cell line development, 1 x 106 
cells of the Master 1 cell line were transfected with 10 µg of vector 1096 (linearized with BspHI, 
see Fig. 44) and mini-pools were generated according to the standard procedure and cultivated 
in Medium D3 containing 200 mg/L Hygromycin B and 10 nM MTX. 
 
Fig. 44: Schematic representation of vector 1096 
On day 32, the best growing mini-pools were selected and transferred to Medium D3 containing 
200 mg/L Hygromycin B and 25 nM MTX. On day 54, the best growing mini-pools were used to 
isolate single clones by FACS. Cells were cultivated in Medium D3 containing 200 mg/L 
Hygromycin B and 25 nM MTX, 8 grown clones were randomly selected and expanded up to 
shake flask scale. Since all clones were growing very well, anyone was chosen, defined as 
Mock cell line and this clone was used for further experiments. 
For the development of Master 2 cell lines, 1 x 106 cells of the Master 1 cell line were 
transfected with 10 µg of vector 726 (linearized with BspHI, see Fig. 45) and mini-pools were 
generated according to the standard procedure and cultivated in Medium D3 containing 
200 mg/L Hygromycin B and 10 nM MTX. 
 
Fig. 45: Schematic representation of vector 726 
Based on the results of a non-quantitative ELISA, the 48 best-producing mini-pools were 
selected and transferred to Medium D3 containing 200 mg/L Hygromycin B and 25 nM MTX. 
Following the amplification procedure, the 10 best-producing mini-pools were selected by 
qELISA and used to isolate single clones by FACS. All growing clones were transferred to 
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24 well plates and cultivated in Medium D3 containing 200 mg/L Hygromycin B, and 25 nM 
MTX. The 48 best-producing clones were identified by nqELISA and expanded up to the 6 well 
scale. 
Tab. 39: Overview of growth and productivity data for the selected clones on 6 well scale 
Clone 1 9 19 21 26 30 31 32 33 36 37 39
Viable cell conc. 
[105 c/mL] 13.4 26.8 30.7 20.0 27.6 13.8 25.5 26.2 23.3 28.7 22.8 21.1
Viability 
[%] 91 95 93 95 95 96 95 95 96 95 96 96
Product conc.
 [mg/L] 38 19 20 23 21 21 31 30 24 25 40 26
Cell sp. productivity 
[pg/cell/day] 23 8 9 12 9 14 16 15 12 12 21 16  
The 12 best-producing clones were determined by qELISA (see Tab. 39) and analyzed in a fed-
batch process. Fig. 46 shows the fed-batch performance of the 3 best-producing clones 
regarding growth, viability and product formation.  
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Fig. 46: Fed-batch experiment with selected Master 2 cell lines  
All clones listed in Tab. 39 were subjected to a fed-batch experiment. During the process all cultures were daily analyzed with 
regard to viable cell concentration (A), viability (B) and product concentration (C). On the end of the experiment cell clone 9, 39 and 
31 were selected and respectively termed Master 2A, 2B and 2C cell line. 
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Tab. 40: Overview of fed-batch results for the selected Master 2 cell lines 
Master 2A Master 2B Master 2C
Peak viable cell 
density [107 c/mL] 198 164 125
Product concentration 
on day 15 [g/L] 1.9 1.7 1.6
Cell specific productivity 
on day 3 [pg/cell/day] 9 11 15  
During the fed-batch process Clone 9, clone 39 and clone 31 produced the highest amount of 
antibody and were defined as Master 2 cell lines, termed Master 2A, 2B and 2C, respectively. 
Fig. 46 shows the fed-batch performance of the selected Master cell lines regarding growth, 
viability and product formation. The most important results are listed in Tab. 40. From the 
combined data, it was concluded, that all three clones showed production characteristics and 
could be used for further experiments. 
6.6. Generation of ER stress reporter cell lines 
6.6.1. Generation of ER stress reporter constructs (RMCE donors) 
According to the results obtained in chapter 6.3, several ER stress promoters and regulatory 
elements were used to create a number of reporter constructs, which were intended to indicate 
antibody expression levels based on GFP fluorescence. A first set of ER stress reporter 
constructs contained an SV40 basal promoter followed by eGFP and three copies of the 
transcription factor binding sites ERSE I, ERSE II, UPRE and AARE in front of the promoter. 
Moreover, a control construct was generated only comprising the SV40 basal promoter and 
eGFP (Fig. 47). The chosen binding sites are present in many promoters involved in ER stress 
pathways and have been reported to play a prominent role during ER stress responses 
(Yoshida 1998; Roy 1999; Kokame 2001; Wang 2000; Ma 2004; Lee 2002). 
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Fig. 47: Overview of used ER stress reporter and control constructs (containing eGFP) 
All ER stress reporter constructs contain a promoterless neomycin resistance gene, three ER stress response elements 
(transcription factor binding sites 3 x ERSE I, 3 x ERSE II, 3 x UPRE or 3 x AARE), and a SV40 basal promoter followed by eGFP. 
The w hole cassette is f lanked by heterospecif ic FRT-sites (FRTw t and FRT3) enabling their use as RMCE donors. Vector 1188 is 
used as a control vector and did not contain any transcription factor binding site 
It has previously been demonstrated, that the promoters of CALR, GRP78, and GRP94 as well 
as the unusual cytosolic splicing process of an XBP1 intron were affected by the unfolded 
protein response (Llewellyn 1996; Yoshida 1998; Renna 2007; Back 2006; Yoshida 1998; 
Llewellyn 1996, Lee 2002). Therefore, in a second set of vectors, the mentioned promoters as 
well as the SV40 basal promoter were placed in front of the d2eGFP reporter gene (Fig. 48). 
Vector 1188  
(SV40-eGFP control) 
Vector 1192 
Vector 1193 
Vector 1194 
Vector 1195 
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Fig. 48: Overview of used ER stress reporter and control constructs (containing d2eGFP) 
As depicted in Fig. 47 also the ER stress reporter constructs contain a promoterless neomycin resistance gene, a natural promoter 
including their 5’ UTR (w ith the exception of the Kozak sequence) followed by d2eGFP. The w hole cassette is f lanked by 
heterospecif ic FRT-sites (FRTw t and FRT3) enabling their use as RMCE donors. Vector 917 is used as a control vector and 
contains just a SV40 basal promoter follow ed by d2eGFP. 
Finally, an artificial d2eGFP construct was generated, comprising the XPB1 intron (Back 2006; 
Iwawaki 2004) placed between the GFP coding region and the adjacent destabilizing PEST 
element (see chapter 5.2.3 and Li and Coffino 1993). The rationale of this construct was as 
follows: upon ER stress, the XBP1 intron is spliced out, thereby causing a shift in the coding 
sequence, which brings an artificial stop codon in frame with the eGFP sequence. By this 
mechanism, the addition of the PEST signal to eGFP is prevented, resulting in a more stable 
version of GFP. In contrast, without any ER stress splicing is not stimulated and the ribosome 
reads though the artificial stop codon (is not in frame). By this mechanism the PEST sequence 
is fused to the GFP and the protein degradation is accelerated resulting in lower GFP 
fluorescence. 
  
Vector 917 
(SV40-d2eGFP control) 
Vector 1101 
Vector 1103 
Vector 1104 
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Fig. 49: Overview of used ER stress reporter construct (containing an artificial variant of d2eGFP) 
The ER stress reporter construct contain a promoterless neomycin resistance gene, SV40 basal promoter followed by eGFP fused 
on a XBP1 fragment and a PEST sequence (construct as described in chapter 5.2.3). The w hole cassette is f lanked by 
heterospecif ic FRT-sites (FRTw t and FRT3) enabling their use as RMCE donors.  
In accord with the promoter-outside concept (Qiao 2009) all above mentioned ER stress 
reporter and control constructs (Fig. 47, Fig. 48 and Fig. 49) were additionally equipped with a 
promoterless neomycin resistance gene and flanked by two heterospecific FRT-sites enabling 
their use as RMCE donors. Thus, by RMCE the constructs could be specifically integrated into 
pre-defined genomic loci of cell lines tagged with a DsRed acceptor construct. Cells undergoing 
RMCE could then be selected for their persistence in the presence of G418.  
6.6.2. Generation and analysis of ER stress reporter cell lines by RMCE 
In order to identify and establish the best possible ER stress reporter system for antibody 
expression, all constructs described in chapter 6.6.1 were evaluated. For this purpose, each 
vector was introduced into the Master 2A, 2B and 2C as well as into the Mock cell line by 
RMCE, as illustrated in Fig. 37 and Fig. 50. All used cell lines were previously tagged with the 
same DsRed RMCE acceptor construct at the same genomic locus. Therefore, a good 
comparability of the obtained results was ensured, because disturbing influences due to 
different genomic integration sites and varying copy numbers could be excluded.  
 
Fig. 50: Schematic representation of the cassette exchange procedure 
During the cassette exchange procedure, the bicistronic DsRed-IRES-HygTK construct was exchanged by a promoterless reporter 
construct coding for a neomycin resistance gene and a GRP78 promoter follow ed by d2eGFP. After the exchange procedure, the 
neomycin resistance gene was localized behind the SV40E promoter and the gain clones were resistant to G418. 
  
Vector 957  
(RMCE target) 
Vector 1103  
(RMCE donor) 
Vector 1023 
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1 x 106 cells of each cell line were co-transfected with 6 µg of every ER stress reporter or 
control construct and 1 µg vector 673, coding for the Flpo flippase. Two days after transfection, 
all pools were transferred to Medium D3 supplemented with 25 nM MTX and 500 mg/L G418. A 
ganciclovir negative selection as described by Qiao (2009) was not performed. In contrast on 
day 7, all cells were analyzed by FACS and GFP positive clones were isolated by single cell 
sorting as depicted in Fig. 51 and cultivated in Medium C1. 
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GRP94 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
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Fig. 51: FACS analysis and single cell sorting of Master 2 and Mock cell lines after RMCE with ER stress reporter or control 
constructs 
The Mock, Master 2A, Master 2B and Master 2C cell lines were co-transfected w ith a Flpo vector and the indicated ER stress 
reporter or control constructs and cultivated in Medium D3 supplemented w ith 25 nM MTX and 500 mg/L G418. On day 7, all cell 
pools were analyzed regarding DsRed and GFP fluorescence by f low cytometry and GFP positive single clones were isolated by 
sorting as indicated (gate “sorted”). The mean GFP fluorescence [au] of the gated population of each cell pools is depicted below 
each image. 
 
Tab. 41: Overview of analysed pools 
The Mock, Master 2A, Master 2B and Master 2C cell lines were analysed as described in Fig. 51 and the ratio between the whole 
population and the gated population (likely exchanged clones) was calculated. 
Exchanged 
clones [%]
Exchanged 
clones [%]
Exchanged 
clones [%]
Exchanged 
clones [%]
 Mock Rep  Master 2A Rep  Master 2B Rep  Master 2C Rep
SV40-eGFP
control 17 6 6 7
3 x ERSE I 20 9 8 9
3 x ERSE II 18 5 6 4
3 x UPRE 18 5 6 5
3 x AARE 19 5 5 7
SV40-d2eGFP
control 3 2 2 2
Intron 6 2 4 3
CALR 12 4 5 6
GRP78 13 3 3 4
GRP94 8 3 5 4  
After single cell sorting all 431 grown clones were expanded in Medium D3 containing 25 nM 
MTX and 500 mg/L G418 and analyzed for correct cassette exchange. Correct cassette 
exchange means that the DsRed RMCE acceptor construct is removed and authentically 
replaced by the donor construct and that no random integration events occurred. In order to 
verify this, genomic DNA of all clones was prepared and subjected to PCR analysis (see 
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chapter 5.2.5). Authentic exchange events, unexchanged clones and random integrations of the 
donor construct could be detected by using appropriate primer pairs as schematically depicted 
in Fig. 52. The obtained results are exemplified in Fig. 52 based on a small number of clones. 
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Fig. 52: PCR analysis of Mock and Master 2 cell clones exchanged with ER stress reporter or control constructs 
The Mock, Master 2A, Master 2B and Master 2C cell lines w ere subjected to RMCE using different ER stress reporter or control 
constructs followed by the isolation of GFP positive clones by cell sorting. As described in chapter 5.2.5, genomic DNA w as 
prepared from all grown clones and analyzed by PCR using specif ic primer pairs to identify authentic exchange events (A), 
unexchanged clones (C) and random integrations of the donor construct (E). The obtained results are exemplif ied based on a small 
number of clones (B, D and F). Authentically exchanged clones, which showed no additional random integrations are highlighted by 
red arrows. 
Upon analysis of all samples, 174 clones were identified, that showed authentic exchange and 
no additional random integrations (see Tab. 42). They were referred to as Mock Reporter, 
Master 2A Reporter, Master 2B Reporter, and Master 2C Reporter and used for further 
experiments. 
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Tab. 42: Overview of clones with authentic exchanged reporter or control constructs (174 clones) 
Detailed information about these clones is shown in Fig. 64 
Number 
of clones
Number 
of clones
Number 
of clones
Number 
of clones
 Mock Rep  Master 2A Rep  Master 2B Rep  Master 2C Rep
SV40-eGFP
control 4 8 5 10
3 x ERSE I 1 6 5 3
3 x ERSE II 1 3 0 3
3 x UPRE 3 5 7 4
3 x AARE 3 6 4 0
SV40-d2eGFP
control 1 10 4 5
Intron 4 11 4 0
CALR 3 5 6 1
GRP78 7 4 1 7
GRP94 3 9 5 3  
All other clones were not exchanged or contained randomly integrated ER stress reporter or 
control cassettes. Actually, 14% of these clones were correctly exchanged, but showed 
additional random integrations, whereas 68% were not exchanged and had only random 
integrations. 18% of all clones did not grow in Medium D3 containing 25 nM MTX and 500 mg/L 
G418, these clones were neither exchanged or showed random integrations. 
6.7. Evaluating the influence of antibody expression on ER stress reporter 
constructs 
Different ER stress reporter constructs were evaluated by analyzing the influence of antibody 
expression on the reporter protein level based on the cell lines generated in chapter 6.6.2. For 
this reason, GFP fluorescence of all generated Mock Reporter, Master 2A Reporter, Master 2B 
Reporter, and Master 2C Reporter cell lines was measured by FACS and normalized to the 
corresponding control constructs. This was done on pool level, 7 days after transfection, as well 
as for all isolated and correctly exchanged clones. 
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Fig. 53: FACS analysis of exchanged cell pools derived from Mock and Master 2 cell lines 
The Mock, Master 2A, Master 2B and Master 2C cell lines were co-transfected w ith a Flpo vector and the indicated ER stress 
reporter or control constructs and cultivated in Medium D3 supplemented w ith 25 nM MTX and 500 mg/L G418. On day 7, all cell 
pools were analyzed regarding GFP fluorescence by f low cytometry and the mean fluorescence intensities of the GFP positive 
populations were determined (cf. Fig. 51 gate “sorted”). The obtained values were normalized to the f luorescence of the 
corresponding SV40-eGFP control (A) or SV40-d2eGFP control (B) construct, which was set to 100%. 
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Fig. 54: FACS analysis of Mock and Master 2 cell clones authentically exchanged with ER stress reporter or control 
constructs 
The Mock, Master 2A, Master 2B and Master 2C cell lines were subjected to RMCE using the indicated ER stress reporter or control 
constructs followed by the isolation of GFP positive clones by cell sorting. As described in chapter 5.2.5, all grown clones were 
evaluated for authentic exchange by PCR on genomic DNA (cf. Fig. 52). Correct clones were analyzed regarding GFP fluorescence 
by f low cytometry and the mean GFP fluorescence intensities of the whole populations were determined. The obtained values were 
normalized to the mean fluorescence of the corresponding SV40-eGFP control (A) or SV40-d2eGFP control (B) clones, which were 
set to 100%. The values represent the average of several independent experiments, as summarized in Tab. 42 (detailed information 
is shown in Fig. 64). 
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Basically, similar results were obtained both on pool and clone level (compare Fig. 53 and Fig. 
54), indicating the robustness of the used test system. Moreover, all clones derived from the 
same reporter construct showed similar GFP levels (small standard deviations in Fig. 54), which 
confirms the generation of isogenic subclones by using the RMCE approach.  
As seen in Fig. 53 and Fig. 54, when introduced into the Mock cell line, most ER stress reporter 
constructs mediated increased GFP levels compared to the SV40-eGFP or SV40-d2eGFP 
control constructs just equipped with a basal SV40 promoter. This implies that most tested 
transcription factor binding sites were able to stimulate the activity of the SV40 basal promoter 
and that the natural promoters of CALR, GRP78 and GRP94 showed generally higher 
transcription rates than the SV40 promoter. However, significant differences between Mock and 
Master 2A, 2B and 2C Reporter cell lines could not be observed for any construct with 
exception of the vector containing the GRP78 promoter. In this case, the GFP fluorescence of 
the Master 2A, 2B and 2C Reporter cells was markedly increased when compared to the 
respective Mock cell line and in addition a correlation between GFP fluorescence and antibody 
concentration was observed (cf. Tab. 40).  
From these data it was concluded, that only the GRP78 promoter is stimulated by antibody 
expression and that all other constructs did not show any significant effect and therefore cannot 
be used as reporters for antibody productivity. By way of contrast, the GRP78 ER stress 
reporter construct might represent an adequate detection system to identify clones producing 
high amounts of antibody. 
6.8. Impact of BFA or CSN treatment on ER stress reporter constructs 
So far, the response of the ER stress reporter constructs to antibody expression was only tested 
at moderate productivities (1.6–1.9 g/L in a fed-batch process). Consequently, the extent of the 
stimulation that could possibly be reached by the individual reporter constructs was unclear. In 
order to analyze, whether the used constructs have the potential to indicate also clones with 
higher productivities, increased ER stress was artificially triggered by the ER stress inducing 
reagents Brefeldin A (BFA) and Castanospermine (CSN) (Pollard 2007; Wang 2000; Saul 1985; 
Ahmed 1995). For this purpose, randomly selected Master 2A and Mock Reporter cell lines 
(generated in chapter 6.6.2) were treated with 10 µg/mL BFA or 100 µg/mL CSN for one day 
and the GFP fluorescence was analyzed by FACS. 
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Fig. 55: FACS analysis of Mock and Master 2 Reporter cell lines treated with BFA or CSN 
One Mock and Master 2A Reporter cell clone containing the indicated ER stress reporter or control constructs, respectively, were 
cultivated for one day in Medium D3 under three different conditions: without BFA and CSN, supplemented w ith 10 µg/mL BFA or 
supplemented w ith 100 µg/mL CSN. Subsequently, cells were analyzed regarding GFP fluorescence by f low cytometry and the 
mean fluorescence intensities of the GFP positive populations w ere determined. The obtained values w ere normalized to the mean 
fluorescence of the corresponding SV40-eGFP control (A) or SV40-d2eGFP control (B) clones, which were set to 100%. 
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The CSN treatment did not result in increased GFP fluorescence for any ER stress reporter 
construct with exception of the one comprising the GRP78 promoter. (Fig. 55 A and B). By BFA 
treatment, it was possible to stimulate the Mock and the Master 2A Reporter cells containing the 
3 x ERSE I, 3 x ERSE II and GRP78 constructs (Fig. 55 A and B). Interestingly, in case of the 
Mock GRP78 and Master 2A GRP78 Reporter cells GFP fluorescence was increased up to 6-
fold, when compared to untreated cells. From these results it was concluded, that especially the 
GRP78 reporter system was not maximally stimulated by the present antibody levels and that 
there should be a high potential to detect also clones with clearly enhanced productivities. 
6.9. Establishment of a novel ER stress based selection system for the isolation of 
high-producing clones 
In the preceding chapters, the GRP78 promoter was identified as most promising response 
element to establish a novel selection system for high-expressing clones based on ER stress. In 
the last part of the present thesis, this system was evaluated regarding its suitability to identify 
and isolate high producers. For this purpose, in a first step, a stable reporter cell line was 
created by the integration of a construct comprising GFP, driven by the trunc GRP78 promoter. 
In contrast to the previously applied reporter construct, this time a truncated promoter region 
and the more stable eGFP were used, resulting in an improved performance (data not shown). 
Furthermore, no FRT-sites were included in order to keep the possibility of RMCE for potential 
future applications. In a second step, the created reporter cell line was subjected to a standard 
cell line development procedure employing an expression construct for a model antibody (both 
steps are depicted in Fig. 56). Finally, the obtained clones were analyzed with regard to a 
potential correlation between productivity and GFP fluorescence. 
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Fig. 56: Schematic representation of the generation of the trunc GRP78 Reporter cell line stably expressing a recombinant 
antibody 
For the generation of the reporter cell line, 1 x 10
6
 CHO DG44 cells were transfected with 10 µg 
of circular vector 527 (see Fig. 57). 
 
Fig. 57: Schematic representation of vector 527 
One day after transfection, cells were transferred into Medium D2 containing 250 mg/mL G418 
and subcultivated every 3 to 4 days, in the same medium. After 26 days, the G418 
concentration was reduced to 100 mg/mL and GFP positive single clones were isolated by 
FACS. The 13 best-growing clones were expanded in Medium D2 containing 100 mg/mL G418 
and analyzed by flow cytometry regarding their GFP fluorescence. One clone showing a 
suitable GFP fluorescence, a very high viability and good growth behaviour was chosen and 
referred to as trunc GRP78 Reporter cell line (Fig. 58). 
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Fig. 58: FACS analysis of trunc GRP78 Reporter cell line 
In order to generate a trunc GRP78 Reporter cell line stably expressing a recombinant antibody, 
the cells were transfected with 7.5 µg of linearized vector 314, coding for a model antibody (see 
Fig. 59). 
 
Fig. 59: Schematic representation of vector 314 
Two days after transfection, cells were transferred to Medium D3 containing 100 mg/mL G418 
and 25 nM MTX and subcultivated every 3 to 4 days in the same medium. After 18 d, these 
cells were subjected to a copy number amplification by increasing the MTX concentration to 300 
nM. After about 14 day, cells had recovered from the treatment and randomly selected single 
cells were isolated by FACS. All grown clones were expanded up to the 6 well scale and 
antibody concentrations were determined by qELISA. Seven clones showing high viabilities, 
good growth behaviour and high cell specific productivities (see Tab. 43) were selected for 
further evaluation in a fed-batch process. 
Tab. 43: Overview of growth and productivity data for selected production clones derived from the trunc GRP78 Reporter 
cell line cultivated under standard conditions 
Clone 42 71 76 94 97 104 115
Viable cell concentration  [105 c/mL] 20.5 15.7 20.7 15.0 30.6 17.2 10.4
Viability [%] 96 93 96 90 97 96 91
Product concentration [mg/L] 46 42 54 42 222 45 30
Cell specific productivity [pg/cell/day] 17 18 20 19 62 18 17  
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As shown in Fig. 60, all clones showed similar viabilities over the whole process, but clearly 
different growth behaviour and product concentrations ranging from 0.5 to 2.1 g/L at day 11. 
The most important results are summarized in Tab. 44. 
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Fig. 60: Fed-batch Experiments w ith selected production clones derived from the trunc GRP78 Reporter cell line 
The indicated production clones, generated based on the trunc GRP78 Reporter cell line w ere subjected to fed-batch experiments. 
During the process all cultures were daily analyzed with regard to viable cell concentration (A), viability (B) and product 
concentration (C). 
Tab. 44: Overview of fed-batch results for selected clones derived from the trunc GRP78 Reporter cell line 
Clone 42 71 76 94 97 104 115
Viable cell concentration on day 8 [105 c/mL] 219 141 271 114 158 310 285
Product concentration on day 11 [g/L] 0.52 1.33 0.56 0.46 2.07 1.25 1.14
Cell specific productivity on day 3 [pg/cell/day] 8 27 12 18 21 13 13  
In order to analyze whether there is a correlation between GFP fluorescence and antibody 
productivity all clones selected in Tab. 43 were analysed by FACS and the GFP fluorescence 
was plotted against viable cell concentration, final product concentration and the cell specific 
productivity observed during the fed-batch process. 
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   B             R2 = 0.63 
 
   C            R2 = 0.67 
 
Fig. 61: Correlation between fed-batch performance (including antibody productivity) and GFP fluorescence in production 
clones derived from the trunc GRP78 Reporter cell line 
7 production clones derived from the tunc GRP78 Reporter cell line w ere analyzed regarding GFP fluorescence by f low cytometry 
and mean fluorescence intensities were determined. In parallel, viabilit ies w ere measured with a CASY cell counter. All clones were 
cultivated in fed-batch experiments and viable cell concentration, product concentrations as well as specif ic productivities were 
determined. For each clone, GFP fluorescences were plotted against viable cell concentration on day 8 (A), product concentrations 
measured on day 11 (B) and cell specif ic productivities calculated on day 3 (C). 
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As expected, no correlation was observed between GFP fluorescence and viable cell 
concentration (Fig. 61 A), whereas both specific productivity (Fig. 61 C) and final product 
concentration (Fig. 61 B) correlated well with the GFP level. These results indicate, that the 
here introduced ER stress reporter system introduced here can be applied to identify and isolate 
high producing clones in a rapid and simple manner, just by measuring their GFP fluorescence. 
Generally, all analyzed clones showed only moderate antibody expression levels. It can be 
assumed that clones with higher productivities could not be isolated because the truncated 
GRP78 reporter system was maximal stimulated by the present antibody levels. In order to 
investigate, whether also clones with higher productivities could be detected by the ER stress 
reporter system, it was evaluated whether a further stimulation of the system was possible. For 
this purpose, clone 42, clone 71 and clone 97 were either cultivated in Medium D6 containing 
50 mg/L G418 and 300 nM MTX or in the same medium additional supplemented with 10 µg/mL 
BFA and 100 µg/mL CSN, respectively, for one day. Subsequently, the mean GFP fluorescence 
was determined by FACS and plotted against the final product concentration obtained in a fed-
batch process as described in Fig. 60. Moreover, the relative mRNA levels of endogenous 
GRP78 were measured by real time RT-PCR for all clones. 
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   A                ▲ R2 = 0.94      ♦ R2 = 0.97 
 
   B                ▲ R2 = 0.91      ♦ R2 = 0.97 
 
Fig. 62: FACS analysis of selected production clones derived from the tunc GRP78 Reporter cell line after treatment with 
BFA or CSN 
Selected production clones derived from the trunc GRP78 Reporter cell line w ere cultivated for one day in Medium D6 containing 
50 mg/L G418 and 300 nM MTX under three different conditions: w ithout BFA and CSN, supplemented w ith 10 µg/mL BFA or 
supplemented w ith 100 µg/mL CSN. Subsequently, cells were analyzed regarding GFP fluorescence by f low cytometry and mean 
fluorescence intensities were determined (see Fig. 65). For each clone, the obtained values w ere plotted against product 
concentrations determined in fed-batch experiments on day 11. (A) Blue rhombi: untreated, red triangles: treated with BFA. (B) Blue 
rhombi: untreated, red triangles: treated with CSN.  
As shown in Fig. 62, GFP fluorescence was clearly increased for all clones upon treatment with 
CSN and BFA. Interestingly, the fluorescence level was raised by a similar factor for all clones, 
independently of the respective basal fluorescence. Consistently, the transcription of GFP78 
was also induced upon treatment with BFA (Fig. 63). The relative GRP78 mRNA level was 
analysed for BFA treated clone 42, clone 71, and clone 97. These levels were compared with 
untreated clones and the results are shown in the following figure. 
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Fig. 63: Real time RT-PCR analysis of selected production clones derived from the trunc GRP78 Reporter cell line after 
treatment with BFA 
Selected production clones derived from the tunc GRP78 Reporter cell line w ere cultivated for one day in Medium D6 containing 
50 mg/L G418 and 300 nM MTX and in Medium D6 medium supplemented 10 µg/mL BFA. Subsequently, RNA was isolated from 
cells and relative mRNA levels of endogenous GRP78 w ere measured by real time RT-PCR and normalized using the neomycin 
resistance gene expression as described in chapter 5.4.6. Fold mRNA level induction represents the ratio of treated to untreated 
cells. The values represent the average of three independent experiments. 
Based on the obtained results it was concluded, that a further stimulation of the reporter system 
can be achieved, which implies that also clones with higher productivities should be detectable.  
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7. Discussion 
7.1. Increase of antibody secretion by signal peptide optimization 
Platform technologies suitable for the development of stable cell lines for the high level 
production of recombinant proteins depend on an efficient expression system. Therefore, many 
efforts have been made to improve existing expression systems, mostly by trying to optimize 
transcription or translation efficiencies or to prevent gene silencing (Bode 2003; Hancock 2000; 
Williams 2005; Kwaks 2005; Zahn-Zabal 2001). However, some approaches also focus on 
downstream processes like protein secretion or folding. In this context, the translocation of 
secretory proteins into the lumen of the endoplasmic reticulum (ER) has been postulated to be a 
limiting step within the classical secretory pathway. Consistently, Knappskog (2007), 
Rance (2010) and Zhang (2005) have demonstrated that protein secretion can be improved by 
alternative signal peptides (signal sequences). Based on these observations, potent signal 
peptides, which result in an enhanced secretion of recombinant antibodies from CHO cells, 
should be identified during the first part of the present study. 
In order to find potent signal peptides, an extensive literature research was preformed and 
16 promising natural signal peptides from different species as well as 3 artificial signal peptides 
(as seen in Tab. 34) were selected and fused to the heavy and the light chain of a recombinant 
model antibody. CHO K1 cells were transiently transfected with corresponding expression 
constructs and the antibody concentration in the culture medium was determined 4 days after 
transfection. Compared to the control signal peptide A2, the cell specific productivity was 
increased by 50-60% using signal peptide B and by 75-100% using signal peptide E in two 
independent experiments. All other analyzed signal peptides resulted in productivities similar to 
or even lower than the control. By co-expressing renilla luciferase as an internal control, it could 
be excluded that the observed effects were due to different transfection efficiencies (Fig. 27 and 
Fig. 28). 
Several obtained results were not in line with the expectations. For example, the used wild-type 
immunoglobulin signal peptides as well as the cystatin-S signal peptide mediated only relatively 
weak secretion, although the latter one was predicted to be the strongest one of 168 signal 
peptides analyzed by the hidden Markov model (Barash 2002). In the same report, the 
azurocidin signal peptide was ranked at position 12, but it clearly outperformed both the 
cystatin-S and the control signal peptide in this study. On the other hand, this observation is in 
good agreement with another study, where the azurocidin signal peptide has been used to 
express various proteins in insect cells and was characterized as very potent (Olczak 2006). 
Surprisingly, all artificial signal peptides, which were designed in order to meet all published 
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requirements for optimal protein secretion, resulted in low or very low antibody expression 
levels. On the other hand, the signal peptide derived from human albumin, which has been 
previously described as very weak when tested in CHO cells (Knappskop 2007; Hesketh 2005 
(WO 2005/001099 A2)), showed the best performance of all analyzed signal peptides. These 
partially inconsistent observations might be explained by the following factors: (i) the 
mechanistic complexity of the translocation process into the ER (comprising signal peptide 
recognition, targeting and translocation as well as signal peptide cleavage), that makes it very 
difficult to predict the efficiency of a signal peptide in silico. (ii) The application of a huge variety 
of test systems and reporter proteins in the literature, which can have a strong influence on the 
performance of a signal peptide. Especially the usage of a dimeric and complex molecule, such 
as a recombinant antibody, during this study complicates the comparison with data from the 
literature, which are often generated with monomeric reporter molecules. Otherwise this fact 
illustrates the importance of the selected secretory protein during this study. 
As shown in chapter 6.1.1, signal peptides B and E fused to the N-terminus of the heavy and 
the light chain of a model antibody mediated a clear increase in secretion efficiency compared 
to the control signal peptide A2. Based on these results it was evaluated whether a further 
improvement of these signal peptides could be achieved through the optimization of their design 
by specific mutations. All introduced mutations were chosen based on literature data and are 
depicted in Tab. 35. For example, in signal peptide E1, an unusual arginine was replaced by 
leucine and in a reverse approach a tyrosine at the same position was replaced by an arginine 
in signal peptide B1, based on the observations of von Heijne 1983. Signal peptide E2 and E3 
were generated in order to create an optimal Kozak sequence (ACC-AUG-G) Kozak (1986 Jan, 
1987). For this purpose, threonine was substituted by alanine or alanine was additionally 
inserted directly downstream of the methionine start codon. In mutant E4, an alanine and in 
mutant E5 a threonine was substituted by leucine within the h-region, because Belin (1996) has 
reported, that the translocation efficiency could be increased by a higher hydrophobicity of the 
h-region. Additionally, the length of the signal peptide was reduced by the deletion (mutant E6) 
or extended by the insertion (mutant E7) of a leucine within the hydrophobic core in order to test 
the influence on the signal peptide cleavage efficiency as described by Nilsson 2002. Finally, in 
mutant E8 the AGG codon of arginine was exchanged by a synonymous CGC codon in order to 
reduce the stability of a secondary mRNA structure, which was predicted by the “AUG_hairpin” 
program (Kochetov 2007). In this way, the efficiency of translation initiation should be improved, 
resulting in enhanced protein synthesis (Baim 1985; Kozak 1986 May; Kozak 1990). 
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All mutated signal peptides were fused to the heavy and the light chain of a model antibody and 
inserted into second generation expression vectors. The constructs were transiently transfected 
into CHO K1 cells and the antibody concentration was measured 3 days after transfection. With 
exception of signal peptide E3, which mediated a similar or slightly lower protein secretion than 
signal peptide E and B, all mutations resulted in clearly decreased productivities compared to 
the corresponding wild-type signal peptides (Fig. 30 and Fig 31). An impact of differing 
transfection efficiencies on the results was excluded by the co-expression of renilla luciferase as 
transfection control. The most likely explanation for the discrepancy between these 
observations and data from the literature are differences in the experimental design. Whereas 
signal peptides were fused to the light and the heavy chain of a recombinant antibody in the 
present thesis, monomeric reporter molecules such as gaussia luciferase, vargula luciferase or 
secreted alkaline phosphatase (SEAP) are used for the majority of all other studies. However, it 
has been reported that the amino acid sequence downstream of a signal peptide can affect its 
efficiency (Folz 1986; Andrews 1988; Wiren 1988). Additionally, literature data were generated 
with different cell lines from various organisms, which might be often not comparable to CHO 
suspension cells. 
In transient transfection experiments, signal peptide B, E and E3 were the most potent ones and 
it was observed that transient antibody expression levels and the productivity of the 
corresponding stable cell line often do not correlate (Rance 2010; Kalwy 2006). Hence, it was 
necessary to analyze the performance of the signal peptides in stably expressing cells, in order 
to find out whether they can be applied to increase the productivity of cell lines. For this 
purpose, signal peptide B, E, E3 and A2 (control) were fused to a recombinant model antibody 
and inserted into third generation expression vectors. The generated constructs were employed 
for a standard cell line development based on DG44 cells and the dhfr selection system by 
using the mini-pool method. At the 6 well level, the cell specific productivities of all obtained 
mini-pools were determined and the top 20 were selected for each signal peptide. These were 
transferred to Production°Medium, expanded to shake flask level and analyzed again regarding 
their productivity. As shown in Tab. 37 and Fig. 33, for all mini-pools good growth behaviour and 
similar viabilities were observed at the 6 well and shake flask level, independent of the signal 
peptide used. Finally, all mini-pools were subjected to a fed-batch production process of 
13 days. The fed-batch experiment was of great importance, because the commercial suitability 
of an expression cell line is determined by its performance in a production process, especially 
by the achieved final product concentration. Furthermore, it has been reported, that the cell 
specific productivity of a cell line is not always consistent with the product concentration 
obtained during a fed-batch process (Birch 2006). 
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Fig. 33 and Fig. 34 shows, that all tested signal peptides clearly outperformed the control (A2) 
regarding the measured product concentration. As expected, generally higher cell specific 
productivities were determined at the 6 well level in Medium D3 than at shake flask level in 
Production°Medium (Fig. 32). This can be explained by increased evaporation and inferior  
growth conditions in 6 well plates and Medium D3, respectively. The best results were obtained 
for signal peptide B, which mediated an average cell specific productivity of 40 pg/cell/day with 
some mini-pools reaching up to 90 pg/cell/day (Fig. 32). Signal peptide E and E3 showed 
average values of 20-30 pg/cell/day, whereas about 10 pg/cell/day were measured on average 
for signal peptide A2 (Fig. 32). On the last day of the fed-batch experiment, an average final 
concentration of 1.6 g/L was obtained for signal peptide B, whereas 1.2 g/L was reached with 
signal peptide E and E3 and only 0.7 g/L with signal peptide A2. Moreover, top productivities of 
3.3 and 4 g/L were observed for mini-pools derived from signal peptide B (see Fig. 34). 
Interestingly, there was quite a good overall correlation between the fed-batch results, the cell 
specific productivities determined at shake flask and 6 well level and even the transient 
expression results.  
In conclusion, the combined data indicate that particularly signal peptide B, but also signal 
peptide E and E3 can be used to generate cell lines with clearly improved production rates 
suitable for commercial purposes. According to the literature, such cell lines should reach cell 
specific productivities of at least 20 pg/cell/day (Chusainow 2009; Wurm 2004; Borth 2000; 
Fann 2000; Huang 2007; Jiang 2006; Lattenmayer 2007; Birch 2005) and during a typical 
production process based on a clonal CHO cell line 1-5 g/L antibody should accumulate within 
14 days (Schlatter 2010 Sep; Birch 2005; Kelley 2009 Sep-Oct; Trexler-Schmidt 2009; Gagnon 
2010 Lindgren 2009; Kennard 2006). The fact, that both requirements could be met with mini-
pools instead of clonal cell lines and in a non-optimized fed-batch process makes the potency of 
the investigated signal peptides even more obvious. 
7.2. Development of an alternative selection system for high producing clones 
It has been reported, that the selection of a high-expressing clone is a particularly labor-
intensive and time-consuming step during the development of cell lines for the manufacturing of 
recombinant proteins (Borth et al. 2000; Carroll 2004; Birch 2006). One of the main challenges 
is the identification and isolation of rare high producer clones out of the vast majority of low- and 
medium-expressing clones. Therefore, efficient platform technologies have to allow the 
selection of high-producing cell lines in a fast and simple way. Interestingly, the overexpression 
and accumulation of unfolded proteins in the ER triggers different pathways like the unfolded 
protein response (UPR) or the ER overload response (EOR). During this process, the protein 
load of the ER is measured and genes related to protein modification, folding or degradation as 
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well as genes for the amino acid transport and many other genes are activated (Rao 2004; 
Kaufman 1999; Kozutsumi 1988; El-Hadi 2005). In this context, it was one aim of the present 
study to develop a novel selection method which uses ER stress pathways for rapid 
identification and isolation of high-expressing production clones. 
It has been reported, that the promoters of CALR, GRP78 and GRP94 as well as the cytosolic 
splicing of the XBP1 intron are stimulated by the unfolded protein response (Llewellyn 1996; 
Yoshida 1998; Renna 2007; Back 2006; Yoshida 1998; Lee 2002). During the first set of the 
experiments, it was investigated whether these ER stress elements could be activated by the 
overexpression of a recombinant model antibody and particularly whether there is a correlation 
between the extent of stimulation and the antibody expression rate. Hence, the levels of CALR, 
GRP78, GRP94 and spliced XBP1 mRNA of CHO DG44 wild-type cells and 8 clones with 
different antibody productivities were determined by real time RT-PCR. As depicted in Fig. 38, 
transcription of GRP78 and GRP94 as well as the cytosolic splicing of XBP1 were stimulated in 
an antibody-dependent manner, whereas no correlation was observed for CALR. These results 
suggested, that the promoters of GRP78 and GRP94 as well as an intron-containing XBP1 
fragment could be used as response elements for the detection of clones producing high 
amounts of antibody. Moreover, it has been reported, that especially the transcription factor 
binding sites ERSE I, ERSE II, UPRE and AARE, which are also present in the tested 
promoters, are important for the ER stress response (Yoshida 1998; Roy 1999; Kokame 2001; 
Wang 2000; Ma 2004). Consequently, these binding sites could be also employed for the 
identification of high producers. 
Therefore, the transcription factor binding sites ERSE I, ERSE II, UPRE, AARE as well as the 
promoter regions of CALR, GRP78, GRP94 and an intron-containing XBP1 fragment were used 
to create 8 different ER stress reporter constructs as shown in Fig. 47, Fig. 48 and Fig. 49. The 
rationale for these constructs was to develop a reporter system that allows the rapid and simple 
identification and isolation of high-producing clones only based on GFP fluorescence 
(exemplified shown in Fig. 35). In order to establish a detection system for high-expressing 
clones, the most suitable ER stress reporter construct had to be determined. Therefore, all 
generated constructs were compared regarding their response to antibody expression. For 
these experiments, several antibody producing cell lines (Master 2A, 2B, 2C) and one mock cell 
line, all containing a genomically anchored DsRed RMCE construct, were generated as 
depicted in Fig. 36. Subsequently, the ER stress reporter constructs (see Tab. 45) were 
introduced into each cell line by targeted integration (RMCE), clones were isolated and 
authentically exchanged clones were evaluated with regard to GFP fluorescence.  
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Tab. 45: Overview about all ER stress reporter and control constructs 
ER stress reporter 
constructs
ER stress reporter 
constructs
SV40-eGFP control SV40-d2eGFP control 
3 x ERSE I XBP1 Intron
3 x ERSE II CALR
3 x UPRE GRP78
3 x AARE GRP94  
By using RMCE, reliable and comparable results were obtained because all reporter and control 
constructs were integrated at the same genomic locus (confirmed by small standard deviations 
in Fig. 54). In this way, misinterpretations due to different gene copy numbers and genomic 
integration sites or disturbing effects, which are sometimes observed during transient 
transfection, could be excluded. Well exchanged clones were isolated by FACS, and the 
correctness of the exchange procedures was proved by an analytical PCR on genomic DNA 
(chapter 6.6.2). The clones were termed Master 2A Reporter, Master 2B Reporter, Master 2C 
Reporter and Mock Reporter cell line. Most ER stress reporter constructs showed an increased 
GFP fluorescence compared to the control constructs (SV40-eGFP and SV40-d2eGFP control). 
Based on these results, it can be concluded that the tested transcription factor binding sites are 
able to stimulate the SV40 basal promoter and the natural promoters of CALR, GRP78 and 
GRP94 are more active than the SV40 basal promoter. However, neither the ER stress 
response elements (ERSE I, ERSE II, UPRE, AARE) nor the CALR and the GRP94 promoter or 
the XBP1 fragment were significantly stimulated by antibody expression (compare Mock and 
Master 2A, 2B, 2C Reporter cell lines in Fig. 53 and Fig. 54). In contrast, the activity of the 
GRP78 promoter was strongly enhanced in antibody producing cells: whereas the Mock 
Reporter clones exhibited an averaged increase in GFP fluorescence of 3.7 fold. In comparison 
the Master 2A, 2B and 2C Reporter clones exhibited an increase between 5.3 and 8.3 fold 
compared to the control cell lines (Fig. 53 and Fig. 54). 
It has been reported, that the accumulation of incompletely assembled immunoglobulin heavy 
chains in the ER (e.g. after transfection of heavy chains in absence of light chains) can activate 
the ER stress pathway (Pahl 1995 Jun; Kaufman 1999) by binding of the luminal ER stress 
sensor GRP78 (BIP) to the heavy chains (Pahl 1999; Hendershot 1987; Kaloff 1995; Haas 
1983; Bole 1986). However, during the present study, ER stress was triggered by the 
expression of both heavy and light chain of an immunoglobulin, which forms a completely 
assembled antibody. Because it has been shown, that GRP78 binds to immunoglobulin light 
chains shortly after their translation (Gardner 1993; Nakaki 1989; Knittler 1992; Lenny 1991), 
this interaction might explain how even the expression of intact antibodies can activate ER 
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stress pathways. Surprisingly, only the GRP78 ER stress reporter construct showed a 
significant stimulation upon antibody expression, whereas all other tested constructs were not 
affected. Mammalian ER stress responses are generally mediated by different cis-acting 
elements such as ERSE I, ERSE II, UPRE and AARE (see Tab. 46 for consensus sequences), 
which are placed within the regulatory regions of several promoters. 
Tab. 46: Cis-acting elements and their consensus sequences 
Cis-acting elements are shown w ith their consensus sequences according to Yoshida 1998; Kokame 2001; Wang 2000; Fafournoux 
2000 and Ma 2004. Notations: R = A or G, K = G or T, N = A or C or G or T 
Cis-acting element Consensus sequence
ERSE I CCAAT-NNNNNNNNN-CCACG
ERSE II ATTGGNCCACG
UPRE TGACGTGR
AARE RTTKCATCA  
Obviously, none of these elements by itself is sufficient to stimulate the transcription of the GFP 
reporter upon antibody expression (cf. 3 x ERSE I, 3 x ERSE II, 3 x UPRE, 3 x AARE reporter 
constructs). The obtained results rather indicate, that a specific combination of response 
elements might be necessary to detect ER stress triggered by antibody production. Such a 
combination could be present in the natural GRP78 promoter, whereas the composition 
contained in the GRP94 and the CALR promoter seem to be inappropriate. Promoter analyses 
show that ERSE I sites are present in the promoters of GRP78, GRP94 and CALR, whereas a 
GGC triplet within the N9 ERSE I spacer (CCAAT-NNNNGGCNN-CCACG) is only found in the 
GRP78 promoter. This GGC triplet has been reported to play an important role in the stimulation 
of ESRE I (Roy 1999). As mentioned above, it can be excluded that the CCAAT-NNNNGGCNN-
CCACG element alone is responsible the stimulation of the GRP78 promoter, because the 
3 x ERSE I construct consists of the same element and was not activated. Furthermore, the 
GRP78 promoter contains 2 UPRE (TGACGGGA and TGACGTAA), one AARE (ATAGCATCA) 
and one ERSE II (ATTGGTCCATG) sites all differing as indicated from the corresponding 
consensus sequences used in the 3 x UPRE, 3 x AARE and 3 x ERSE II constructs. A further 
explanation for the observed results might be that the ER stress triggered by antibody 
expression was only sufficient to stimulate the GRP78 reporter construct but not all other 
constructs. Alternatively, the activation of the GRP78 reporter by antibody production could be 
due to a so far unknown ER stress-independent mechanism, which does not involve the 
mentioned ER stress response elements. 
  
  Discussion 
Page 123 
For the GRP78 ER stress reporter construct, a significant stimulation upon antibody expression 
was observed. Since the analyzed Master 2A, 2B and 2C cell lines showed only moderate 
productivities between 9 and 15 pg/cell/day (resulting in 1.6 to 1.9 g/L in a 15 day fed-batch 
experiment), additional experiments were necessary to evaluate if the system is applicable to 
the identification of high-producers. For that purpose, it should be analyzed whether at higher 
ER stress levels a further stimulation of the reporter constructs was observed. It has been 
shown, that ER stress can be triggered by different drugs such as Brefeldin A (BFA) and 
Castanospermine (CSN). Whereas BFA blocks the exit of secretory proteins from the ER, 
resulting in the activation of UPR and ERO, CSN disturbs the formation of complex N-
glycosylated proteins, thereby activating the UPR pathway (Pahl 1995 Jun; Wang 2000; Saul 
1985; Ahmed 1995). Hence, Mock and Master 2A Reporter cell lines were treated with BFA and 
CSN and the GFP fluorescence was measured (see Fig. 55). With exception of GRP78, none of 
the reporter cell lines was stimulated by CSN, whereas a significant activation was observed for 
the Master 2A 3 x ERSE I, 3 x ERSE II, GRP78 and GRP94 Reporter cell lines. The GRP78 
reporter construct showed the strongest effect, resulting in a 2-3 fold GFP fluorescence upon 
BFA treatment. Compared to data from the literature, this is an unusually strong stimulation of 
GRP78. A possible explanation is, that a very large GRP78 promoter fragment of 1500 bp 
containing almost the whole 5’ UTR was used, whereas others employed shorter fragments for 
their studies (Renna 2007; Li 1993; Yang 1997). Moreover, the GRP78 promoter fragment of 
the present thesis was derived from the chinese hamster (Cricetulus griseus), whereas the 
fragments in other reports were usually isolated from mouse (Mus musculus). Based on the 
obtained results, it was concluded, that especially in case of the GRP78 reporter construct, the 
detection of clones with specific productivities far beyond 15 pg/cell/day should be possible. 
In the last part of this thesis, the suitability of the novel ER stress detection system to identify 
and isolate high-producing clones was evaluated. For this purpose, a cell line was generated by 
stably introducing a reporter construct comprising GFP driven by a truncated GRP78 promoter 
region. Subsequently, the obtained reporter cell line was stably transfected with an expression 
vector encoding a model antibody and MTX amplification was performed. Several clones, 
characterized by different productivities were isolated and analyzed regarding GFP 
fluorescence. As illustrated in Fig. 61, the overexpression of the recombinant antibody resulted 
in an increased activity of the GRP78 reporter construct. Additionally, a strong correlation was 
found between the amount of secreted antibody and GFP fluorescence as well as between cell 
specific productivity and GFP fluorescence. These results indicate, that the used reporter 
system is able to display the level of antibody expression (IgG) in recombinant CHO cells. 
However, the system was only tested with clones with moderate productivities. Therefore, 
further experiments should elucidate, if the system possesses the potential to detect also high-
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producers. For this reason a selection of clones was treated with the ER stress inducers BFA 
and CSN and the GFP fluorescence was determined. Additionally, the mRNA levels of 
endogenous GFP78 were measured by real time RT-PCR. For all clones, a strong stimulation 
both of the reporter system and endogenous GRP78 was observed. Based on these results, it 
was concluded, that the novel ER stress based selection system, developed during this thesis, 
should also be suitable to identify and isolate clones expressing high amounts of antibody.  
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8. Outlook 
In the first part of the present thesis, two natural signal peptides (derived from human azurocidin 
and human albumin) have been found, that mediate highly efficient secretion of a recombinant 
antibody. However, it has been reported, that the efficiency of a signal peptide can be affected 
by the sequence immediately downstream of the peptide. For this reason, further studies are 
required to analyze whether the identified signal peptides can be universally used to improve 
the secretion of any recombinant protein or whether the observed effects are limited to certain 
products. To clarify this issue, the performance of the selected signal peptides will be evaluated 
for a variety of antibodies and non-antibody proteins (e.g. Fc-fusion proteins). Furthermore, 
various propeptides could be tested to enhance the product concentration or to improve the 
quality of the expressed gene of interested. Such propeptides could be also very advantageous 
to ensure a proper signal peptide processing independently of the expressed protein. 
In the second part of this thesis, a novel ER stress based technology for the identification and 
isolation of clones expressing high amounts of antibodies, out of a pool mainly consisting of low- 
and medium-producing cells has been established. The basic principle of the developed method 
is, that a Master GRP78 cell line (harbouring a GRP78 reporter construct) can be transfected 
with a gene of interest for example a recombinant antibody. This leads to the upregulation of the 
GRP78 reporter construct and an increased amount of the reporter gene (GFP) can be detected 
by FACS. Hence, sorting for clones with a very high GFP fluorescence should enable the 
isolation of high productive clones. Further studies are necessary to evaluate the performance 
of this system especially compared to other selection methods such as cell surface staining with 
fluorescently labelled antibodies or co-expression of GFP (analogous to Brezinsky 2003 and 
Enenkel 2008 (US 7384744 G)). Moreover, the applicability of the technology to other 
recombinant antibodies as well as non-antibody products has to be investigated. In order to 
smoothly integrate the system into the existing platform technology, a suitable Master GRP78 
Reporter cell line needs to be identified, which should be characterized by the following 
features: ability to produce high amounts of adequately glycosylated recombinant proteins, good 
growth behaviour in all applied media and low production of toxic metabolic by-products such as 
lactate and ammonium. Finally, the selection procedure has to be optimized by the 
determination of appropriate sorting parameters like the fraction of GFP positive cells, which 
should be isolated, and the ideal time after transfection to perform the sorting procedure 
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9. Appendix 
9.1. FACS analysis of Mock Reporter and Master 2 Reporter cell lines  
SV40-eGFP control 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-1 
 
708 
Clone 30-2 
 
871 
Clone 31-2 
 
795 
Clone 32-2 
 
998 
Clone 29-2 
 
797 
Clone 30-3 
 
801 
Clone 35-1 
 
1353 
Clone 32-4 
 
795 
Clone 29-3 
 
719 
Clone30-5 
 
852 
Clone 35-2 
 
1077 
Clone 36-1 
 
674 
Clone 33-4 
 
826 
Clone 30-8 
 
1055 
Clone 35-3 
 
889 
Clone 36-2 
 
510 
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Clone 30-11 
 
1128 
Clone 35-4 
 
1308 
Clone 36-3 
 
471 
 
Clone 30-12 
 
 
969 
 
Clone 36-4 
 
1013 
 
Clone 30-13 
 
822 
 
Clone 36-5 
 
773 
 
Clone 30-15 
 
829 
 
Clone 36-7 
 
1230 
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Clone 36-8 
 
1066 
   
Clone 36-9 
 
898 
 
3 x ERSE I 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 33-8 
 
1260 
Clone 30-16 
 
1424 
Clone 31-6 
 
1612 
Clone 32-7 
 
1300 
 
Clone 30-17 
 
1868 
Clone 31-7 
 
1602 
Clone 36-10 
 
1202 
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Clone 30-21 
 
1593 
Clone 35-5 
 
3005 
Clone 36-11 
 
1669 
 
Clone 30-24 
 
1474 
Clone 35-6 
 
1479 
 
 
Clone 34-5 
 
2300 
Clone 35-7 
 
2217 
 
 
Clone 34-8 
 
1115 
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3 x ERSE II 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 33-18 
 
1080 
Clone 30-28 
 
1584 
 
Clone 32-8 
 
998 
 
Clone 30-37 
 
1766 
 
Clone 36-13 
 
1015 
 
Clone 34-15 
 
1378 
 
Clone 36-15 
 
1192 
 
3 x UPRE 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-8 
 
658 
Clone 30-39 
 
1086 
Clone 31-12 
 
1166 
Clone 32-9 
 
960 
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Clone 33-22 
 
792 
Clone 30-42 
 
1126 
Clone 35-14 
 
1654 
Clone 36-16 
 
925 
Clone 33-24 
 
923 
Clone 34-19 
 
855 
Clone 35-15 
 
1590 
Clone 36-17 
 
1205 
 
Clone 34-20 
 
1296 
Clone 35-16 
 
1582 
Clone 36-19 
 
756 
 
Clone 34-23 
 
1267 
Clone 35-17 
 
1507 
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Clone 35-18 
 
1561 
 
  
Clone 35-19 
 
1761 
 
 
3 x AARE 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-9 
 
976 
Clone 30-45 
 
1277 
Clone 31-17 
 
864 
 
Clone 33-28 
 
851 
Clone 30-46 
 
1375 
Clone 31-19 
 
856 
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Clone 33-33 
 
879 
Clone 30-49 
 
1374 
Clone 35-22 
 
559 
 
 
Clone 30-50 
 
1451 
Clone 35-25 
 
1060 
 
 
Clone 30-51 
 
1040 
  
 
Clone 34-25 
 
1052 
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SV40-d2eGFP control 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 33-39 
 
108 
Clone 30-53 
 
92 
Clone 31-35 
 
122 
Clone 32-14 
 
103 
 
Clone 30-56 
 
88 
Clone 31-36 
 
150 
Clone 32-15 
 
117 
 
Clone 30-57 
 
104 
Clone 31-37 
 
174 
Clone 36-24 
 
118 
 
Clone 30-59 
 
91 
Clone 35-27 
 
116 
Clone 36-25 
 
66 
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Clone 30-60 
 
89 
 
Clone 36-26 
 
97 
 
Clone 30-63 
 
117 
  
 
Clone 34-28 
 
116 
  
 
Clone 34-29 
 
136 
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Clone 34-35 
 
154 
  
 
Clone 34-38 
 
114 
  
 
Intron 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-14 
 
140 
Clone 30-69 
 
168 
Clone 31-20 
 
285 
 
Clone 29-17 
 
123 
Clone 30-72 
 
175 
Clone 31-23 
 
307 
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Clone 33-44 
 
145 
Clone 30-73 
 
174 
Clone 35-39 
 
205 
 
Clone 33-46 
 
137 
Clone 30-74 
 
241 
Clone 35-43 
 
220 
 
 
Clone 30-75 
 
186 
  
 
Clone 30-77 
 
292 
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Clone 30-78 
 
200 
  
 
Clone 34-40 
 
207 
  
 
Clone 34-41 
 
144 
  
 
Clone 34-42 
 
167 
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Clone 34-44 
 
220 
  
 
CALR 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-21 
 
261 
Clone 30-79 
 
314 
Clone 31-26 
 
306 
Clone 36-27 
 
268 
Clone 29-23 
 
329 
Clone 30-80 
 
267 
Clone 31-27 
 
441 
 
Clone 33-49 
 
327 
Clone 30-81 
 
284 
Clone 31-28 
 
363 
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Clone 30-84 
 
333 
Clone 31-29 
 
334 
 
 
Clone 30-86 
 
297 
Clone 35-45 
 
430 
 
  
Clone 35-48 
 
243 
 
 
GRP78 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-25 
 
602 
Clone 34-53 
 
970 
Clone 31-31 
 
964 
Clone 32-21 
 
752 
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Clone 29-28 
 
448 
Clone 34-55 
 
1147 
 
Clone 32-22 
 
453 
Clone 29-30 
 
506 
Clone 34-58 
 
1080 
 
Clone 32-23 
 
541 
Clone 29-31 
 
585 
Clone 34-60 
 
893 
 
Clone 32-25 
 
739 
Clone 29-32 
 
458 
  
Clone 36-29 
 
781 
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Clone 33-54 
 
448 
  
Clone 36-30 
 
622 
Clone 33-55 
 
553 
  
Clone 36-31 
 
511 
 
GRP94 
Mock Rep Master 2A Rep Master 2B Rep Master 2C Rep 
Clone 29-33 
 
186 
Clone 30-92 
 
177 
Clone 31-33 
 
384 
Clone 32-26 
 
165 
Clone 29-34 
 
119 
Clone 30-93 
 
240 
Clone 35-64 
 
158 
Clone 32-27 
 
205 
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Clone 33-58 
 
175 
Clone 30-95 
 
186 
Clone 35-65 
 
147 
Clone 32-29 
 
175 
 
Clone 30-96 
 
203 
Clone 35-66 
 
269 
 
 
Clone 34-66 
 
269 
Clone 35-67 
 
190 
 
 
Clone 34-67 
 
187 
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Clone 34-69 
 
221 
  
 
Clone 34-70 
 
211 
  
 
Clone 34-72 
 
210 
  
Fig. 64: FACS analysis of Mock Reporter and Master 2 Reporter cell lines 
The Mock Reporter and Master 2 Reporter cell lines were generated and analysed regarding GFP fluorescence by f low cytometry 
as described in chapter 6.6.2 (Fig. 54). All results (mean GFP fluorescence [au]) are depicted below each image. 
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Untreated 
Clone 42 
 
3100 
Clone 71 
 
5130 
Clone 97 
 
6071 
 
 
 
BFA treated 
Clone 42 
 
5494 
Clone 71 
 
7693 
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Clone 97 
 
8437 
 
 
 
CSN treated 
Clone 42 
 
3948 
Clone 71 
 
6896 
Clone 97 
 
7662 
 
Fig. 65: FACS analysis of selected production clones derived from the tunc GRP78 Reporter cell line after treatment with 
BFA or CSN 
The tunc GRP78 Reporter cell line stably expressing a recombinant antibody were generated and analysed regarding GFP 
fluorescence by f low cytometry as described in chapter 6.9 (Fig. 62). All results (mean GFP fluorescence [au]) are depicted below 
each image. 
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9.2. Abbreviations  
5,6,7,8-THF  5,6,7,8-tetrahydrofolate  
7,8-DHF  7,8-dihydrofolate 
AARE   amino acid response element 
ARE   Adenine uridine rich element 
ATCC   American type culture collection 
ATF4   activating transcription factor 4 
ATF6   activating transcription factor 6  
au   arbitrary units 
Becton  Becton Dickinson 
Bethyl   Bethyl Laboratories 
BFA   Brefeldin A 
Bio-Rad  Bio-Rad Laboratories  
BIP    binding immunoglobulin protein 
bp   base pairs 
BSA   bovine serum albumin 
CALR   calreticulin  
CANX   calnexin 
CD    Chemical Defined 
cell strainer tube Polystyrene Round-Bottom Tube with Cell Strainer Cap 5 mL 
CERT   ceramide transfer protein 
Cf.    compare 
CHO   chinese hamster ovary 
CHOP   transcription factor C/EBP homologous protein 
CMV   cytomegalo virus 
c-region  C-terminal region 
CSN   Castanospermine 
d2eGFP  enhanced green fluorescent protein, MODC PEST fusion protein 
dhfr   dihydrofolate reductase gene 
DNA   Deoxyribonucleic acid 
dsDNA  Double stranded DNA 
DSMZ   German Collection of Microorganisms and Cell Cultures 
DsRed   Discosoma sp. red fluorescent protein 
E. coli   Escherichia coli 
E.Bühler  Edmund Bühler 
e.g.   for example 
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eGFP   enhanced green fluorescent protein 
eIF2   eukaryotic translation initiation factor 2  
ELISA   enzyme linked immunosorbent assay 
EOR   ER overload response 
ER   endoplasmic reticulum  
ERAD   ER associated degradation 
ERSE   ER stress element 
FA   folic acid 
FACS   fluorescence activated cell sorting 
FB Serum  Fetal Bovine Serum 
Fig.    figure 
FRT 3   flip recombinase target mutant 3 
FRT wt  flip recombinase target wild-type 
G418   G-418 Sulphate 
GC content  guanine cytosine content 
gDNA   genomic DNA 
GFP   green fluorescent protein 
Gln   L-Glutamine 
Gly   Glycine 
GOI   gene of interest 
Greiner  Greiner bio-one 
GRP78   glucose regulated protein 78 kDa  
GRP94  glucose regulated protein 94 kDa 
GTN   GFP, thymidine kinase, neomycin phosphotransferase fusion protein 
h   hour 
HC   Heavy Chain 
Herolab  Herolab Laborgeräte 
HPLC   High Pressure Liquid Chromatography 
h-region  hydrophobic core 
hRluc   Renilla luciferase gene 
HRP   horse radish peroxidase 
HT supplement hypoxanthine, thymidine supplement 
HygTK   hygromycin, thymidine kinase fusion gene  
IgG   immunoglobulin G 
IRE1   inositol requiring enzyme 1  
IRES   internal ribosome entry site 
JNK    c-Jun N-terminal kinase  
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ϰ   kappa 
kb    kilo base 
LB   Luria Bertani 
LC   light Chain 
MARs   matrix attachment regions 
min   minute 
MODC   murine ornithine decarboxylase  
mRNA   messenger RNA 
MTX   methotrexate 
NEB   New England Biolabs 
Neo   neomycin phosphotransferase gene 
NF   nuclear factor  
nqELISA   non-qualitative ELISA 
n-Region  N-terminal region 
OD   Optical density 
Omega  Omega Bio-Tek 
ON   Oligonucleotide 
PAA   PAA Laboratories 
PAC   puromycin N-acetyl transferase 
PBS   Dulbecco's phosphate buffered saline 
PCMV   cytomegalo virus promoter 
PCR   polymerase chain reaction 
PDI   disulfide isomerase  
PERK   PKR-like ER kinase 
PEST   proline, glutamic acid, serine, threonine rich sequence 
PID   protein disulfide isomerase  
PKR   Pancreatic eIF2a kinase 
PRL   renilla specific product concentration 
PSV40   Simian virus 40 promoter 
PSV40E   Simian virus 40 promoter with enhancer 
PTK   thymidine kinase promoter 
qELISA,  qualitative ELISA 
QP   cell specific product concentration 
R2   Coefficient of determination 
Rep   Reporter 
RLU   Relative Light Units 
RMCE   recombinase mediated cassette exchange 
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RNA    ribonucleic acid 
Roth   Carl Roth 
rpm   rounds per minute 
RT-PCR  real time PCR 
s   second  
SP   Signal peptide 
SR   Spacer region (unique nucleotide sequence) 
SRP   signal recognition particle 
STAR   stabilizing and antirepressor element  
SV40   Simian virus 40 
SV40E  Simian virus 40 with enhancer 
Tab.   table 
TB   Terrific Broth  
TBE   Tris-borat-EDTA 
TC Plate  tissue culture plate 
TF   Transcription factor 
Thermo  Thermo Scientific 
TK   thymidine kinase  
TM   Hybridization Temperature 
TRAM protein  translocating chain-associated membrane protein 
Tris   Tris[hydroxymethyl]aminoethane 
U   unit (enzyme activity) 
UCOEs  ubiquitous chromatin opening elements 
UPR   unfolded protein response 
UPRE   unfolded protein response element 
UTR   untranslated region 
VCD   viable cell density (viable cell concentration) 
WFI   water for injection  
Wt   wild-type 
XBP1   X-box binding protein 1 
XBP1(sp.)  spliced X-box binding protein 1 
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